Structural and functional analysis of Coxsackievirus protein 2B: a molecular genetic approach by Kuppeveld, F.J.M. van
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/123881
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
Structural and Functional Analysis 
of Coxsackievirus Protein 2B 
a molecular genetic approach 
Frank J. M. van Kuppeveld 

Structural and Functional Analysis 
of Coxsackievirus Protein 2B 
a molecular genetic approach 
een wetenschappelijke proeve op het gebied 
van de Medische Wetenschappen 
Proefschrift 
ter verkrijging van de graad van doctor 
aan de Katholieke Universiteit Nijmegen 
volgens besluit van het College van Decanen 
in het openbaar te verdedigen op 
donderdag 13 maart 1997 
des namiddags om 1.30 uur precies 
door 
Franciscus Johannes Maria van Kuppeveld 
geboren op 25 augustus 1965 
teOss 
Promotor: Prof. Dr. J.A.A. Hoogkamp-Korstanje 
Co-promotores: Dr. W.J.G. Melchers 
Dr. J.M.D. Galama 
Manuscriptcommissie: Prof. Dr. J.J.H.H.M. de Pont 
Prof. Dr. P.J.M. Rottier (UU) 
Prof. Dr. W.J.M. Spaan (RUL) 
Cover illustration: 
Electron microscopic photograph of the enleroviral replication complex containing protein 2B at the 
outer surface of the virus-induced membrane vesicles. Protein 2B was visualized by immuno-
cytochemical labeling with antibodies against 2B and colloidal gold. The photograph was kindly 
provided by Dr. K. Bienz, University of Basel, Switserland. 
The research presented in this thesis was carried out at the Department of Medical Microbiology of the 
University of Nijmegen, The Netherlands 
All published papers were reprinted with permission and credit to their resource. 
CIP Data, Koninklijke Bibliotheek, Den Haag 
van Kuppeveld, Franciscus Johannes Maria 
Structural and functional analysis of coxsackievirus protein 2B / 
Franciscus Johannes Maria van Kuppeveld. - [S.l. : s.n.]. - 111. 
Thesis Katholieke Universiteit Nijmegen. - With réf. - With summary in Dutch. 
ISBN 90-9010179-9 
Subject headings: enterovirus / RNA replication / virus-host interactions 
1997 
Offset: Ponsen & Looijen b.v. 
2B or not 2B, that is the question 
vrij vertaald naar William Shakespeare (1564 - 1616) 

Contents 
Preface 7 
Chapter 1 General introduction 11 
Chapter 2 Genetic analysis of a hydrophobic domain of Coxsackie B3 21 
virus protein 2B: a moderate degree of hydrophobicity is 
required for a cz's-acting function in viral RNA synthesis 
Chapter 3 Coxsackie В 3 virus protein 2B contains a cationic amphipathic 35 
helix that is required for viral RNA replication 
Chapter 4 Structure-function analysis of Coxsackie B3 virus protein 2B 51 
Chapter 5 Mutagenesis of the Coxsackie B3 virus 2B/2C cleavage site: 61 
determinants of processing efficiency and effects on viral 
replication 
Chapter 6 Chimeric Coxsackie B3 virus genomes that express hybrid 75 
coxsackie-poliovirus 2B proteins: functional dissection 
of structural domains involved in RNA replication 
Chapter 7 Coxsackievirus protein 2B is a viroporin 85 
Chapter 8 Summary and general discussion 103 
Chapter 9 Samenvatting (Summary in Dutch) 109 
Dankwoord (Acknowledgments) 115 
Curriculum vitae 117 
List of publications 118 

Preface 
Enteroviruses are common human pathogens that usually cause an acute infection. These viruses 
may, however, be involved in chronic diseases such as polymyositis/dermatomyositis, idiopathic 
dilated cardiomyopathy, and juvenile (type I) diabetes mellitus. Two different mechanisms have 
been proposed to explain an involvement of enteroviruses in the etiology of these chronic diseases; 
1) The virus may cause a persistent infection; 
2) The virus may induce an autoimmune process in the organs or tissues affected. 
Both possibilities are under investigation at the Virology Section of the Department of Medical 
Microbiology, University Hospital Nijmegen. 
Usually, enterovirus reproduction results in cell death within a short time. This excludes a chronic 
course of infection. A persistent infection may therefore reflect an alteration in virus reproduction. 
The process of viral replication itself and the alterations in cellular functions and structures that 
take place during virus reproduction are still incompletely understood. This thesis was undertaken 
to gain more insight into these issues. As an approach, the structure and function of one of the viral 
proteins involved in virus reproduction was investigated. 
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General Introduction 
During the enteroviral life cycle, a number of com­
plex activities must be performed and coordinated 
These include receptor binding, cell entry, virion uncoat-
ing, synthesis and proteolytic processing of a polypro-
tem, replication of the plus-strand RNA via a minus-
strand intermediate, virion assembly, and cell lysis Dur­
ing infection, enteroviruses induce a number of altera­
tions in cellular functions and structures, most of which 
serve to facilitate viral replication In this chapter, an 
overview will be given of the genetic organization of the 
viral genome, the replication cycle, the virus-induced 
modifications of host cell functions and structures, and 
the functional roles of the nonstructural proteins in virus 
reproduction 
GENETIC ORGANIZATION OF THE VIRAL 
GENOME 
The genus Enterovirus belongs to the family of the 
Picornavindae, a group of small, nonenveloped RNA 
viruses that contain a single-stranded RNA genome of 
about 7,500 to 8,000 nucleotides Other viruses that 
belong to this family are the rhinoviruses, cardioviruses, 
aphtoviruses, and hepatovirus Replication and genome 
organization of the enteroviruses and rhinoviruses ap­
pear to be basically similar, but genomic organization of 
the cardioviruses, aphtoviruses, and hepatovirus differs 
in a number of aspects (47) 
The genus Enterovirus consists of polioviruses, Cox­
sackie group A and В viruses, ECHO viruses, and sever­
al distinct enterovirus serotypes Despite their great 
divergence in tissue tropism and in disease syndromes 
they produce, these viruses share a striking similarity in 
virion structure, gene organization, and replication cycle 
Enteroviruses are possibly the best known of all viruses 
due to the extensive studies on pohovirus (77) Due to 
the advances in molecular biology much has been leamt 
during the last 15 years about the structure, molecular 
organization and expression of the enteroviral RNA 
genome Milestones in enterovirus genetic research were 
the cloning of a pohovirus cDNA and the elucidation of 
its genetic map (36, 62), and the finding that cDNAs and 
copy RNA transcripts were infectious when transfected 
into cultured mammalian cells (63, 75), discoveries that 
created the possibility to construct and test genetically 
manipulated RNA genomes A genetic map that is typi­
cal of all enteroviruses is shown in Fig 1 The enterovi­
ral RNA (± 7,500 nucleotides) is of plus-strand polarity 
and is thereby equivalent to cellular mRNAs A viral 
protein VPg (virion protein, genome linked) is cova-
lently attached to the 5' end and a genetically encoded 
polyadenosine tail is present at the 3' end of the RNA 
The large open reading frame is preceded by an unusual­
ly long 5' noncoding region and followed by a short 3' 
noncoding region 
The 5' noncoding region contains about 750 nucleo­
tides upstream of the AUG codon used for the initiation 
of translation in vivo This region is highly structured 
and possesses multiple noninitiating AUGs Genetic 
studies suggest that the higher order structures in this 
region are required for functions in replication, trans­
lation, and neurovirulence Mutational analysis and 
chemical and enzymatic probing of the first 100 nucleo­
tides have shown that a cloverleaf secondary structure is 
crucial for viral replication and that such a structure is 
functional in plus-strand RNA synthesis (2) Further­
more, this region harbors a novel c/j-acting genetic 
element called the internal ribosome entry site (1RES) 
This element, which is composed of multiple cloverleaf 
and stem-loop structures, has been identified in all 
Picornavirus genera and drives internal initiation of 
translation by allowing a cap- and 5'-mdependent entry 
of ribosomes (33, 57) Mutations in this element have 
been found to attenuate neurovirulence, possibly due to 
their effect on translational efficiency (70, 71) Attenu­
ated pohovirus strains have been successfully applied as 
vaccines in the fight against poliomyelitis (68) 
The viral RNA is monocistronic and directs the syn­
thesis of a polyprotein, a large polypeptide of about 250 
kDa that is proteolytically processed to yield individual 
proteins with different functions The polyprotein encod­
ing region can be divided into three segments The PI 
region, the 5' terminal segment of the viral coding re­
gion, encodes the four structural capsid proteins (VP4, 
VP2, VP3, and VP1, from 5' to 3') that were identified in 
purified virions The P2 region, the middle segment, en­
codes three nonstructural proteins, 2A, 2B, and 2C The 
P3 region encompasses the carboxy-terminal segment of 
the coding region The nonstructural gene products of 
this region are protein ЗА, 3B, 3C, and 3D For the 
release of these proteins, enteroviruses do not rely on 
cellular proteolytic activities but, instead, encode their 
own proteinases Synthesis of a polyprotein has the 
advantage that genetic elements specifying the regula­
tion of transcription of different genetic units are unnec­
essary and allows the compaction of the RNA genome 
To optimally benefit the minimum of genetic informa­
tion, most viral proteins have multiple functions The 
effective genetic content is further enlarged by the use of 
processing intermediates that have functions in RNA 
replication distinct from those of their cleavage products 
Unlike minus-strand RNA viruses, overlapping open 
reading frames are not exploited 
The 3' noncoding region consists of approximately 
70 nucleotides which, just like the 5' noncoding region, 
are extensively folded Several cloverleaf structures (59), 
a pseudoknot (29, 32), and a loop-loop (kissing) interac­
tion (46) have been proposed The phenotypes of con-
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Figure 1. Schematic structure of the cnleroviral genomic RNA Shown is the 7 5-kb single-stranded RNA genome with a VPg protein 
covalenti) bound at the 5 end of the nontranslated region ( M R ) and the genomic encoded poly(A) tract at the end of the 3 nonlrans-
lated region The protein coding region is shown boxed Iranslalion vields a single polyprotein that is proteolytically processed by the 
viral proteinases 2Арш 3CpTO, and 3CD""° to produce the structural capsid PI region proleins and the individual nonstructural P2 and P3 
region proteins Polyprotein processing yields both the individual proteins as well as some relatively stable processing intermediates 
with functions in viral replication distinct from those of their cleavage products 
О 
structs bearing mutations in these domains suggest that 
the higher order structures serve as recognition signals 
for minus-strand RNA synthesis (69) 
R E P L I C A T I V E C Y C L E 
Enteroviruses have a lytic infection cycle (Fig 2) 
Viruses enter the cell via specific cell surface receptors 
Pohoviruses bind to a member of the immunoglobulin 
superfamily (48) Coxsackie В viruses attach to a nucle-
olin-related membrane protein (61) The mtegrin VLA-2 
has been identified as a receptor for ECHO virus (6) 
The mechanisms of entry and uncoating are unknown, 
but uptake probably involves the endocytotic pathway 
(44) Once released in the cytoplasm, the 5'-terminal 
VPg is removed from the genomic RNA by a cellular 
unlinking enzyme (76) The viral RNA then serves as a 
mRNA to direct the synthesis of the polyprotein via an 
IRES-mediated initiation of translation This polyprotein 
is processed by viral proteinases to yield the products 
required for RNA replication Replication starts with the 
synthesis of a complementary minus-strand RNA in the 
cytoplasm by the RNA-dependent RNA polymerase 
3DP°', yielding a double-stranded replicative form (4) 
This process has been proposed to involve (ι) undylation 
of the 3' poly(A) of plus-strand RNA, presumably by a 
host terminal transferase, (π) hybridization of the re­
sultant oligo(U) to the adjacent poly(A) tail, and (in) 
initiation of minus-strand RNA synthesis at the 3' termi­
nus of the ohgo(U) by a template-priming mechanism 
(22) Plus-strand RNA synthesis takes place in replica­
tion complexes, specialized structures composed of 
partially double-stranded replicative intermediates and 
viral replication proteins The replication complex can 
be found in the center of a rosette formed by many virus-
induced membrane vesicles (Fig 3) These vesicles are 
derived from the rough endoplasmic reticulum (ER) and 
are homologous to the intermediate or transport vesicles, 
which carry proteins to the Golgi apparatus (8) Both 
initiation of viral RNA synthesis and release of RNA 
from the complexes are dependent on the association of 
the replication complex with the vesicles (8) Newly 
synthesized RNA that is released from the replication 
complex may go into another round of translation and 
replication, processes that are tightly coupled, or be 
packaged into capsid proteins to produce infectious virus 
particles Encapsidation, a gradual process that occurs 
via a number of assembly intermediates (67), is highly 
specific since purified virions contain only plus-strand 
viral RNA and exclude VPg-lacking plus-strand viral 
mRNA, VPg-containing minus-strand viral RNA, as 
well as rRNA, tRNA, and other cytoplasmic mRNAs 
(77) This specificity is indicative for the occurrence of 
an encapsidation signal Extensive mutagenesis of VPg 
(ι e , protein 3B) did not reveal any packaging mutants 
(77) It is therefore presumed that a cu-acting RNA 
segment provides packaging specificity The mechanism 
employed to induce cell lysis, a process required to re­
lease virus progeny, is completely unknown 
MODIFICATIONS OF HOST CELL FUNCTIONS 
AND STRUCTURES 
During enterovirus infection, the host cell undergoes 
dramatic metabolic and morphological changes One of 
the most saillant effects is the inhibition of cap-depend-
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Figure 2. Overview of the enteroviral life cycle. Infection starts with binding of the virus to a specific receptor at the outer membrane of 
the cell. After cndosomal uptake, the viral RNA is released and translated to produce a large polyprotein. Proteolytic processing of this 
polyprotein yields the structural capsid proteins and the nonstructural proteins implicated in RNA replication. For RNA replication, the 
genomic RNA is used as a template to synthesize a complementary minus-strand RNA, which, in turn, is transcribed into new molecules 
of virion RNA. Newly formed plus-strand RNAs are packaged into capsids to produce new viruses. Cell lysis is induced to release virus 
progeny. 
ent translation of cellular mRNAs (20). Translation of 
enterovirus RNA, one of the few RNAs that can be 
translated in the infected cell (54) is not affected because 
it is initiated by a cap-independent internal binding of 
ribosomes to the 1RES in the 5' noncoding region. Most 
likely the virus inhibits cellular translation to recrute all 
ribosomes for the translation of the viral genome. The 
virus inhibits cellular RNA synthesis (28) by inactivat­
ing transcription factors required for RNA polymerases 
I, II, and III (13, 14, 66). The plasma membrane be­
comes permeable for monovalent cations and small 
translation inhibitors that are normally nonpermeative 
(10). Of the morphological changes, the most prominent 
is the massive accumulation of small, cytoplasmic mem­
brane vesicles with which the replication complexes are 
associated (8). This membrane proliferation starts with 
the formation of membrane protrusions at the rough ER, 
which then grow into membranous vesicles. The inhibi­
tion of viral replication by Brefeldin A, a fungal meta­
bolite that blocks ER-to-Golgi traffic by preventing the 
formation of transport vesicles, suggests that an intact 
secretory pathway function is required for the generation 
of the vesicles (30, 45). The activities of phospholipases 
С and A2 are modified (25) and phospholipid synthesis 
is enhanced (52), presumably to account for the prolifer­
ation of the membrane vesicles. Inhibitors of lipid syn-
Figure 3. F.lectron microscopic photograph of a replication 
complex surrounded by and attached to a rosette of virus-
induced membrane vesicles. Immunocytochemical labeling with 
anti-2B and colloidal gold shows that protein 2B is localized at 
the outer surface of the membrane vesicles. This structure was 
isolated from poliovirus-infected Hep-2 cells by sucrose step 
gradient centrifugation at 4 h postinfection and negatively stained. 
The photograph was kindly provided by dr K. Bienz. University 
of Basel. 
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thesis abolish viral replication, suggesting that the for­
mation of the membrane vesicles is at least in part a 
result of de novo synthesis (24). Whether the virus-
induced inhibition of vesicular protein transport between 
the ER and medial Golgi compartments (17) is responsi­
ble for the accumulation of the vesicles, or merely a 
consequence, is yet unknown. Other virus-induced alter­
ations in cellular architecture are the remodeling of the 
intermediate filament system (41), structural alterations 
of cytoskeletal proteins (34), and the rounding and 
detachment of infected cells from the substrate. Collec­
tively, these biochemical and structural alterations are 
known as the cytopathic effect. 
FUNCTIONS OF NONSTRUCTURAL PROTEINS 
IN VIRAL REPLICATION 
The individual roles of the nonstructural proteins and 
of their precursor products in RNA amplification and 
modification of cellular functions and structures are yet 
poorly understood or even unknown. The functions of 
individual viral gene products have been investigated by 
purification and enzymatic assays in vitro, by analysis of 
well defined mutants, and by expression in bacteria and 
eucaryotic cells. The putative action of each of the non­
structural products will be described. 
Protein 2A. The 2A region codes for a protease that 
is autocatalytically released from the nascent polyprotein 
by rapid cotranslational cleavage at its own amino termi­
nus. Cleavage is a prerequisite for further proteolytic 
processing of the capsid precursor region. A second 
function of 2A is to initiate the cleavage of the p220 
subunit of the ribosomal initiation factor eIF-4F com­
plex, leading to the inhibition of 51- and cap-dependent 
translation of host cell mRNAs but not translation of 
uncapped viral mRNAs (21, 37). Proteolysis of p220 
seems to be necessary but may not be sufficient to com­
pletely inhibit cellular translation, because substantial 
levels of host cell protein synthesis can take place when 
all p220 is degraded (9, 31, 58). Expression of protein 
2A in mammalian cells led to a marked reduction in 
RNA polymerase II transcription and, to a lesser extent, 
to a reduction in DNA replication and translation (16). 
Although it was unclear whether these effects were 
direct or indirect, these results imply the existence of 
further activities of 2A and indicate how mechanisms 
other than p220 cleavage might contribute to the com­
plete shutoff of host protein synthesis in infected cells. 
Another role of 2A may be as a specific enhancer of 
viral mRNA translation (26). Second-site compensating 
mutations mapping in 2A have been isolated in response 
to mutations in the 1RES element (43). 7Van,y-activation 
of translation may be important for efficient translation 
of viral mRNAs early in infection, when host mRNAs 
can still compete for the cellular protein synthesis 
machinery. In addition, recent studies suggest that pro­
tein 2A may be involved in RNA replication (51, 78). 
Proteins 2B, 2C, and 2BC. The functions of the 
proteins coded for by the 2B and 2C regions are poorly 
understood. Mutations in either of these proteins led to 
strong defects in RNA replication (35, 42). These pro­
teins, and their precursor 2BC, are contained exclusively 
at the outer surface of the virus-induced membrane 
vesicles at which viral plus-strand RNA synthesis takes 
place (8) (Fig. 3). Protein 2BC seems to be responsible 
for the induction of these vesicles. Electron microscopic 
examination of infected cells in which complete proces­
sing of the polyprotein was inhibited showed a correla­
tion between the accumulation of vesicles and the pres­
ence of detectable levels of this protein (7). Consistent 
with this, it was found that expression of 2BC, but not 
that of 2B or 2C, either individually or in combination, 
induced the formation of membrane vesicles in yeast 
cells (5). Beside 2BC, also 2C was found to induce 
membrane proliferation and vesicle induction in vaccinia 
virus-infected cells, although the vesicles induced by 
protein 2BC were more similar to those that appear 
during virus infection (1, 12). The finding that 2C can 
induce vesicle formation should be taken with caution 
because vaccinia virus modifies the vesicular system 
itself, and complementation of enterovirus gene products 
by vaccinia virus proteins has been reported (55). 
Poliovirus 2B mutants exhibited noncomplementable 
defects in viral RNA replication and displayed a domi­
nance over wild-type virus, suggesting that 2B may 
interact with a limiting factor (e.g., another protein or a 
membrane attachment site) and that 2B, or 2BC, may be 
involved in the formation of a replication complex 
around the same RNA strand from which it is translated 
(35). Expression of protein 2B in either bacteria or 
mammalian cells led to an increased membrane permea­
bility (17, 39). In addition to this modification, protein 
secretion was inhibited in 2B-expressing mammalian 
cells (17). Examination of the subcellular localization of 
a coexpressed secreted protein showed that 2B did not 
block a specific step in membrane transport. Therefore, 
inhibition of protein secretion may be a side effect 
caused by the permeabilization of the plasma membrane 
and/or a nonspecific leakiness of organelle membranes 
(17). 
Protein 2C has also been implicated in the structural 
and functional organization of the viral replication com­
plex. The RNA and membrane binding capacities of this 
protein suggest that 2C, or 2BC, may be responsible for 
the attachment of the viral RNA to the vesicular mem­
branes (19, 65). Biochemical studies have shown that 2C 
possesses ATPase and GTPase activities (49, 64). This 
NTPase activity may reflect a helicase function required 
for viral RNA strand separation during replication. The 
resemblance of 2C with the small GTPases involved in 
regulation of membrane transport, however, suggests 
that 2C may participate in the traffic of the virus-induced 
membrane vesicles (64). 
Proteins ЗА, 3B, and ЗАВ. 3B is usually referred to 
as VPg, the hydrophilic peptide of 22 amino acids cova-
lently linked via tyrosine to the 5' termini of all full-
length and nascent viral plus- and minus-strand RNAs. 
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VPg has been proposed in the initiation of viral RNA 
synthesis. The current view is that an uridylylated form 
of VPg, VPg-pU or VPg-pU-pU, acts as a primer of 
plus-strand RNA synthesis (38, 72). Uridylylation is 
strictly dependent on the presence of intact membranes 
(72). The observation that mutations in ЗА, a hydro­
phobic membrane protein (15), affected uridylylation of 
VPg and selectively inhibited initiation of plus-strand 
RNA synthesis suggests that ЗАВ, i.e., the precursor of 
VPg, may serve as an anchor and a donor for VPg in the 
membrane-associated RNA-synthesizing complex (23). 
VPg is not required for the initiation of minus-strand 
RNA synthesis. The covalent linkage of VPg to the 
minus-strand RNA has been claimed to occur by a self-
catalyzed transesterification reaction which requires only 
the replication intermediate and VPg (73), but this has 
not yet been substantiated by any observation in vivo. 
In addition to its role as anchor and donor for VPg, 
protein ЗАВ has been found to interact with 3CDp,° and 
3DP°' and to serve as a cofactor for (i) the binding of 
protein 3CDpro to the 5' and 3' terminal cloverleafs of the 
RNA genome (27), (¡i) the polymerase activity of ЗО1"1 
(40, 56), and (iii) the autocatalytic processing of 3CDp,° 
to 3Cpro and 3D·"1 (50). 
Protein ЗА, but not ЗАВ, inhibits protein secretion to 
a similar extent as 2B when expressed in mammalian 
cells (17). In contrast to 2B, however, protein ЗА caused 
the accumulation of a coexpressed secreted protein in 
the ER, suggesting that ЗА specifically blocks transport 
from the ER to the Golgi apparatus. 
Proteins 3C, 3D, and 3CD. The 3C region codes for 
a protease (3Cpr") that is responsible for the maturation 
cleavages between the nonstructural P2 and P3 region 
proteins in the precursor polyprotein (18). Proteolysis by 
3Cp'° occurs in an incompletely understood cascade of 
cis- and frans-cleavages mainly at AxxQiG sites (where 
χ may be any amino acid). Cleavage of the PI precursor 
protein, which is cotranslationally released by 2AP">, to 
the individual capsid proteins is performed in trans by 
3CDp,°. There is convincing evidence that 3Cpro, or 
ЗСО
рто
, is responsible for the inhibition of host cell RNA 
transcription by proteolytic inactivation of the TATA-
binding protein subunit transcription factor IID, required 
for RNA polymerases I and II, and transcription factor 
UIC, required for RNA polymerase III (13, 14, 66). 
The 3D region codes for a template- and primer-
dependent RNA polymerase (3DP°I). This polymerase 
accepts any polyadenylated RNA as template in vitro, 
suggesting that the observed specificity in vivo must be 
confered by a yet unknown viral or host component(s) 
(38). A second activity of ЗГУ"' is an RNA hehcase 
activity, suggesting that the RNA duplex unwinding 
activity required for melting the double-stranded RNA 
replicative form may be an intrinsic activity of ЗО1"1 
rather than being provided by protein 2C (11). Further­
more, ЗО
1
"
1
 has been shown to possess terminal adenylyl 
transferase activity (53, 60, 74), suggesting that ЗО1"1 
may be responsible for the uridylylation of Vpg. 
Besides being a proteinase, 3CDpro has been shown to 
be involved in the formation of a ribonucleoprotein com­
plex, together with protein ЗАВ, around the 5' terminal 
cloverleaf in the 5' noncoding region and the higher 
order structures in 3' noncoding region of the viral plus-
strand RNA (2, 3, 27). These ribonucleoprotein com­
plexes are most likely involved in the initiation of plus-
strand and minus-strand RNA synthesis, respectively. A 
model for the membrane-bound initiation of plus-strand 
RNA synthesis in trans has been proposed and involves 
the following steps (3, 27) (Fig. 4); (i) Uridylylation of 
membrane-bound ЗАВ to yield 3AB-pU-pU. (ii) Un­
winding of the 5' end of the replicative form, consisting 
Figure 4. A model for plus-strand RNA synthesis, the trans-
lnitiation mechanism (adapted from Andino et al [3] and Harris et 
al [27]) Three steps of initiation of RNA synthesis are shown 
The upper picture represents a minus-strand (-) acting as a 
template and a resident plus-strand (+) holding the ribonucleopro­
tein complex consisting of the 5' cloverleaf RNA, 3CD, and 
membrane-bound ЗАВ as donor for the primer peptide VPg (ι e , 
3B) The middle picture shows the progress of the reaction after 
VPg-pU(pU) is used as a primer for 3D1"1, stimulated by ЗА, to 
begin the elongation reaction The bottom picture shows that after 
ЗО
1
"
1
 has synthesized at least the first 100 nucleotides of a plus-
strand RNA a new cloverleaf structure will form, allowing the 
formation of a new ribonucleoprotein complex that can then 
catalyze the initiation of the next plus-strand RNA For more 
details, the reader is directed to the text. 
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of the 5' end of the plus-strand and the 3' end of the 
minus-strand, by a helicase activity, (iii) Formation of a 
ЗАВ-ЗСО*"° complex around the plus-strand RNA clo-
verleaf. (iv) Cleavage of the uridilylated form of ЗАВ to 
yield VPg-pU-pU. (v) Initiation of plus-strand synthesis 
in trans by VPg-pU-pU at the 3' end of the neighboring 
minus-strand, (vi) Autocatalytic processing of 3CDP'° in 
as, stimulated by ЗАВ, to activate 30"°'. When plus-
strand RNA synthesis is proceeding, a new 3AB-3CDpro 
complex may form around the 5' end of the newly syn­
thesized plus-strand and catalyze the synthesis of an­
other plus-strand. Initiation of minus-strand RNA syn­
thesis most likely involves a similar mechanism, except 
that priming seems to occur by an oligo(U) driven 
template-priming mechanism (see above) rather than by 
an uridylylated form of VPg. 
AIM AND OUTLINE OF THE THESIS 
In the next chapters of this thesis, experiments are 
described undertaken to study; (i) the functional role of 
enterovirus protein 2B in viral RNA replication and the 
modification of cellular functions and structures, and (ii) 
the structural determinants that are involved in these 
functional activities. 
A detailed computer analysis suggested that 2B is a 
membrane protein and predicted the occcurence of two 
putative transmembrane domains, of which one had the 
potential to form a cationic amphipathic α-helix. An 
extensive genetic analysis of each of these domains was 
performed. Well defined mutations were introduced in a 
full-length cDNA clone of coxsackievirus and their 
effects on virus viability, RNA replication, polyprotein 
synthesis and processing, and complementability in 
trans were examined (chapters 2 and 3). To examine 
whether coxsackievirus 2B is able to inhibit cellular 
protein secretion and increase the permeability of the 
plasma membrane similar as poliovirus 2B does, and to 
identify the essential domains for these activities, both 
wild-type and several mutant 2B proteins were expres­
sed in mammalian cells (chapter 4). A mutational analy­
sis of the 2B/2C cleavage site was performed to study 
the determinants that regulate processing efficiency at 
this site and to examine the effects of altered levels of 
proteins 2B and 2C on viral replication (chapter 5). The 
construction of chimeric coxsackievirus genomes that 
express hybrid coxsackievirus-poliovirus 2B proteins 
was used to further dissect the structural requirements of 
protein 2B for its role in viral reproduction (chapter 6). 
The ability of 2B to increase membrane permeability 
and its localization at the outer surface of the ER-derived 
membrane vesicles suggested that 2B might mobilize 
calcium from ER stores. Therefore, the effect of CBV3 
infection and protein 2B expression on intracellular 
calcium homeostasis was assayed (chapter 7). In addi­
tion, a function of protein 2B in the virus release was 
investigated (chapter 7). In the last chapter, the experi­
mental data described in this thesis are summarized and 
discussed (chapter 8). 
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Genetic Analysis of a Hydrophobic Domain of Coxsackie B3 Virus 
Protein 2B: a Moderate Degree of Hydrophobicity Is Required 
for a cis-Acting Function in Viral RNA Synthesis 
FRANK J M VAN KUPPEVELD, JOCHEM M D GALAMA, JAN ZOLL, AND WILLEM J G MELCHERS 
Department of Medical Microbiology University of Nijmegen The Netherlands 
Coxsackie В virus protein 2B contains near its C-terminus a hydrophobic domain with an 
amino acid composition that is characteristic for transmembrane regions. A molecular genetic 
approach was followed to define the role of this domain in virus reproduction and to study the 
structural and hydrophobic requirements of the domain. Nine substitution mutations were 
introduced in an infectious cDNA clone of Coxsackie B3 virus. The effects of the mutations were 
studied in vivo by transfection of Buffalo green monkey cells with copy RNA transcripts. The 
results reported here suggest that a critical degree of hydrophobicity of the domain is essential for 
virus growth. The mutations S77M, C75M, I64S and V66S, which caused either a small increase 
or decrease in mean hydrophobicity, yielded viable viruses. The double mutations S77M/C75M 
and I64S/V66S, which caused a more pronounced increase or decrease in hydrophobicity, were 
nonviable. Negatively charged residues (mutations А71Б, I73E, and А71Е/Г73Е) abolished virus 
growth. The mutations had no effect on the synthesis and processing of the viral polyprotein. 
Replication and complementation were studied by using a subgenomic coxsackievirus replicón 
containing the luciferase gene in place of the capsid coding region. Analysis of luciferase 
accumulation demonstrated that the mutations cause primary defects in viral RNA synthesis that 
cannot be complemented by wild-type protein 2B provided in trans. The hydrophobic domain is 
predicted by computer analysis to form a multimene transmembrane helix. The proposed 
interaction with the membrane and the implications of the mutations on this interaction are 
discussed. 
The genus Enterovitw,, a subgroup of the Picornavi-
ndae, consists of the polioviruses, coxsackieviruses, 
echoviruses, and enterovirus serotypes 68 to 71 The 
structure, genomic organization, and molecular biology 
of these viruses are relatively well known from the ex-
tensive studies on poliovirus Enteroviruses are positive-
strand RNA viruses with a single-stranded genome of 
approximately 7,500 nucleotides (nt) A small virally 
encoded protein, VPg, is covalently attached at the 5' 
end of the RNA, and a genetically encoded poly(A) tail 
is present at the З'-end (see Fig 2A) The viral genome 
acts as mRNA to direct the synthesis of a polyprotein 
Translation occurs via a cap-independent binding of 
ribosomes to the 5' nontranslated region (19, 32) The 
viral polyprotein is proteolytically processed by the virus 
encoded proteases 2Apo, 3Cpro, and 3CDpro to functional 
cleavage intermediates and the individual proteins The 
proteins encoded by the PI region of the genome are 
capsid proteins The nonstructural proteins encoded by 
the P2 and P3 regions are involved in viral RNA 
(vRNA) replication For more details on the genomic 
structure of enteroviruses, we refer to a recent review of 
Wimmer et al of the genetics of poliovirus (40) 
Replication of the enterovirus RNA genome starts 
with the synthesis of a complementary negative RNA 
strand in the cytoplasm of the host cell b> the RNA-
dependent RNA polymerase 3D1*1 (3) Viral positive 
RNA strand synthesis takes place in replication com­
plexes, which are specialized structures composed of 
partially double-stranded replicative intermediates plus 
the replication proteins (17) Genetic and biochemical 
studies have shown that the proteins encoded by the P3 
region are involved in vRNA synthesis within these 
complexes (40) The replication complexes are closely 
associated with virus-induced membrane vesicles (6) 
Both the initiation ot vRNA synthesis and the release of 
vRNA from the complexes are dependent on these vesi­
cles (7, 37, 38) The inhibition of poliovirus RNA repli­
cation by Brefeldin A, an antibiotic that blocks mem­
brane traffic between the endoplasmic reticulum (ER) 
and the Golgi apparatus and between the cis and trans 
Golgi apparatus, further indicates that intact secretory 
pathway traffic is required for vRNA replication (14, 18, 
28) 
Enterovirus proteins 2B, 2C, and 2BC seem to be 
involved in the functional and structural organization of 
the replication complexes These proteins are rough-ER 
(rER) associated soon after their synthesis and are 
exclusively localized at the cytoplasmic surface of the 
ER-denved membrane vesicles that surround the viral 
replication complex (5, 6, 8) Electron microscopy and 
biochemical studies have shown that protein 2C or its 
precursor 2BC is involved in the attachment of the 
vRNA to the vesicular membranes (7, 9, 35) Further-
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hydropathy of CBV3 protein 2B 
20 40 60 
residue number 
Figure 1 (A) Hydropathy plot of CBV3 protein 2B according 
to Kyle and Doolittle (24) The hydropathv window si¿e used 
for this figure is 9 residues Positive hydropathy indicates a 
hydrophobic nature The numbers of ammo acid residues are 
indicated on the ordinate (B) Alignment of the ammo acid 
sequences of the 2B protein of enteroviruses for which se-
quences are known The enteroviruses are divided in a CBV-like 
subgroup and a pohovirus (PV)-like subgroup Enteroviruses 
with distinct amino acid sequences are shown apart In this 
alignment wc have included the 2B amino acid sequence of five 
nonrelated CBV1 isolates with highly divergent 2AP™ regions 
(41) Virus propagation, RNA extraction, reverse transcription 
amplification by PCR and sequence analysis of the 2B coding 
region of these five CBV1 isolates were performed as described 
elsewhere (41 ) Abbreviations CBV Coxsackie В virus, CAV 
Coxsackie A virus, ECHO, echovirus SVDV swine vesicular 
disease virus CBVlTuc, myolropic CBV1 strain Tucson 
CBVIIsr, strain isolated 23 July 1978 from an immigrant child 
from Israel CBVlNet strain isolated in 1992 from a patient in 
The Netherlands, CBVlCol, strain isolated 1 April 1986 from 
an immigrant child from Colombia, CBVlsur strain isolated 6 
July 1981 from surface water in The Netherlands PVl(M), 
pohovirus type 1 stram Mahoney, PV2(L) pohovirus type 2 
stram Lansing, PV3(L) pohovirus type 3 strain Leon, LV70 
enterovirus type 70 BFV1, bovine enterovirus type 1 
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more, it has been shown that pohovirus protein 2C is an 
NTPase with both ATPase and GTPase activities (29, 
35) The transient expression of pohovirus protein 2C or 
its precursor 2BC in eucaryotic cells resulted in the 
proliferation of cellular membranes and accumulation of 
membrane vesicles in a way similar to that seen during 
virus infection, suggesting that protein 2C belongs to the 
family of small GTPases involved in the regulation of 
membrane traffic Enterovirus protein 2B is a small 
hydrophobic protein which has profound effects on 
cellular membranes Mutations mapping to the N termi­
nus of pohovirus protein 2B exhibited primary defects in 
RNA synthesis (20, 27) These 2B mutants displayed a 
dosage-dependent dominance over the wild-type virus, 
which led to the suggestion that protein 2B plays a struc­
tural role in the viral replication complexes, possibly by 
interacting with a limiting membrane attachment site 
(20) The expression of both pohovirus and Coxsackie 
B3 virus (CBV3) protein 2B in Escherichia coli resulted 
in a modified membrane permeability (26, 39a) Rccent-
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ly, it has been shown that the expression of polio virus 
protein 2B in eucaryotic cells leads to permeabihzation 
of the cell membrane and inhibition of secretory path-
way function (13) These observations suggest that en-
terovirus protein 2B is a membrane-active protein which 
may be involved in the accumulation of membrane vesi-
cles for vRNA replication 
The regions of protein 2B that are involved in the 
interaction with the ER membrane are not yet known 
Membrane anchors are typically composed of mainly 
hydrophobic amino acids and a significant portion of 
serine and threonine residues (15) About 18 amino acid 
(aa) residues are required to span the ER membrane 
(31) Analysis of the hydropathy of CBV3 protein 2B 
according to the method described by Kyte and Doolittle 
(24) demonstrates the existence of two hydrophobic 
domains (Fig 1A) The hydrophobicity of these domains 
is well conserved in all enteroviruses, despite extensive 
differences in ammo acid sequence among members of 
the CBV-like and pohovirus-like subgroups (Fig IB) 
The hydrophobic domain near the C-terminus of CBV3 
protein 2B is composed of a stretch of 18 aa (aa 63 to 
80) which is devoid of charged residues The amino acid 
composition of this hydrophobic domain is characteristic 
for transmembrane domains, since it contains 12 hydro-
phobic aa, 4 threonine residues, and 2 serine residues 
The importance of this domain is reflected in the conser-
vation of the hydrophobic features among all enterovi-
ruses The limited intratypic sequence heterogeneity 
found in 5 CBV1 isolates containing divergent 2A cod-
ing regions (41) further strenghtens the importance of 
conservation in this region of protein 2B (Fig IB) 
To examine the structural and hydrophobic require-
ments of this domain and to define its role in viral repro-
duction, we have constructed nine CBV3 protein 2B 
mutants The effect of the mutations on virus viability 
was assayed by transfection of Buffalo green monkey 
cells (BGM) with copy RNA transcripts Translation and 
processing of the viral polyprotein were examined both 
in vitro and in vivo Replication and complementation of 
the mutants were tested by introduction and analysis of 
the mutations in a subgenomic replicón in which the 
capsid-coding region had been replaced by the luciferase 
gene The results reported here indicate that a moderate 
degree of hydrophobicity of the domain is essential for 
the function of protein 2B Mutations which caused a 
major increase or decrease in hydrophobicity as well as 
the introduction of negatively charged residues inter-
fered with virus growth These mutations caused prima-
ry defects in vRNA synthesis that could not be comple-
mented in trans by wild-type protein 2B The proposed 
interaction of this hydrophobic domain with the mem-
brane and the implications of the mutations on this inter-
action are discussed 
MATERIALS AND METHODS 
Cells and viruses. Virus propagations and RNA transfec-
tions were performed with BGM cells Plaque assays were 
performed with Vero cells The cells were grown in minimal 
essential medium (MEM) (GIBCO) supplemented with 10% 
fetal bovine serum (GIBCO) After infection, cells were fed 
with MEM containing 3% fetal bovine serum After transfec-
tion, MEM containing 10% fetal bovine serum was added to 
the cells Virus yields were determined by endpoint titration 
Serial 10-fold dilutions were tested in 8 replicative wells of 
96-well plates containing BGM cell monolayers (36) Virus 
titers were calculated according to the method described by 
Reed and Muench and expressed in 50% tissue culture infec-
tive dose (TCID50) values (34) 
Ohgonucleotide-directed site-specific mutagenesis. Plas-
mid pCB3/T7 was kindly provided by R Kandolf (University 
of Tubingen, Germany) This plasmid contains a full-length 
copy DNA of Coxsackie B3 virus (strain Nancy) cloned behind 
a T7 RNA polymerase promoter (22) In vitro mutagenesis 
was performed using the Altered Sites in vitro mutagenesis 
system (Promega) according to the recommendations of the 
manufacturer For mutagenesis, the Hmdlll (nt 2080) to Xbal 
(nt 4947) fragment of pCB3/T7 was introduced in phagemid 
pALTER-1 to generate pALTCB3/2080-4947 Synthetic 
oligonucleotides were used to introduce site-specific muta-
tions The nucleotide sequence of the mutant pALTCB3 clones 
was verified by dideoxy chain termination sequence analysis 
of plasmid DNA with oligonucleotide 5 -CCATTCAATGAA 
TTTCTG-3 (complementary to nt 4117 to 4134), using the 
Ampli Cycle sequencing kit according to the instructions of 
the manufacturer (Perkin-Elmer) From these clones, the Spel 
(nt 3837)-to-BííHH (nt 4238) fragment was cloned in рСВЗ/ 
T7 
Transcription and transfection of cells with copy RNA 
transcripts. Plasmids were linearized by digestion with Sail, 
extracted with phenol/chloroform, and precipitated Copy 
RNA transcripts were generated in a 100-μΙ reaction mixture 
containing 2 μg of linearized template DNA, 40 mM Tns-HCl 
(pH 7 5), 10 mM NaCl, 6 mM MgCI2, 2 mM spermidine, 2 5 
mM each nucleoside triphosphate, 100 U of RNAsin (Prome­
ga), and 30 U of T7 RNA polymerase (Promega) Small por­
tions (2μΙ) were analyzed on a 1% agarose gel Twenty micro­
liters of the transcription mixture (2 to 4 μg RNA) was used 
for transfection of BGM cells by the DEAE-dextran method 
(39) with some modifications Briefly, 80 μΐ of a Ν-Ί-
hydroxyethylpiperazine-^V -2-ethanesulfonic acid (HEPES)-
buffered salt solution (HBS) (20 mM HEPES pH 7 05, 137 
mM NaCl, 5 mM KCl, 1 mM №2НРО,, 5 5 mM glucose) was 
added to a 20-μ1 transcription mixture and mixed with 100 μΙ 
of a DEAE-dextran solution (1 mg/ml in HBS), and the solu­
tion was incubated on ice for 30 mm BGM monolayer cells 
grown in 25-cm2 flasks to a confluency of 75%, were washed 
three times with phosphate buffered saline (PBS) and in­
cubated with the RNA-DEAE-dextran mixture for 30 mm at 
room temperature The cells were washed three times with 
PBS, overlayed with cell culture medium, and incubated at 
either 33 or 36°C for the times indicated in the text When 
virus growth was observed, the cultures were incubated until 
cytopathic effect (CPE) was complete The cultures were then 
subjected to three cycles of freezing and thawing, and the 
viruses were aliquoted in stocks of 1 ml and stored at -80°C 
Sequence analysis of the 2B coding region of mutant 
viruses. RNA was isolated from 100 μΙ of virus stock using a 
single extraction procedure with guanidinium thiocyanate-
phenol-chloroform according to the method described by 
Chomczynski and Sacchi (11) Reverse transcription of RNA 
and amplification of cDNA by PCR with forward primer 5'-
GCAA1GGAACAGGGAGTGAAGGACTATGTGGA-3' (nt 
3733 to 3765) and reverse primer 5-TTGGGATGGCGCGCT 
CTGCTC-3 (nt 4231 to 4251 ) were performed as described 
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previously (42) The resulting 519-bp PCR products were 
purified by low-melting-point agarose gel electrophoresis 
Sequence analysis of the PCR products was performed as 
described above 
Plaque assays. Plaque assays were carried out with 100% 
confluent monolayers of Vero cells on 10-cm2 dishes in 6-well 
plates Virus dilutions were made in MEM containing 3% fetal 
bovine serum Vero cells were infected with different virus 
dilutions and incubated for 30 mm at room temperature After 
removal of the inoculum, the cells were overlayed with 5 ml of 
cell culture medium containing 1% plaque agarose (Servo) and 
25 mM MgCl, The cells were grown at 33, 36, and 39°C, and 
plaque phenotypes were analyzed at 3 to 5 days postinfection 
Single-cycle growth analysis. BGM cell monolayers 
grown in 25-cm2 flasks (5 χ IO' cells per flask) were infected 
with virus at a multiplicity of infection (MOI) of I TCID,0 per 
cell After 30 mm of adsorption, the cells were washed three 
times with MEM and 5 ml of cell culture medium was added 
The cells were incubated at 33, 36, or 39°C for 2, 4, 6, or 8 h 
Viruses were released by three succesive cycles of freezing 
and thawing Virus liters were determined by titration on BGM 
cell monolayers in 96-well plates 
Construction of subgenomic replicón pCB3/T7-LlTC. 
For the substitution of the capsid-coding region by the lucifer-
ase coding sequence, the PI capsid-coding region was deleted 
from рСВЗЛ"7 by two subsequent PCR product subcloning 
steps by using the unique restriction sites for SJul (nl 250), 
Bglll (nt 2024), and BssHll (nt 4238) PCRs were performed 
with UITma DNA polymerase (Perkin-Elmer), a DNA 
polymerase containing proofreading activity First, nt 243 to 
745 were amplified with primers 5'-AAC TAC TTC GAA 
AAA ССТ AGT AAC ACC-3' (nt 243 to 269) and 5'-TTG 
CGT AGA ТС Г GCG GCC GCC CAT ГТТ GCT GTA TTC 
AAC TTA-3' (complementary to nt 721 to 745 plus restriction 
sites, which are underlined, for λοίΐ and Bglll) This PCR 
product was cut with S/HI and Bglll and cloned in pCB3/T7 
cut with the same enzymes In the resulting plasmid pCB3/T7-
Δ746/2024, the N-terminal half of the PI region is deleted 
Second, nt 3280 to 4251 were amplified with primers 5'-ACT 
ACT AGG AGA TCT GTT AAC АСА ATG АСА AAT ACG 
GGC GCA-3 (nt 3280 to 3300 plus restriction sites for Bglll 
and IIpaY) and 5'-TTG GGA TGG CGC GCT CTG CTC-3' 
(complementary to nt 4231 to 4251) This PCR product was 
cut with Bglll and £«H1I and introduced in pCB3/T7-
Δ746/2024 cut with the same enzymes In the resulting plas­
mid (рСВЗ/Т7-ДР1), nt 746 to 3279 of the PI coding region 
are deleted and replaced by the sequence GGC GGC CGC 
AGA TCT GTT AAC (the restriction sites for Soil, Bglll, and 
Hpal, respectively) Except for its initiation and stopcodon, 
the fireflv luciferase gene was amplified by PCR using plas­
mid pGFM-luc (Promega) as template with primers 5'-GCC 
CGG AGC GGC CGC GAA GAC GCC AAA AAC ATA-3' 
and 5'-AGT TAC GTT AAC CAA TTT GGA CTT TCC 
GCC-3', cut with JVoiI and Hpal, and cloned in рСВЗ/Т7-ДР1 
cut with the same enzymes The resulting plasmid was 
designated pCB3/T7-LUC (see Fig 4A) Because of the clon­
ing procedure, the luciferase product contains three additional 
amino acids (Gly-Gly-Arg), which correspond to the Voil site, 
after the initial methionine The guanidine residue following 
the initiation codon was retained in order to keep the Kozak 
consensus sequence intact (23) Furthermore, luciferase con­
tains seven additional residues at its С terminus The Val and 
Asn residues correspond to the Hpal site The five C-terminal 
amino acids of VP1 were retained to ensure a correct proteo­
lytic processing by 2A1"0 
Analysis of viral positive-strand RNA synthesis. BGM 
cell monolayers grown in 25-cm* flasks to a confluency of 
75% were transfected with 0 5 to 1 0 μg of Г7 RNA polym-
erase-generaled pCB3/T7-LL'C copy RNA derived from Sail· 
linearized plasmids At the indicated times posttransfection, 
the cells were washed three times with PBS and lysed in 400 
μΐ of lysis buffer, and the luciferase activity was measured in a 
liquid scintillation counter with the luciferase assay system 
according to the recommendations of the manufacturer (Pro­
mega) 
In vitro translation reactions. Copy RNA transcipts were 
synthesized and translated in T7 TNT rabbit reticulocyte lysate 
(Promega) according to the manufacturer's recommendations 
The translation reaction mixtures (20 μΙ) were programmed 
with 0 5 μg of Sa/I-linearized plasmid DNA and supplemented 
with 20% (vol/vol) HeLa cell initiation factors (kindly provid­
ed by J Flanegan, University of Florida) In vitro-synthesized 
proteins were labeled with 20 μΟ of ["SJcysteine (specific 
activity >1,000 Ci/mmol, Amersham) for 3 h at 30°C After 
this incubation, RNA was degraded by treatment with RNase 
T, (500 U) and RNase A (5 μg) for 10 mm at 30°C Transla­
tion products (5μ1) were analyzed on a 12 5% Polyacrylamide 
gel containing sodium dodecyl sulfate (SDS) (25) The gels 
were fixed in 30% methanol-10% acetic acid, rinsed in di­
methyl sulfoxide, fiuorographed with 20% 2,5-diphenyl-
oxa7olc in dimethylsulfoxide, dried under vacuum, and ex­
posed to Kodak XAR film at -80'C 
Analysis of viral protein synthesis in vivo. BGM mono­
layer cells (2 χ 10') were infected with either wild-type or 
mutant viruses at a MOI of 50 After virus adsorption for 30 
mm at room temperature, medium was added and the cells 
were incubated at 36°C At various times postinfection, the 
cells were washed for three times with PBS and pulse-labeled 
in methionine- and serum-free MFM (Gibco) containing 10 
μΟ of Tran"S-label (a mixture of [,5S]methionine and 
["S]cystcine, specific activity, >1,000 Ci/mmol, ICN) After 1 
h, the medium was removed and the cells were lysed in cold 
lysis buffer containing 500 mM Tns-HCl (pi I 8 0), 150 mM 
NaCl, 0 I mM phenylmethylsulfonyl fluoride, 1% Nonidet P-
40 and 0 05% SDS Labeled proteins were analyzed by 
Polyacrylamide gel electrophoresis as described above 
RESULTS 
Introduction of mutations in a hydrophobic do­
main of CBV3 protein 2B. Nine CBV3 mutants con­
taining ammo acid substitutions in a hydrophobic 18-
residue domain of protein 2B were constructed by site-
directed mutagenesis The mutations were verified by 
sequence analysis and introduced in the infectious 
cDNA clone pCB3/T7 The integrity of the resulting 
plasmids was checked by restriction enzyme analysis 
Figure 2 shows the genotype of the mutants and the pre­
dicted effects of the mutations on hydrophobicity On 
basis of the effects of the mutations on the mean hydro­
phobicity and net charge of this region, the pCB3/T7 2B 
mutants can be divided into three groups as follows (ι) 
In mutants 2B-S77M, 2B-C75M, and 2B-S77M/C75M, 
serine 77 (TCG) and cysteine 75 (TGT) were replaced 
by more hydrophobic methionine (ATG) residues (n) In 
mutants 2B-164S, 2B-V66S, and 2B-I64S/V66S, the 
mean hydrophobicity is decreased by substitution of 
hydrophobic residues isoleucine 64 (АТС) and valine 
66(GTG) by polar serine residues (codons AGT and 
TCG, respectively), which contain alipalhic hydroxy 1 
side chains (in) In mutants 2B-A71E, 2B-I73E, and 2B-
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2B-C75M M 
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Figure 2. (A) Schematic structure of the genome of CBV3 showing the 7.5-kb single-stranded RNA genome with the covalently bound 
VPg protein at the 5' end of the nontranslated region (NTR) and the genomic encoded poly(A) tract at the end of the 3' NTR. The boxed 
region shows the polyprotein containing the structural PI region proteins and the nonstructural P2 and P3 region proteins. Also shown is 
the partial amino acid sequence of protein 2B including the hydrophobic domain formed by aa 63 to 80 (which is underlined) and the 
mean <II> per residue of this domain according to Eisenberg et al. (15). (В) aa 63 to 80 of the pCB3/T7 2B mutant plasmids, the mean 
<H> per residue of this hydrophobic region, and the effect of the mutations on virus growth. 
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А71ЕЛ73Е, the mean hydrophobicity is decreased by 
the replacement of alanine 71 (GCC) and isoleucine 73 
(АТС) by negatively charged glutamic acid (GAG) 
residues. 
Effect of the mutations on virus growth. The effect 
of the mutations on virus viability was studied by trans-
fection of BGM cells with copy RNA transcripts. For 
each mutant, eight transfections were performed. Four 
transfected cell cultures were incubated at 33°C, and 
four were incubated at 36°C. Cells transfected with copy 
RNA of mutants 2B-S77M, 2B-I64S, and 2B-V66S 
exhibited complete CPE at 48 to 72 h posttransfection, 
which is similar to that of wild-type pCB3/T7. Transfec-
tion of copy RNA of mutant 2B-C75M showed a de­
layed virus growth. Complete CPE was not observed 
before 72 to 96 h posttransfection. No CPE was ob­
served up to 5 days posttransfection at either 33°C or 
36°C after transfection with copy RNAs of mutants 2B-
S77M/C75M, 2B-I64S/V66S, 2B-A71E, 2B-173E, and 
2B-A71E/I73E. These cell cultures were subjected to 
three cycles of freezing and thawing, and 250 μΐ was 
subsequently passaged to fresh BGM cell monolayers. 
CPE was observed after passage of one of the cell cul­
tures transfected with copy RNA of mutant 2B-S77M/ 
C75M (see the following paragraph), but not after pas­
sage of cells transfected with copy RNAs of any of the 
other mutants. 
Sequence analysis of the 2B coding region of the 
viable mutant viruses showed that the original mutations 
introduced by site-specific mutagenesis were retained in 
the vRNA and that no other amino acid replacements 
had occurred. Viral growth characteristics were exam­
ined by plaque assays and single-cycle growth analysis. 
Viruses VCB3-2B-S77M, -I64S, and -V66S exhibited 
wild-type growth. Virus vCB3-2B-C75M exhibited a 
small-plaque phenotype (Fig. 3). In single-cycle infec­
tions, this virus produced 3 and 5% of the wild-type 
virus yield at 6 and 8 h postinfection, respectively (data 
not shown). All mutant viruses showed similar repro­
ductive capacities at 33, 36, and 39"C, which indicates 
that none of the mutations caused temperature-sensitive 
growth defects. The results of the transfections and the 
characterization of the viable mutants are summarized in 
Fig. 2B. 
Isolation of two revertant viruses. Passage of cells 
transfected with copy RNA of mutant 2B-S77M/C75M 
revealed virus growth in one of the cultures grown at 
33°C. Sequence analysis demonstrated that these viruses 
still contained the methionine at position 77 but a rever­
sion of the introduced methionine (AUG) at position 75 
to a valine (GUG) residue. This partial revertant virus, 
VCB3-2B-S77M/C75V, exhibited a small-plaque pheno­
type at all temperatures (data not shown). In single-cycle 
infections, this mutant produced 10 and 20% of wild-
type virus yield at 6 and 8 h postinfection, respectively 
(data not shown). Amplification and sequence analysis 
of the 2B coding region of virus from the primary trans­
fected culture showed that the reversion had already 
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wild-type C75M 
Figure 3. Plaque phenotype of vCB3-2B-C75M and wild-type 
virus grown at 36°C at 3 days postinfection. Plaque assays were 
performed on Vero cells as described in Materials and Methods. 
I he arrow in the plate of VCB3-2B-C75M indicates the occur­
rence of a large-plaque revenant (vCB3-2B-C75V). 
occurred in the transfected cells. 
The plaque assay plates of mutant vCB3-2B-C75M 
contained predominantly small plaques; however, larger 
plaques were also observed (Fig. 3). Three large plaques 
and three small plaques were picked from the plates, and 
the viruses were grown on BGM cells. Sequence analy­
sis demonstrated that the viruses isolated from the small 
plaques had retained the introduced methionine (AUG) 
residue. However, the viruses isolated from the three 
large plaques contained a valine (GUG) residue at amino 
acid position 75 instead of the introduced methionine 
and were named vCB3-2B-C75V. No other mutations in 
the 2B coding sequence were observed. This revenant, 
vCB3-2B-C75V, exhibited a wild-type plaque size at all 
temperatures. 
To investigate if the reversions in the mutants СВЗ-
2B-C75V and vCB3-2B-S77M/C75V were solely re­
sponsible for the observed phenotypes, we introduced 
these mutations into the wild-type pCB3/T7 clone. For 
this purpose, the 519-bp PCR products (nt 3733 to 4251) 
that were used for the sequence analysis of the 2B cod­
ing region (nt 3746 to 4041) were cut with Spel (nt 
3837) and BssHll (nt 4238), purified, and cloned in 
pCB3/T7. Nucleotides 4042 to 4238 were sequenced to 
verify that no additional mutations had occurred in this 
region. BGM cells were transfected with copy RNA 
generated from the resulting plasmid clones 2B-C75V 
and 2B-S77M/C75V. Sequence analysis of the 2B cod­
ing regions of the resulting viruses demonstrated that the 
introduced mutations were retained in the vRNA. These 
viruses exhibited the same plaque phenotype that the 
revenants obtained after transfection of cells with copy 
RNA of mutants 2B-C75M and 2B-S77M/C75M, re­
spectively, exhibited, which indicates that the reversions 
were sufficient to confer the observed phenotypes (data 
not shown). 
Analysis of vRNA replication with subgenomic 
replicón pCB3/T7-LUC. The observation that the cap-
sid-coding PI region could be deleted from poliovirus 
RNA without any effect on the efficiency of genome 
replication (21) has led to the construction of chimeric 
subgenomic poliovirus replicons in which the PI region 
was replaced by reporter genes (2, 33). Andino et al. (2) 
have described a subgenomic poliovirus replicón (RLuc-
31) in which the PI region was replaced by the lucif-
erase gene and have shown that the activity of the re-
porter protein following transfection correlated with the 
levels of accumulated RNA (2). 
To study vRNA replication of the 2B mutants, chi-
meric subgenomic replicón pCB3/T7-LUC was con-
structed (Fig. 4A). In this replicón, the PI region of 
pCB3/T7 is substituted by the firefly luciferase gene. 
The suitability of this replicón to study vRNA replica-
tion was examined by transfection of BGM cells with 
copy RNA of pCB3/T7-LUC or the replication defective 
control pCB3/T7-LUC-A3D. This plasmid contains a 
large in-frame deletion in the 3Dpo1 region by deletion of 
the BbrP\ fragment (nt 6117 to 7152). At several times 
posttransfection, the cells were lysed and the levels of 
luciferase activity were measured. Figure 4B demon-
strates that the kinetics of luciferase production by 
pCB3/T7-LUC copy RNA can be divided into three 
phases, which are similar to those described for RLuc-31 
(2). In phase I (1 to 3 h posttransfection), luciferase acti-
vity increased as a result of translation of the input RNA. 
Phase II (3 to 5 h posttransfection) is characterized by a 
steady state in luciferase activity. Phase III (5 to 12 h 
posttransfection) demonstrated a second increase ( 10- to 
50-fold) in luciferase activity as result of the translation 
of newly synthesized chimeric RNA strands. In contrast, 
phase III of RLuc-31 is already detectable from the third 
h posttransfection, and replication results in a 100- to 
500-fold increase in luciferase activity (2). This differ-
ence is probably due to the low infectivity of pCB3/T7-
derived copy RNA, which is only 14 to 30 PFU/^g of 
copy RNA (22). Upon transfection of pCB3/T7-LUC 
RNA, luciferase activity is generated in all transfected 
cells, but only in a few of these cells will an infectious 
cycle be initiated. The exponential increase in luciferase 
activity as result of vRNA replication will, therefore, be 
less evident and cannot be detected before 6 h post-
transfection. However, the absence of phase III in cells 
transfected with copy RNA of pCB3/T7-LUC-A3D (Fig. 
4B) demonstrates the suitability of replicón pCB3/T7-
LUC to study vRNA replication. 
Growth-defective 2B mutants display defects in 
vRNA synthesis. vRNA synthesis of the nine originally 
constructed mutants was examined after introduction of 
the Spe\-to-BssHll\ fragments in replicón pCB3/T7-
LUC. BGM cells were transfected with copy RNA of 
pCB3/T7-LUC replicons containing the 2B mutations 
and grown at 36°C, and the luciferase activities were 
determined at several times posttransfection. Replicons 
carrying the nonviable 2B mutations (S77M/C75M, 
I64S/V66S, A71E, I73E, and A71E/I73E) displayed 
defects in RNA replication (Fig. 4C). These replicons 
exhibited phases I and II of the luciferase production, 
which are the result of translation of the input RNA, but 
not the phase III increase that reflects translation of 
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Figure 4. Analysis of vRNA replication of the 2B mutants with chimeric luciferase replicón pCB3/T7-LUC (A) Nucleotide and amino 
acid sequences of construct pCB3/T7-LUC at the N and С termini of the introduced luciferase gene The last 5 aa are conserved in this 
construct to ensure a correct cleavage by protease 2A Underlined are the Λ'οίΙ and Hpal restriction sites used for the introduction of the 
luciferase gene (B-D) Luciferase accumulation after transfection of BGM cells with copy RNAs of wild-type pCB3/T7-LUC and 
pCB3/T7-LUC-A3D (B), pCB3/T7-LUC containing the lethal 2B mutations (C), and pCB3/T7-LUC containing the viable 2B muta­
tions (D) Luciterase activities were measured as described in Materials and Methods and are expressed on a logarithmic scale 
newly synthesized RNA strands. Replicons carrying the 
viable mutations S77M, I64S, and V66S, which pro­
duced viruses with wild-type growth characteristics, 
displayed the same kinetics of luciferase production that 
the wild-type pCB3/T7-LUC did (Fig. 4D). Mutation 
C75M, which yielded virus with a small-plaque pheno-
type, caused a severe reduction in RNA synthesis. The 
absence of an increase in luciferase activity above the 
translation level, which might have been expected from 
a low level of replication, is most likely due to the low 
infectivity of the copy RNA transcripts. 
Figures 4C and 4D show that the luciferase activity 
generated by the replication-defective replicons re­
mained constant up to 10 h posttransfection. Because 
luciferase is an unstable епгуте in vivo (2), the constant 
level must represent an equilibrium between translation 
of the input RNA and degradation of luciferase. The 
constant level of luciferase activity suggests that none of 
the 2B mutations affected the translation ability or stabil­
ity of the chimeric input RNA. 
In vitro protein synthesis and processing of RNAs 
containing mutations in protein 2B. In vitro translation 
reactions were performed to investigate whether the 
mutations affect translation and processing of the 
polyprotein. Figure 5 shows that the patterns of [35S]-
cysteine-labeled proteins obtained with the 2B mutant 
27 
chapter 2 
Figure 5. In vitro translation of RNA derived from pCB3/T7 
wild-type and the 2B mutant plasmids. Sa/I-linearized plasmid 
DNA (0.5 μg) was incubated for 3 h in TNT reticulocyte lysate, 
a coupled transcription-translation system, supplemented with 
HeLa initiation factors. The [35S]cysteine-labeled translation 
products were analyzed on an SDS-12.5% Polyacrylamide mini-
gel. An extract from wild-type virus-infected cells, labeled with 
[35S]methionine for 1 h at 4 h postinfection, was used as marker. 
plasmids were similar to that produced by wild-type 
plasmid, which indicates that none of the mutations 
caused defects in synthesis and processing of the viral 
polyprotein. The positions of proteins 2BC and 2C were 
identified by in vitro translation of copy RNAs carrying 
the 2BC or 2C coding sequence behind the encephalo-
myocarditis virus 5' nontranslated region (data not 
shown). In vitro translated protein 2B (± 11 kDa) could 
not be visualized because of the presence of only two 
cysteines in protein 2B and the interference of the excess 
of globine in the reticulocyte lysate with a correct migra­
tion of proteins with molecular masses of less than 15 
kDa. However, the production of protein 2C at levels 
equal to that produced by wild-type RNA demonstrates 
that none of the mutants displayed processing defects at 
the 2B-2C junction. 
Analysis of the viral protein synthesis in vivo. The 
rates of viral protein synthesis in cells infected with 
small-plaque viruses vCB3-2B-C75M and vCB3-2B-
S77M/C75V were compared with that in wild-type 
virus-infected cells to examine whether the defects in 
RNA synthesis are a consequence of an impaired level 
of viral protein synthesis in vivo. BGM cells were in­
fected with either vCB3-2B-C75M, vCB3-2B-S77M/ 
C75V, or wild-type virus at an MOI of 50, and proteins 
were labeled with [35S]methionine at different times 
postinfection. Figure 6 shows that the shutoff of host cell 
translation after infection with these two mutant viruses 
was similar to the shutoff induced by wild-type virus. At 
4 and 5 h postinfection, the level of viral protein synthe­
sis in the mutant virus-infected cells cells was slightly 
below the level in wild-type-infected cells. At 6 h post­
infection, the rates of viral protein synthesis in the 
mutant-infected and wild-type-infected cells were simi-
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lar, which indicates that it is unlikely that the mutations 
cause primary defects in the rate of synthesis of the viral 
polyprotein. In the previous paragraphs, it has been 
shown that mutations in protein 2B cause defects in 
vRNA synthesis. The slightly decreased level of viral 
protein synthesis in cells infected with vCB3-2B-C75M 
and VCB3-2B-S77M/C75V at 4 and 5 h postinfection is 
probably a reflection of the defects in RNA synthesis 
and, as a consequence, the reduced amount of available 
viral positive RNA strands. The reduction in vRNA syn­
thesis is probably also responsible for the delay in CPE 
and, as result, for the prolonged synthesis of viral pro­
teins up to 7 h postinfection, when viral protein synthe­
sis in wild-type virus-infected cells is already severely 
decreased. 
Defects in vRNA synthesis caused by mutations in 
a hydrophobic domain of protein 2B cannot be res­
cued in trans. To study whether the defects in vRNA 
synthesis could be rescued in vivo by wild-type protein 
2B provided in trans, genetic complementation experi­
ments were performed. We studied complementation of 
the defects caused by mutation C75M, which yields 
small-plaque viruses, and the nonviable mutations 
S77M/C75M, I64S/V66S, A71E, I73E, and A71E/I73E. 
To assay for complementation, BGM cells were trans-
fected with copy RNAs of the mutant pCB3/T7-LUC 
replicons, were incubated at 36 °C, and at 90 min post-
transfection were either mock or virus infected with 
wild-type virus at a MOI of 50. At 4 and 8 h posttrans-
fection, the cells were lysed and the luciferase activity 
was measured. Wild-type pCB3/T7-LUC copy RNA 
transcripts were tested to exclude the possibility that the 
replication of wild-type virus interfered with the lucif­
erase accumulation. The results shown in Table 1 dem­
onstrate that virus growth did not adversely affect repli­
cation and translation of the pCB3/T7-LUC RNA 
strands. Complementation tests with the mutant рСВЗ/ 
pulse labeling after (hours) 
wild-type C75M S77M/C75V 
Figure 6. Protein synthesis in BGM cells infected with wild-
type virus, VCB3-2B-C75M, and vCB3-2B-S77M/C75V. BOM 
cells were infected at a MOI of 50 and were grown at 36°C. At 
the indicated times, the cells were incubated with mefhionine-
and serum-free MEM containing 10 цСІ of Tran35S-label (a 
mixture of [35S]methionine and [35S]cysteine). After a 1-h label­
ing period, the cells were washed and lysed. The labeled pro­
teins were analyzed on an SDS-12.5% Polyacrylamide minigel. 
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Table 1. Complementation tests between pCB3/T7-LUC 
copy RNAs containing the 2B mutations and wild-type virus". 
Mutation or 
wild-type 
C75M 
S77M/C75M 
I64S/V66S 
A71E 
I73E 
А71ЕЛ73Е 
wild-type 
Luciferase activity (cpm [ 101])' 
4 h pi 
142 
106 
354 
185 
198 
373 
251 
8h pt 
(mock-infected) 
244 
181 
212 
326 
95 
405 
(1.7V 
(1.7) 
(0 6) 
(1.8) 
(0 5) 
(1.1) 
3,491(13.9) 
8h 
(virus-in 
376 
137 
283 
152 
93 
370 
P« 
fected) 
(2.6) 
(1.3) 
(0.8) 
(0.8) 
(0.5) 
(1.0) 
3,050(12.1) 
' BGM cells were transfected with 0 5 μ§ RNA of рСВЗЛ7-
ІДІС carrying the 2B mutations and either mock or virus infected 
with wild-type virus at a MOI of 50 at 90 mm posttransfcction 
(pi) At 4 and 8 h posttransfection, the cells were lysed and the 
luciferase activities were determined. 
* Values in parenthesis are the rallos of the luciferase activities 
to those measured at 4 h posttransfection 
T7-LUC replicons showed similar levels of luciferase 
activity at 8 h posttransfection in the mock- and virus-
infected cells (Table 1). The luciferase activities meas­
ured at 8 h posttransfection in both mock- and virus-
infected cells were comparable to the activities meas­
ured at 4 h posttransfection, a time point at which the 
level of luciferase activity reflects the translation of the 
input copy RNA. The absence of major increases in 
luciferase activity in the virus-infected cells suggests that 
the defects in RNA synthesis caused by mutations in a 
hydrophobic domain of protein 2B could not be effi­
ciently complemented by the function of wild-type pro­
tein 2B provided in trans. However, the possibility that 
low levels of complementation have occurred cannot be 
excluded. Low levels of replication are difficult to detect 
because of the low ¡nfectivity of the copy RNA tran-
scripts (see above) and the small variations in transfec-
tion efficiency and luciferase assays that were observed. 
DISCUSSION 
Enterovirus protein 2B is a small hydrophobic pro-
tein that is localized at the outer surfaces of the virus-
induced membrane vesicles on which vRNA synthesis 
takes place. The nature of the interaction of protein 2B 
with the membrane is yet unknown. Examination of the 
amino acid sequence of protein 2B of CBV3 revealed an 
18-aa hydrophobic domain (aa 63 to 80) with a composi-
tion that is characteristic for integral transmembrane 
regions. In this study, we examined the effects of amino 
acid substitutions in this hydrophobic domain of CBV3 
protein 2B on virus growth, vRNA replication, and viral 
polyprotein processing to gain more insight in the role of 
this domain in the function of protein 2B. The mutations 
that were introduced can be divided into three groups on 
basis of their effects on hydrophobicity and net charge of 
the domain (Fig. 2). In the first group, serine 77 and 
cysteine 75 were replaced by more hydrophobic methio-
nine residues. Mutation S77M yielded virus with wild-
type growth characteristics. Mutation C75M yielded 
mutant virus with a small-plaque phenotype because of a 
reduction in vRNA synthesis. Large-plaque revenants of 
this mutant were isolated and found to contain a rever-
sion of methionine 75 to a valine residue (vCB3-2B-
C75V). The double mutation S77M/C75M caused a de-
fect in vRNA synthesis and was nonviable. However, 
the isolation of small-plaque revertant virus VCB3-2B-
S77M/C75V demonstrates that mutation S77M/C75M 
did not completely abolish vRNA replication. In the 
second group, hydrophobic amino acids with alipathic 
side chains (isoleucine 64 and valine 66) were replaced 
with polar serine residues with alipathic hydroxyl side 
chains. Mutations I64S and V66S produced mutant 
viruses with wild-type plaque phenotypes. However, the 
double mutation I64S/V66S disturbed vRNA synthesis 
and was nonviable. In the third group, alanine 71 and 
valine 73 were replaced with negatively charged glu-
tamic acid residues. Mutations A71E, I73E, and A71E/ 
I73E disturbed vRNA replication and were all non-
viable. RNA synthesis seemed to be completely abro-
gated, since no revertant viruses could be isolated. In 
vitro translation reactions and analysis of the viral pro-
tein synthesis in infected cells demonstrated that none of 
the mutations interfered with the synthesis or processing 
of the viral polyprotein, indicating that the mutations in 
the hydrophobic domain primarily affected vRNA syn-
thesis. 
The results presented here suggest that the hydro-
phobic character of the domain is crucial for the function 
of protein 2B in vRNA replication. Furthermore, the 
data suggest that for efficient functioning of the domain, 
the hydrophobicity (<H>) is restricted by both lower and 
upper hydrophobicity limits. The single amino acid sub-
stitutions that caused only minor alterations in hydro-
phobicity (S77M [<H>, 0.57], I64S [<H>, 0.44], V66S 
[<H>, 0.45] and C75M [<H>, 0.54]) all yielded viable 
viruses. These structural alterations and the concomitant 
increases or decreases in mean hydrophobicity had no 
effect or only little effect (small-plaque mutation C75M) 
on the function of protein 2B in vRNA synthesis. How-
ever, both double mutations S77M/C75M (<H>, 0.59) 
and I64S/V66S (<H>, 0.37) were nonviable. Since each 
of the single substitutions did not severely affect the 
structure of the domain, the disturbance of vRNA syn-
thesis caused by the double mutations is most likely due 
to the more profound increase or decrease in overall 
hydrophobicity of the domain. The suggestion that the 
hydrophobicity of the domain is restricted by an upper 
limit is further supported by the observation that re-
vertant VCB3-2B-S77M/C75V (<H>, 0.61) exhibited a 
small-plaque phenotype, whereas viruses containing 
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each of the single mutations displayed wild-type growth. 
The disturbance of the hydrophobic character of the 
domain by the nonviable mutations A71E (<H>, 0.45), 
I73E (<H>, 0.40), and А71ЕЛ73Е (<H>, 0.33) may be 
due to the introduction of the negative charges rather 
than to the decrease in overall hydrophobicity of the 
domain, since the decrease caused by mutation A7IE is 
similar to those caused by mutations 164S and V66S. 
Another observation which cannot simply be explained 
by means of hydrophobicity is the finding that mutation 
C75M (<H>, 0.54) yielded a small-plaque virus, where­
as a revertant containing a reversion of the introduced 
methionine 75 to a valine residue (<H>, 0.57) displayed 
a wild-type growth. It is difficult to explain the adverse 
effect of mutation C75M. The wild-type growth of re­
vertant СВЗ-2В-С75 makes it unlikely that the sulf-
hydryl group of cysteine 75 is involved in the formation 
of disulfide bridges. The defect in vRNA synthesis 
caused by mutation C75M may be caused by the rela­
tively long side chain of the methionine residue, which 
may interfere with the structure of the domain or the 
interaction of the domain with its target. 
The exact function of protein 2B in vRNA replica­
tion is not yet known. The expression of poliovirus pro­
tein 2B led to an increase in plasma membrane permea­
bility and the inhibition of protein secretion (13), sug­
gesting that protein 2B has profound effects on cellular 
membranes. Protein 2B has a high affinity for mem­
branes and becomes associated with the rER membrane 
immediately after its synthesis (5). It is likely that the 
hydrophobic domain is involved in this association and 
that major alterations in the hydrophobic domain inter­
fere with the localization of protein 2B at the vesicular 
membrane. The displacement of protein 2B from the 
membrane may hinder a functional role of protein 2B in 
vRNA synthesis in the replication complex. Alternative­
ly, the disturbance of the interaction with the membrane 
may interfere with a structural role of protein 2B in the 
organization of the viral replication complex (20). The 
interaction of protein 2B with the membrane may be a 
prerequisite for the inhibition of protein secretion. Muta­
tions that disturb the interaction of protein 2B with the 
membrane may interfere with the accumulation of mem­
brane vesicles for vRNA synthesis and thereby account 
for the defects in the synthesis of viral positive RNA 
strands. However, it cannot be excluded on the other 
hand that this hydrophobic domain is involved in a spe­
cific interaction with another viral or cellular protein 
required for vRNA synthesis. Alterations in hydro­
phobicity or structure of the domain would affect these 
protein-protein interactions and in this way account for 
the observed defects in vRNA synthesis. 
The possible disposition of protein 2B in the mem­
brane was analyzed by a theoretical method. Eisenberg 
and coworkers have developed an algorithm to identify 
membrane-associated helices in membrane proteins and 
to distinguish them from helices in globular proteins 
(15). Candidate membrane-associated helices are identi­
fied by calculating the hydrophobicity of 21-residue 
windows run over the entire protein. Candidate helices 
must have a mean <H> value of at least 0.42. Further­
more, there must be either one highly hydrophobic helix 
with an <H> value of at least 0.68 or two moderate 
hydrophobic helices, which may be provided either 
intra- or ¡ntermolecularly, with a summation value of at 
least 1.10. Candidate helices are then classified as either 
a monomeric transmembrane helix, a multimeric trans-
membrane helix, or a surface-seeking helix with the aid 
of the hydrophobic moment plot, on which the hydro-
phobic moment of the helix is plotted as function of its 
hydrophobicity (15). We have identified candidate 
membrane-associated helices in enterovirus protein 2B 
using 18- to 21-residue windows, since it has been re-
ported that 18 aa are appropriate for spanning the ER 
membrane (31). In members of the CBV-like subgroup, 
the most hydrophobic segment is formed by aa 63 to 80 
(<H>, 0.52 to 0.60). In members of the poliovirus-like 
subgroup, the segment with the highest <H> value is 
formed by residues 64 to 81 (<H>, 0.49 to 0.55). The 
mean hydrophobicity of these segments is probably too 
low for the integration as a monomeric transmembrane 
helix but may be sufficient to form a multimeric trans-
membrane helix. Classification of these segments on the 
hydrophobic moment plot also suggests that they form 
multimeric transmembrane helices, i.e., protein segments 
that are cooperatively associated within the lipid bilayer 
and stabilized by either an intermolecular (e.g., in the 
form of multimers) or an intramolecular linkage with 
other transmembrane α-helices. 
At present, there is no biochemical evidence for the 
prediction that the hydrophobic domain forms an inte­
gral transmembrane helix that is associated with other 
transmembrane helices. However, the suggestion that the 
hydrophobic domain forms a multimeric rather than a 
monomeric transmembrane helix is supported by several 
observations made in this study, (i) The mean hydro­
phobicity of the mutants with wild-type phenotypes 
varied between 0.44 and 0.57. These values are too low 
for monomeric transmembrane proteins to efficiently 
penetrate the membrane and maintain an energetically 
stable configuration (15). (ii) The substitution of cys­
teine 75 by a more hydrophobic methionine residue 
interfered with vRNA synthesis, which makes it unlikely 
that this residue is involved in a hydrophobic interaction 
with the lipid bilayer. (iii) The mutations which caused 
the greatest increase in hydrophobicity of the domain 
were either lethal for virus growth (S77M/C75M [<H>, 
0.59]) or resulted in a small-plaque virus (S77M/C75V 
[<H>, 0.61]). This suggests that there may exist an upper 
hydrophobicity limit for the domain and that by exceed­
ing this limit, the domain may become too hydrophobic 
to efficiently interact with other transmembrane helices. 
A complementation analysis was performed to exam­
ine whether the defects in vRNA synthesis caused by the 
mutations in the hydrophobic domain could be rescued 
by wild-type proteins provided in trans. Mutations in the 
N-terminal part of poliovirus protein 2B have been re­
ported to cause noncomplementable defects in vRNA 
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synthesis (4, 12, 20, 27). However, complementation ex­
periments with protein ЗА mutants have shown that even 
within one protein, cw-acting and trans-aclmg functional 
regions can be discriminated (4, 16). We found that none 
o f the mutations in the hydrophobic domain that caused 
phenotypes in vRNA synthesis could be efficiently com­
plemented by wild-type protein 2B. Both the N-terminal 
region and the hydrophobic domain of protein 2B appear 
to be involved in a си-acting function in vRNA repli­
cation. It is not clear whether the effects that are ob­
served upon expression of poliovirus protein 2B (i.e., 
permeabilization of the plasma membrane and inhibition 
of protein secretion) (13) reflect different functions of 
protein 2B or whether one of these effects is the conse­
quence of the other. If permeabilizing the plasma 
membrane were the primary function o f the hydrophobic 
domain and if the inhibition of protein secretion were 
only a side effect of this function, then a certain degree 
of trans complementation should have been expected. 
The lack of complementability does not exclude the 
possibility that the hydrophobic domain is involved in 
permeabilization of the plasma membrane but suggests 
that the hydrophobic domain is also involved in another 
function of protein 2B in vRNA synthesis. 
Several explanations may account for the cis-acting 
function of protein 2B. First, protein 2B may interact 
directly with the ER membrane to function in the accum­
ulation or structural organization of virus-induced mem­
branous structures around the same positive RNA strand 
from which it is synthesized. This mechanism would en­
sure a tight linkage between translation and replication 
and prevent RNAs other than viral positive RNA strands 
from being replicated by 30*°', which lacks template 
specificity (30). A second possibility is that wild-type 
2B proteins cannot reach the mutant templates. Replica­
tion o f the vRNA takes places in close conjunction with 
membranes. This membranous environment may inter­
fere with the functional interchange of mutant and wild-
type protein 2B. A third possibility is that the mutant 2B 
proteins interact with a limiting target and that wild-type 
prolein 2B, which is provided later, cannot efficiently 
compete with them. This possibility was raised by 
Johnson and Samow (20), who found that poliovirus 2B 
mutants exhibited a dosage-dependent dominance over 
wild-type protein 2B. The interaction of the mutant 
CBV3 2B proteins with this limiting target may interfere 
with the action of wild-type protein 2B and thereby 
account for the lack of complementation. 
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Enterovirus protein 2B has been shown to increase plasma membrane permeability. We have 
identified a conserved putative amphipathic α-helix with a narrow hydrophilic face and an 
arrangement of cationic residues that is typical for the so-called lytic polypeptides. To examine 
the functional and structural roles of this putative amphipathic α-helix, we have constructed nine 
Coxsackie B3 virus mutants by site-directed mutagenesis of an infectious cDNA clone. Six mutants 
contained substitutions of the charged residues in the hydrophilic face of the α-helix. Three 
mutants contained insertions of leucine residues between the charged residues, causing a 
disturbance of the amphipathic character of the α-helix. The effect of the mutations on virus 
viability was assayed by transfection of cells with copy RNA transcripts. The effect on positive-
strand RNA replication was examined by introduction of the mutations in a subgenomic 
luciferase replicón and the analysis of the luciferase accumulation following transfection of BGM 
cells with RNA transcripts. It is shown that both the amphipathy of the domain and the presence 
of cationic residues in the hydrophilic face of the α-helix are required for virus growth. Mutations 
that disturbed either one of these features caused defects in viral RNA synthesis. In vitro 
translation reactions and the analysis of viral protein synthesis in vivo demonstrated that the 
mutations did not affect synthesis and processing of the viral polyprotein. These results suggest 
that a cationic amphipathic α-helix is a major determinant for a function of protein 2B, and 
possibly its precursor 2ВС, in viral RNA synthesis. The potential role of the amphipathic α-helix 
in the permeabilization of cellular membranes is discussed. 
Enteroviruses contain a single-stranded RNA 
genome of positive polarity with a genetically encoded 
poly(A) tail at their 3'end. The viral RNA (vRNA) 
directs the synthesis of a single polyprotein which is 
processed by the virally encoded proteases 2Apro, 3Cpr°, 
and ЗСОР™. The PI region of the genome encodes the 
structural capsid proteins. The proteins encoded by the 
P2 and P3 regions have been implicated in viral rep­
lication (reviewed in reference 47). Replication starts by 
the formation of a complementary negative-stranded 
RNA molecule which serves as the template for the 
synthesis of progeny viral positive-stranded RNAs (5). 
The proteins encoded by the P3 region are physically 
involved in the process of postive-strand RNA synthesis 
(3, 22, 42, 43), which occurs in replication complexes on 
virus-induced cytoplasmic membrane vesicles (8). The 
proteins encoded by the P2 region are involved in the 
induction of some of the structural and metabolic 
alterations that occur in the infected cell. Protein 2Apro 
induces the cleavage of the 220-kDa component of the 
eucaryotic initiation factor eIF-4F, which results in an 
inhibition of cap-dependent host cell translation (18, 20, 
29). Translation of vRNA is not affected, because it is 
initiated via a cap-independent binding of ribosomes to 
secondary structures in the 5' nontranslated region (26, 
35). Precursor protein 2BC has been implicated in the 
rearrangement of membranes and the generation of the 
membrane vesicles at which positive-strand RNA 
synthesis occurs (7-10). The observation that protein 2C 
alone is also capable to induce this rearrangement (2, 14) 
is hampered by the use of a recombinant vaccinia virus, 
which modifies vesicular traffic itself. Protein 2C is a 
nucleoside triphosphatase (33, 39) with RNA binding 
capacities (39) that is localized at the outer surface of the 
virus-induced membrane vesicles (7, 9, 10), which sug­
gests that protein 2C may be involved in the structural 
organization of the viral replication complex by attach­
ing the vRNA to the vesicular membranes. 
Two other metabolic alterations that occur during an 
enterovirus infection are the inhibition of cellular protein 
secretion (16) and the permeabilization of the plasma 
membrane (12). Upon expression of individual polio-
virus proteins, Doedens and Kirkegaard found that pro­
tein 2B, as well as its precursor 2BC, was capable of 
inducing both alterations (16). The significance of these 
alterations, which become evident from the third hour 
postinfection, for virus replication is unclear. The block 
in protein secretion may be involved in the accumulation 
of cytoplasmic vesicles for vRNA synthesis. Apart from 
this, the inhibition of cellular protein secretion may 
interfere with host cell responses as interferon secretion 
and antigen presentation. Modification of the membrane 
permeability occurs in the late phase of infection of most 
cytolytic viruses and requires viral gene expression 
(reviewed by Carrasco et al. in reference 13). The 
modification is such that gradients of monovalent 
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cations are gradually destroyed and compounds that do 
normally not pass the membrane leak out of the cell or 
leak into the cytoplasm Carrasco et al (13) have sug-
gested that the resulting influx of sodium ions may be 
involved in the virus-induced shutoff of host cell 
translation, because the cleavage of the 220-kDa compo-
nent of eIF-4P may not be sufficient to completely shut 
off host cell translation (11, 36) High concentrations of 
sodium are inhibitory to host mRNA translation, where-
as vRNA is optimally translated under these altered 
conditions by the use of specialized structures in the 5' 
nontranslated region (13) Another function of the mem-
brane modification may be the induction of the cell lysis 
needed to liberate newly formed virus particles 
Enterovirus protein 2B and its precursor 2BC are 
localized exclusively at the outer surface of the virus-
induced membrane vesicles at which positive-strand 
RNA synthesis occurs (7, 8) Genetic evidence suggests 
that protein 2B, or possibly its precursor 2BC, is re-
quired for a ciï-acting function in vRNA replication (27, 
46) The expression of protein 2B in both bacteria and 
eucaryotic cells led to an increase in cell membrane 
permeability, which suggests that protein 2B possesses 
membrane-active or lonophoric properties Both func-
tions require amphipathic helix motifs with high helical 
hydrophobic moments (19) We have identified a well 
conserved amphipathic helix motif in enterovirus protein 
2B with a narrow hydrophilic face and an arrangement 
of cationic residues that is typical for the so-called lytic 
polypeptides The conserved nature of this structural do-
main is indicative of an important role in the functioning 
of protein 2B To examine the structural and functional 
roles of this putative amphipathic o-hehx, we have con-
structed mutant Coxsackie B3 virus cDNAs that con-
tained substitutions of the charged residues in the 
hydrophilic face or insertions of hydrophobic leucine 
residues that disturb the amphipathic character of the 
helix The effects of the mutations on virus viability, 
RNA synthesis, viral protein synthesis and polyprotein 
processing were examined Our results indicate that a 
cationic amphipathic α-helix is indeed required for а 
function of protein 2B, and possibly also its precursor 
2BC, in vRNA synthesis but not for viral protein syn­
thesis or polyprotein processing The potential role of 
the amphipathic e-helix in the permeabihzation of the 
plasma membrane is discussed 
MATERIALS AND METHODS 
Cells and viruses. Virus propagations, endpoint titrations, 
and RNA transfections were performed with Buffalo green 
monkey (BGM) cells Plaque assays were performed with 
Vero cells The cells were grown in minimal essential medium 
(MEM) supplemented with 10% fetal bovine serum After 
infection, cells were fed with MEM supplemented with 3% 
fetal bovine serum After transfection, cells were fed with 
MEM containing 10% fetal bovine serum 
Oligonucleotide-directed site-specific mutagenesis. In 
vitro mutagenesis was performed with a subgenomic pALTER 
phagemid clone containing nucleotides (nt) 2080 to 4947 of 
Coxsackie B3 virus (CBV3) (46), using the Altered Sites in 
vitro mutagenesis system (Promega) according to the instruc­
tions of the manufacturer The nucleotide sequence of the 
antisense synthetic oligonucleotides (Isogen Bioscience, The 
Netherlands) used for the construction of the mutants (shown 
in parentheses) are as follows 5'-TGATATTATCCTAAC 
ТАAGGCTCTTAGAGATCTCTCTAAGAT-3' (2B-K[41,44, 
48]R [This mutant contains K-to-R mutations at positions 41, 
44, and 48]), 5-TGATATTATCTCAACTAAGGCCTCTAA 
GATTCCTCTAAGAT-3' (2B-K[41,44,48]E), 5'-TAAGGCT 
TTTAGAG AGAGCTCTA AGATGGAGTC-3' (2B-K[41 ]L), 
5'-TATCTTAACTAAGGCTAGCAGAGAGAGCTCTAAG 
ATGGAGTC-3' (2B-K[41,44]L), 5'-TTTTAGAGATTTCTTT 
AAAATGGAGTCTTGACC-Э' (2B-E[40]K), 5'-GGCTTTT 
AGAGATTTGTCTAGAATGGAGTCTTGACCCAC-3' (2B-
E[40]D), S'-AACTAAGGCTTTTAGAGACTTAAGCTCTAA 
GATGGAGTCTTGACC-3' (2B-ins[41]L), 5'-TATTATCTT 
AACTAAGGCCTTAAGTAGAGATTTCTCTAAGATGGA-
3' (2B-ins[44]L), S'-TACTAAGGCTGArATTATCTTAAGA 
ACTAAGGCTTTTAGAGATTT-3' (2B-ins[48]L) Each of 
these oligonucleotides created a novel restriction endonuclease 
site Mutant clones were identified by restriction enzyme 
analysis The nucleotide sequences of the mutant pAlTFR 
clones were verified by dideoxy chain termination sequencing 
of plasmid DNA with the oligonucleotide 5'-CCATTCAATG 
AATTTCTG-3' (nt 4117 to 4134) using the Ampli Cycle 
sequencing kit according to the instructions of the manufac­
turer (Perkin-Elmer) The 402-bp Spel-to-BssHll fragments of 
the mutant clones were introduced in the unique Spel (nt 3837) 
and ÄttHII (nt 4238) sites of plasmid pCB3/T7 which contains 
a cDNA of CBV3 (strain Nancy) behind a T7 RNA polym-
erase promoter (28) 
Construction of plasmid 2B-bomlI. Nucleotides 3862 to 
3906 of pCB3/T7 (coding sequence for protein 2B amino 
acids [aa] 40 to 55) were replaced by 45 nt encoding 15 aa of 
bombolitin II by using PCR with the synthetic 105-mer 5'-
GAATCACTAGTGGGTCAAGACTCCATCTTAAGCAAGA 
TCACCGATATCCTCGCGAAGCTTGGAAAAGTACTGG 
£C_ATTGTGGTGAGGAACCACGATGACCTGATC-3' (nt 
3832 to 3936, nucleotides encoding the bombolitin II amino 
acids are underlined) and the oligonucleotide 5'-TTGGGAT 
GGCGCGCTCTGCTC-3' (complementary to nt 4211 to 
4251) PCRs were performed with LiLTma DNA polymerase 
(Perkin-Elmer), a thermostable DNA polymerase with proof-
reading activity, and pCB3/T7 DNA as the template DNA 
The thermal profile consisted of 20 cycles of denaturation at 
94°C for 1 min, primer annealing at 55 °C for 1 min, and 
primer extension at 72°C for 2 mm The resulting PCR prod-
uct was cut with Spel and ЯиНІІ and cloned in pCB3/T7 cut 
with the same enzymes The entire introduced fragment was 
verified by sequence analysis The resulting plasmid was 
designated 2B-bomII 
Transfection of cells with copy RNA transcripts. Plas­
mids were linearized with San and transcribed by phage T7 
RNA polymerase as described previously (46) The integrity 
of the RNA transcripts was checked on a 1% agarose gel 
BGM cell monolayers grown in 25-cnr flasks to a confluencv 
of 70 to 80% were transfected with 5 μg of RNA transcripts 
using the DEAE-dextran method as described previously (46) 
After transfection, the cells were incubated at either 33 or 
36°C When virus growth was observed, the cultures were 
incubated until cytopathic effect was complete The cultures 
were then subjected to three cycles of freezing and thawing, 
and the viruses were aliquoted in stocks of I ml and stored at 
-80-C 
Sequence analysis of the 2B coding region of mutant 
viruses. Extraction of RNA, cDNA synthesis, and amplifica­
tion by PCR were performed as described previously (46), 
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using forward primer 5'-TGGTGTCATTGGCATTGTGACC 
ATGGGGGG-3' (nt 3648 to 3677) and reverse primer 5'-
TTGGG<\TGGCGCGCTCfGCTC-3' (nt 4231 to 4251) The 
resulting 604-bp PCR products were purified by low-melting-
point agarose gel electrophoresis Sequence analysis was 
performed as describe above 
Plaque assays and single-cycle growth analysis. Plaque 
assays were performed with 100% confluent Vero cell mono­
layers grown in 6-well plates as described previously (46) For 
single-cycle infections, 100% confluent BGM cell monolayers 
grown in 25-cm2 flasks (5 χ IO6 cells) were infected with virus 
at a multiplicity of infection (MOI) of 1 50% tissue culture 
infective dose per cell for 30 mm at room temperature The 
cells were grown at 33, 36, or 39"C for 2, 4, 6, or 8 h Viruses 
were released by three cycles of freezing and thawing Viruses 
were titrated on BGM cell monolayers in 96-well plates, as 
described (46) 50% tissue culture infective dose values were 
calulated according to the method of Reed and Muench (38) 
Analysis of RNA synthesis. To study the effect of the 
mutations on RNA synthesis, the Spel-to-BssHll fragments of 
the mutant plasmids were cloned in the chimeric subgenomic 
replicón pCB3/T7-LUC (46), which contains the firefly lucif-
erase gene in place of the capsid coding PI region BGM cell 
monolayers in 25-cm2 flasks grown to a confluency of 70 to 
80% were transfected with 0 5 μg of T7 RNA polymerase 
generated RNA transcripts derived from Sa/I-lineanzed 
рСВЗЛЧ-LUC constructs Cells were grown at 36°C, and at 
the indicated times posttransfection they were washed for three 
times with phospate-buffered saline (PBS) and lysed in 400 μΙ 
of lysis buffer The luciferase activity was measured in a liquid 
scintillation counter using the Luciferase Assay System accor­
ding to the recommendations of the manufacturer (Promega) 
In vitro translation reactions. Copy RNA transcipts were 
synthesized and translated in T7 TNT rabbit reticulocyte lysate 
(Promega) supplemented with 20% (vol/vol) HeLa cell initia­
tion factors (kindly provided by J Flanegan, University of 
Florida) The translation reactions (20 μ!) contained 0 5 μg 
circular plasmid DNA and 20 μΟ of Tran"S-Iabel (a mixture 
of [35S]methionine and [35S]cysteine, specific activity, > 1,000 
Ci/mmol, 1CN) After 3 h of incubation at 30°C, RNA was 
degraded by treatment with RNase T, (500 U) and RNase A (5 
μg) for 10 mm at 30°C Labeled translation products were 
analyzed on a 12 5% Polyacrylamide gel containing sodium 
dodecyl sulfate (SDS) (30) Gels were fixed, fluorographed, 
and exposed to Kodak XAR film at -80°C 
Analysis of viral protein synthesis in vivo. BGM cell 
monolayers (2x10s cells) were infected with cither wild-type 
or mutant virus at a MOI of 25 At the indicated times post­
infection, the cells were washed with PBS and incubated in 
methionine- and serum-free MEM (Gibco) containing 10 μΟ 
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Figure I. Analysis of the hydrophobic moment (amphipalhy) and hydrophobicity of Coxsackie B3 virus protein 2B according to the 
method of Fisenberg et al (19) The h\ drophobic moment (mom ) and hydrophobicity (hyd ) values for each amino acid were calculated 
using an 11-rcsiduc moving window A positive hydrophobic^ indicates a hydrophobic nature Single and double asterisks indicate one 
and two standard deviations respectively, above the average amphipathy of the Protein Identification Resource Database (1989) A plus 
sign indicates that the 11-residue window satisfies the criterion for membrane binding according to the method of Eisenberg et al (19) 
At the top of the figure is shown the 7 5-kb single-stranded RNA genome of CBV3 containing (from 5'lo 3 ) the 5' nontranslated region 
(NIR) with protein VPg covalenti} bound at its 5' end the polvprotein-encoding region (boxed), which can be divided in the structural 
PI protein region and the nonstructural P2 and P3 protein regions and the 3 NTR containing a polyadcnylate tract at its 3 end 
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of Tran31S-label. After 30 min, the medium was removed and 
the cells were lysed ¡n cold lysis buffer containing 500 mM 
Tns-HCl (pH 8 0), 150 mM NaCI, 0 l m M phenylmcthylsulf-
anyl fluoride, 1% Nomdet P-40, and 0 05% SDS Labeled 
proteins were analyzed by Polyacrylamide gel electrophoresis 
as described above 
RESULTS 
Identification and classification of a putative am-
phipathic helix in enterovirus protein 2B. We have 
searched for the presence of amphipathic helix motifs in 
CBV3 protein 2B by calculating the mean hydrophobic 
moment and hydrophobicity of 11-residue windows 
according to the method of Eisenberg et al. (19). Figure 
1 shows that amino acids 37 to 54 form the segment with 
the highest amphipathic potential. The high hydrophobic 
moment and the moderate hydrophobicity of the 11-
residue segment with the highest hydrophobic moment 
(aa 40-50; moment, 0.67; hydrophobicity, 0.11) are char-
acteristic for surface seeking amphipathic helices (19), 
i.e., helices which insert their hydrophobic part in the 
lipid membrane and expose their hydrophilic part to the 
aquous face. Graphic representation on a helical wheel 
diagram according to Schiffer and Edmundson (40) 
shows that this segment forms a putative amphipathic a-
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Figure 2. (A) Helical wheel diagrams of the putative amphipathic helices found in the 2B proteins of several enteroviruses according to 
the method of Schiffer and Edmundson (40) Positively charged (R and K.) and negatively charged (D and E) residues are underlined 
Hydrophobic ammo acids are boxed Abbreviations CBV, Coxsackie В virus, CAV, Coxsackie A virus, ECHO, echovirus, SVDV, swine 
vesicular disease virus, PV, poliovirus, BEV, bovine enterovirus (B) Helical wheel diagrams of lytic polypeptides bombolitin II, a 
heptadecapeptide isolated from the venom of bumblebee M pennsylvamcus (4), and mastoporan, a tetradecapeptide isolated from the 
venom of the wasp Vespula ¡eutsu (23) 
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helix with a narrow hydrophilic face on one side of the 
helix (Fig. 2A). The distribution of charged residues 
(three lysines and one glutamic acid) on the hydrophilic 
face is well conserved among all enteroviruses, except 
that bovine enterovirus protein 2B contains arginines 
rather than lysines at positions 44 and 48 (Fig. 2A). The 
hydrophilic face of poliovirus protein 2B is somewhat 
larger because of the occurrence of polar asparagine and 
serine residues at aa 43 and 50, respectively. On basis of 
their physical-chemical and structural properties, amphi­
pathic helices are grouped into seven classes (41). The 
arrangement of the charged residues in the putative 
amphipathic helix of CBV3 protein 2B is typical for the 
class of the so-called lytic polypeptides. These lytic 
polypeptides form a group of small cationic amphipathic 
α-helical peptides that are characterized by narrow polar 
faces with intermediate charge densities, the occurrence 
of 4 times as many positively charged residues as nega­
tively charged residues, and the occurrence of mainly 
lysine residues in the hydrophilic face (mean lysine/ 
arginine ratio = 30). Figure 2B shows examples of heli­
cal wheel diagrams of two lytic polypeptides: bombolittn 
II (4) and mastoporan (23). 
Construction of mutations in the putative amphi­
pathic helix of CBV3 protein 2B. The function and the 
structural requirements of the putative amphipathic helix 
in CBV3 protein 2B were examined by a genetic analy­
sis. A total of nine mutants, containing either substitu­
tion or insertion mutations, were generated by site-
directed mutagenesis. The mutations were verified by 
sequence analysis and introduced in the infectious 
cDNA clone pCB3/T7. The genotype of the mutant 
plasmids and the effects of the mutations on mean hy­
drophobic moment and hydrophobicity are shown in Fig. 
ЗА. Two mutants were constructed to examine the re­
quirement for lysine residues at aa 41, 44, and 48. In 
these mutants, the lysine residues were replaced with 
either arginine residues (2B-K[41,44,48]R) or negatively 
charged glutamic acid residues (2B-K[41,44,48]E). Two 
mutant plasmids were constructed to examine the mini­
mal number of lysine residues required for the role of 
this domain in the function of protein 2B. In mutant 2B-
K[41]L, lysine 41 is replaced with a leucine residue. In 
mutant 2B-K[41, 44]L, both lysine 41 and lysine 44 are 
replaced with leucine residues. In the remaining two 
substitution mutants, the importance of the negatively 
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Figure 3. (A) Partial amino acid sequence (residues 37 to 54) and the hydrophobic moment and hydrophobicity values of the 2B 
proteins encoded by wild-type pCB3/T7 and the pCB3/T7-derived mutant plasmids. The effects of the mutations on the hydrophobic 
moment (mom.) and hydrophobicity (hyd.) of bolh the entire 18-aa amphipathic helix and the most amphipathic 11-aa segment (aa 40 to 
50) are shown. Furthermore, the effects of the mutations on virus growth are summarized. (B) Helical wheel diagrams of the insertion 
mutants 2B-ins[41]L, 2B-ins[44]L, and 2B-ins[48]L, containing leucine insertions at residue positions 4 1 , 44, and 48, respectively. 
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charged glutamic acid 40 was examined. In these mu­
tants, glutamic acid 40 was replaced with either a lysine 
(2B-E[40]K) or an aspartic acid residue (2B-E[40]D). In 
the three insertion mutants (2B-ins[41]L, 2B-ins[44]L, 
and 2B-ins[48]L), hydrophobic leucine residues were 
introduced at aa 41, 44, and 48, respectively. The inser­
tion of these residues leads to the dispersion of the 
charged residues and, as a consequence, the disruption 
of the narrow polar face of the putative amphipathic 
helix (Fig. 3B), without disturbing the overall hydro-
phobicity of the domain (Fig. ЗА). 
Effect of the mutations on virus growth. The effect 
of the mutations on virus viability was studied by 
transfection of BGM cells with RNA transcripts. For 
each mutant, eight transfections were performed. After 
transfection, the cells were incubated at either 33 or 
36°C. In case no virus growth was observed after 5 days, 
the cells were subjected to three cycles of freezing and 
thawing and 250 μΙ was passaged to fresh BGM cell 
monolayers, which were incubated for another three 
(36°C) or five days (33°C). Viruses were obtained con­
sistently with RNA transcripts carrying mutations 
K[41,44,48]R, K[41]L, К[41,44]L, and E[40]D. Plaque 
assays were performed and four individual plaques were 
isolated from each mutant virus. Sequence analysis of 
the 2B coding region of these viruses showed that the 
mutations introduced by site-directed mutagenesis were 
retained in the vRNA and that no other amino acid re­
placements had occurred. These viruses were designated 
vCB3-2B-K[41,44,48]R, vCB3-2B-K[41]L, VCB3-2B-
K[41,44]L, and vCB3-2B-E[40]D, respectively. No vi­
rus growth was observed upon transfection of BGM 
cells with RNA transcripts containing mutations K[41, 
44,48]E, ins[41]L, ins[44]L, or ins[48]L. To ensure that 
the nonviability of these mutations was not due to addi­
tional mutations in the plasmid DNA, new constructs 
carrying these mutations were made and RNA tran­
scripts were assayed for their viability. Consistent with 
our initial results, no virus growth was observed follow­
ing transfection. 
Upon transfection with RNA transcripts of mutant 
2B-E[40]K, virus growth was observed in only two of 
the eight transfected cultures. In one cell culture, virus 
growth was observed at the second day posttransfection. 
Sequence analysis of the 2B coding region of these 
viruses showed that the introduced lysine 40 (AAG) was 
reverted to the original glutamic acid (GAG) by a single 
point mutation. No cytopathic effect was observed in the 
remaining seven transfected cell cultures. Upon passage 
of these cultures, however, virus growth became visible 
in one of the cultures grown at 33 °C. Sequence analysis 
of the 2B coding region of these viruses showed that the 
introduced lysine 40 (AAG) was retained in the vRNA 
and that no other mutations had occurred. This finding 
was rather unexpected, because the lack of virus growth 
in the other cultures suggested that a reversion of the 
introduced mutation to a more favorable residue or a 
second-site compensating mutation in protein 2B had 
occurred. To investigate whether mutation E[40]K in-
virus yield (log TCID50/ml) 
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Figure 4. Single-cycle growth curves of wild-type and mutant 
viruses vCB3-2B-K[41,44,48]R, vCB3-2B-K[41]L, vCB3-2B-
K[41,44]L, and vCB3-2B-b[40]D BGM cells were infected at a 
MOI of 1. incubated at 36°C. and harvested at 2, 4, 6, and 8 h 
postinfection Viruses were released from the infected cells b> 
three cycles of freezing and thawing, and the virus titers were 
determined by titration on BUM cells at 36°C TCID,„, 50% 
tissue culture infective dose 
deed allows virus growth and to exclude the possibility 
that the phenotype of the original mutation was influ­
enced by an additional mutation elsewhere in the plas­
mid DNA, which might have arisen during the plasmid 
construction, virus nt 3837 to 4238 (which were found to 
be identical to those of plasmid 2B-E[40]K) were ampli­
fied, cut with Spel and BssHU, and cloned into wild-type 
pCB3/T7. BGM cells were transfected with RNA tran­
scripts of several independently reconstructed plasmids. 
However, no virus growth was observed in any the 
transfected cell cultures. These data strongly suggest that 
mutation E[40]K is nonviable, and that the viability and 
phenotype of the isolated virus are due to a second-site 
mutation outside 2B. For this reason, the virus was not 
included in further characterization studies. 
Viral growth characteristics were examined both by 
plaque assay and single-cycle growth analysis (at 33, 36, 
and 39°C). Mutant viruses vCB3-2B-K[41,44,48]R and 
vCB3-2B-E[40]D exhibited a wild-type growth at all 
temperatures. Mutant virus vCB3-2B-K[41]L displayed 
a small-plaque phenotype. In single-cycle infections, this 
virus produced 20% of the wild-type virus yield at 8 h 
postinfection, irrespective of the temperature. Virus 
vCB3-2B-K[41,44]L exhibited a minute-plaque pheno­
type. This virus appeared to be slightly cold-sensitive as 
the virus yield was 1% ofthat of the wild-type virus at 
36 and 39°C, but only 0.05% of that of the wild-type 
virus at 33 °C. Figure 4 shows the viral growth curves of 
the mutant viruses at 36°C. The effects of the mutations 
on virus growth arc summarized in Fig. 3. 
Effect of the mutations on RNA replication. In a 
previous study, we reported the construction and use of 
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chimeric subgenomic replicón pCB3/T7-LUC, which 
carries the luciferase gene in place of the PI protein 
coding region, to study RNA replication (46). Upon 
transfection of BGM cells with RNA transcripts of 
pCB3/T7-LUC, a triphasic pattern of luciferase accumu-
lation was observed; luciferase acitivity increased as a 
result of translation of the input RNA (phase I), re-
mained constant until the fifth hour posttransfection 
(phase II), and showed a second increase as a result of 
the translation of newly synthesized chimeric RNA 
strands (phase III). That luciferase accumulation indeed 
reflected vRNA replication was demonstrated by meas-
uring replicón RNA levels by dot blot hybridization 
(data not shown). To study the effect of the mutations on 
RNA replication, the Spel-to-BssHll fragments of the 
mutant plasmids were cloned in replicón pCB3/T7-LUC. 
BGM cells were transfected with RNA transcripts of the 
mutant replicons, and luciferase activity was determined 
at 1,4, 6, 8, and 10 h posttransfection. The effects of the 
viable mutations on RNA replication are shown in Fig. 
4 -
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Figure 5. Effects of the viable (A) and nonviable (B) mutations 
on the replication of chimeric luciferase replicón pCB3/T7-
LUC BGM cell!, were transfected with copy RNA transcripts of 
mutant replicons, and the luciferase activity was determined as 
described in Materials and Methods at the indicated times 
posttransfection (C) Luciferase accumulation alter transfection 
of BGM cells with copy RNA of mutant replicón pCB3/T7-
LUC-bomll. which contains a substitution of protein 2B aa 40 
to 54 by 15 aa of lytic peptide bombolitin II. 
5A. The introduction of mutation K[41]L resulted in a 
reduced level of RNA replication, as the increase in 
luciferase activity was only fourfold, whereas the in-
crease in luciferase accumulation was 10- to 20-fold in 
the case of mutations K[41,44,48]R and E[40]D and 
wild-type pCB3/T7-LUC. Mutation K[41,44]L caused a 
more drastic reduction in RNA synthesis, as demon-
strated by the absence of a notable increase in luciferase 
activity. The failure to detect a low level of RNA rep-
lication is most likely due to the low infectivity of the 
RNA transcripts, as has been explained previously (46). 
The effects of the nonviable mutations on replicón repli-
cation are shown in Fig. 5B. This figure shows that each 
of the mutations K[41,44,48]E, E[40]K, ins[41]L, 
¡ns[44]L, and ins[48]L, disturbed RNA replication but 
not translation of the chimeric RNA transcripts. The 
stability of the RNA appeared to be unaffected by the 
mutations, as the activity of luciferase, which is an un-
stable enzyme in vivo, remained constant up to 10 h 
posttransfection, suggesting a balance between transla-
tion of the input RNA and luciferase degradation. 
Analysis of in vitro protein synthesis and polypro-
tein processing. In vitro translation reactions were per-
formed to examine whether any of the mutations af-
fected polyprotein synthesis and processing. RNA was 
synthesized and translated in a single reaction mixture 
using T7 TNT rabbit reticulocyte lysate, a combined 
transcription-translation system, supplemented with 
HeLa cell initiation factors. The patterns of 35S-labeled 
proteins translated from the mutant pCB3/T7 RNAs are 
shown in Fig. 6A. The results demonstrate that none of 
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Figure 6. In vitro translation reactions of RNA transcripts 
derived from the plasmids carrying mutations in the putative 
amphipathic helix (A) and plasmid 2B-bomII (B). Circular 
plasmid DNA (0.5 μg) was incubated for 3 h in TNT rabbit 
reticulocyte lysate, a coupled transcription-translation system, 
supplemented with HeLa cell initiation factors. The f"S]-
methionine-labeled translation products were analyzed on an 
SDS-12.5% Polyacrylamide mintgel. An extract from wild-type-
virus-infected cells, labeled with [35S]methionine for 30 min at 4 
h postinfection, was used as a marker. 
the mutations caused abnormalities in polyprotein pro­
cessing. All cleavage products migrated with a correct 
mobility and the translation patterns of all mutants were 
similar to that of wild-type pCB3/T7. Although it cannot 
be excluded that minor differences in the levels of the 
replication proteins contribute to the viral phenotypes, 
these results suggest that it is unlikely that the defects in 
vRNA synthesis caused by nonviable mutations K[41, 
44,48]E, E[40]K, ins[41]L, ins[44]L, and ins[48]L, and 
the reductions in vRNA synthesis caused by viable 
mutations K[41]L and K[41,44]L are due to defects in 
polyprotein processing. 
Time course of protein synthesis in infected cells. 
The possibility that the reductions in virus yield and 
vRNA synthesis caused by mutations K[41]L and 
K[41,44]L are due to a reduced level of viral protein 
synthesis was considered. To examine this possibility, 
we studied viral protein synthesis in vivo. BGM cells 
were infected with either mutant or wild-type virus at a 
MOI of 25, and labeled with [35S]methionine for 30 min 
at various times postinfection. Figure 7 shows the elec-
trophoretic analysis of the labeled proteins. From this 
figure, it can be seen that all viruses cause a similar 
shutoff of host protein synthesis, but that viral protein 
synthesis is delayed in cells infected with the mutant 
viruses. Viral protein synthesis in wild-type-virus-
infected cells peaks at 4 to 5 h postinfection and is inhib­
ited from the sixth hour. In cells infected with small-
plaque virus vCB3-2B-K[41]L viral protein synthesis 
peaks at 5 to 6 h postinfection, whereas in cells infected 
with minute-plaque mutant vCB3-2B-K[41,44]L, viral 
protein synthesis is even delayed up to 6 to 7 h postin­
fection. These differences probably reflect a delayed 
growth of the mutant viruses and, as a result, a delay in 
cytopathic effect. Although viral protein synthesis is 
delayed in the mutant-infected cells, the level of viral 
protein synthesis is similar to that in wild-type-virus-
infected cells, suggesting that it is unlikely that the re­
ductions in growth and vRNA synthesis of these viruses 
are due to an impaired level of viral protein production. 
Replacement of the amphipathic helix with lytic 
peptide bombolitin II. After having demonstrated that a 
cationic amphipathic α-helix is required for a function of 
protein 2B, we tested whether the α-helix could be func­
tionally replaced by cationic lytic polypeptide bombo­
litin II. Bombolitin II is a heptadecapeptide (Ser-Lys-Ile-
Thr-Asp-Ile-Leu-Ala-Lys-Leu-GIy-Lys-Val-Leu-Ala-
His-Val) identified in the venom of the bumblebee 
Megabombus pennsylvanicus (4). A helical wheel repre-
2 3 4 5 6 7 8 
vCB3-2B-K[41]L vCB3-2B-K[41,44]L СВЗ wild-type 
Figure 7. Protein synthesis in BGM cells infected with vCB3-2B-K[4l]l., vCB3-2B-K[4l,44]L, and wild-type virus. Cells were infected 
at a MOI of 25. grown at 36°C, and incubated with methionine- and serum-free MEM containing 10 μ ο of Tran"S-label (a mixture of 
["S]methionine and [5,S]cysteine) at various times postinfection (indicated [in hours] above each lane). After a 30-min labeling period, 
the cells were washed and lyscd. The labeled proteins were analyzed on an SDS-12.5% Polyacrylamide minigel. 
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sentation of this peptide shows that if can form an 
amphipathic α-helix with a narrow polar face of six 
amino acids containing three lysine residues, one nega­
tively charged aspartic acid, and two polar residues (Fig. 
2B). Alignment of the amino acid sequences of both 
helices showed that bombolitin 11 resembles aa 40 to 56 
of CBV3 protein 2B (Fig. 8A). We have replaced the 
nucleotide sequence encoding aa 40 to 54 with a se­
quence encoding the first 15 aa of bombolitin II. The 
nucleotide sequence of the introduced PCR product was 
verified, and the resulting plasmid was designated 2B-
bomll. A helical wheel diagram of aa 37 to 54 of this 
chimeric plasmid is shown in Fig. 8B. In vitro transla­
tion of RNA from this plasmid showed a processing 
pattern that was similar to that produced by wild-type 
рСВЗЯ7 RNA (Fig. 6B). То study the viability of this 
chimeric construct, BGM cells were transfected with T7 
RNA polymerase-generated RNA transcripts. A total of 
10 transfections, including passage of the transfected cell 
cultures to fresh cells, was performed. In none of the 
transfected cell cultures, however, was virus growth 
observed. The Spel-to-ÄswHII fragment of 2B-bomII 
was introduced in subgenomic replicón pCB3/T7-LUC 
to study RNA replication. Analysis of the luciferase 
accumulation following the transfection of BGM cells 
with copy RNA transcripts demonstrated a defect in 
replication of the replicón RNA (Fig. 5C). This finding 
suggests that despite the structural similarities between 
the amphipathic helix motifs, the cationic α-helix of 
bombolitin II cannot fulfill the function of the cationic 
Cationic Amphipathic α-Helix in CBV3 Protein 2B 
amphipathic α-helix of CBV3 protein 2B in vRNA 
synthesis. 
DISCUSSION 
Membrane permeabilization is a phenomenon that 
occurs during the late phase of the replication cycle of 
most cytolytic viruses. This modification of the mem­
brane is dependent on viral gene expression. A number 
of viral proteins involved in modifying membrane per­
meability have been identified in recent years, and a 
general term for this kind of proteins has been intro­
duced: viroporins (13). A general feature of these viro-
porins is the presence of amphipathic helix motifs, 
which are thought to destabilize the membrane integrity 
by interacting with the lipid bilayer. Until recently, the 
identity of an enterovirus viroporin was unknown. Upon 
expression of the poliovirus nonstructural proteins in 
Escherichia coli, it was found that both proteins 2B and 
ЗА modified the bacterial cell membrane (31). Very 
recently, it has been shown that poliovirus protein 2B, 
but not protein ЗА, permeabilizes the plasma membrane 
in eucaryotic cells (16), suggesting that protein 2B is 
most probably the enterovirus viroporin. Consistent with 
this idea, we have identified an amphipathic helix motif 
in protein 2B that is conserved among all enteroviruses 
(Fig. 2A). The arrangement of charged residues in a 
narrow hydrophilic face and the predominant occurrence 
of cationic lysine residues are typical of amphipathic 
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Figure Η. (A) Alignment of aa 37 to 57 of CBV3 protein 2B with the amino acid sequence of cationic α-helical lytic polypeptide 
bombolitin II (4) Positively charged (R and K) and negatively charged (D and E) residues are underlined Hydrophobic amino acids are 
boxed (B) Helical wheel diagrams showing the amphipathic α-helices (аа 37 to 54) of wild-type CBV3 protein 2B (as encoded in 
plasmid pCB3T7) and chimeric protein 2B encoded in plasmid 2B-bomII. In plasmid 2B-bomII, nt 3862 to 3906 (coding for aa 40 to 
54) are replaced with 45 nt encoding the first 15 aa of bombolitin II. 
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helices formed by members of the class of lytic poly­
peptides 
In this study, we have examined the functional and 
structural roles of the putative amphipathic helix in 
CBV3 protein 2B Nine mutant cDNAs were construct­
ed by site-directed mutagenesis The results obtained 
with the mutants carrying substitutions of the lysine 
residues (aa 41, 44, and 48) suggest that cationic resi­
dues are required for the role of the amphipathic helix in 
the function of protein 2B Replacement of the lysine 
residues with arginine residues (K[41,44,48]R) did not 
affect virus growth, whereas substitution of the lysine 
residues with negatively charged glutamic acid residues 
(K[41,44,48]E) was nonviable because of defects in 
vRNA replication Substitution of lysine 41 by a leucine 
residue (K[41]L) yielded a small-plaque virus that pro­
duced 20% of the wild-type virus yield in a single-cycle 
infection, because of a reduction in vRNA synthesis 
Substitution of both lysine 41 and lysine 44 by leucine 
residues (K[41,44]L) yielded a minute-plaque virus that 
produced only 1% of the wild-type virus yield in a 
single-cycle infection, because of a more severe defect 
in vRNA synthesis These results suggest that the pres­
ence of cationic residues is a major determinant for the 
function of the amphipathic helix in protein 2B The 
introduction of negatively charged residues m the hy-
drophihc face of the helix disrupts the function of pro­
tein 2B, although the amphipathic helix containing mu­
tation K.[41,44,48]E displays a hydrophobic moment that 
is equal to or even larger than the moments of the helices 
containing mutations K[41]L or K[41,44]I, respectively 
(Fig ЗА) 
Two substitution mutations were introduced to inves­
tigate the importance of the negatively charged glutamic 
acid 40 in the function of the amphipathic helix The 
introduction of a lysine residue (b[40]K) was highly 
detrimental for virus growth, although this mutation has 
virtually no effect on the amphipathy of the α-helix (Fig 
ЗА) Viruses containing this mutation were isolated only 
on one occasion The failure to recover viruses from 
simultaneously transfected cell cultures suggested that a 
second-site compensating mutation might have occurred 
No such mutation was found in protein 2B Recon­
struction of the mutation into wild-type cDNA followed 
by transfection of cells with RNA transcripts of the 
resulting clones did not give rise to virus growth These 
data are indicative of the occurrence of an additional 
second-site mutation outside 2B Experiments to test this 
possibility are currently in progress The wild-type 
growth characteristics of viruses carrying a replacement 
of glutamic acid 40 with a negatively charged aspartic 
acid (E[40JD) demonstrate that a negatively charged 
residue is preferred at this position The reason for the 
preference for a negatively charged residue in the h>dro-
philic face of this cationic amphipathic o-hehx is un­
known None of the substitution mutations interfered 
with viral protein synthesis and polyprotem processing, 
indicating that the effects of these mutations on virus 
growth are primarily attributable to defects in vRNA 
replication 
The importance of the amphipathic character of the 
helix for the function of protein 2B was demonstrated by 
the characterization of the three insertion mutants Leu­
cine residues were inserted between the charged residues 
(ins[41]L, ins[44]L, and ins[48]L), such that the amphi­
pathy of the α-helix was severely disturbed whereas its 
mean hydrophobicity was unaffected These mutations 
caused severe defects in vRNA synthesis and were all 
nonviable The hydrophobic moments of these helices 
were similar to that containing mutation K[41,44]L (Fig 
ЗА) A main difference, however, is that because of the 
insertion mutations, the charged residues are dispersed 
and even located in the hydrophobic part of the helix, 
which probably interferes with the hydrophobic inter­
action with the membrane, whereas the narrow hydro-
philic face and the hydrophobic part of the o-helix are 
maintained by mutation K[41,44]L None of the inser 
Hon mutations affected the synthesis and processing of 
the viral protein, indicating that they primarily affected 
vRNA synthesis Altogether, the results obtained with 
both the substitution and insertion mutants suggest that 
an amphipathic α-helix containing predominantly cation­
ic lysine residues in a narrow hydrophihc face is a major 
structural determinant involved in a function of protein 
2B, and possibly its precursor 2BC, m vRNA replica­
tion 
The structure of the cationic amphipathic a-heliccs 
found in enterovirus protein 2B shows close similarities 
to that of the cationic amphipathic a-hchcal peptides that 
form the class of lytic polypeptides (41) Most of these 
short cationic lytic polypeptides have been identified in 
the venom of insects or the skin of amphibies and are 
involved in an antibacterial defense system Two models 
of action have emerged from the structural and function­
al studies on these peptides (reviewed in reference 6) In 
one model, the cytolytic helices form aqueous channels 
by spanning the membrane and forming oligomers, 
exposing their hydrophobic sides to the lipid bilayer and 
their hydrophihc faces to the aqueous pores Although 
anion selectivity may be predicted, membrane currency 
measurements have demonstrated that cationic peptides 
can form either anion-selective (15, 17, 45) or cation-
selective ion channels (1, 24, 44) These channels pro­
duce ionic imbalances which will ultimately result in 
colloid osmotic lysis A second model proposes that 
these peptides produce lysis by disrupting the phospho­
lipid structure of the membrane by lying parallel to the 
membrane and perturbing the membrane, making the 
membrane phospholipids more susceptible to the en­
zymatic degradation by phospholipases (6, 41) The 
resulting lesions in the membrane would allow a flux of 
ions, causing the ionic imbalances that are responsible 
for lysis of the cell 
The modification of the plasma membrane that oc­
curs during an enterovirus infection is such that both 
gradients of sodium and potassium are disturbed and 
small nonpermeative translation inhibitors like neomy­
cin В and edeine can enter the virus-infected cells (13) 
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Later in infection the cellular membrane becomes more 
severely disrupted, and enzymes and sugars can also 
leak out of the infected cells (13) The initial permeabil­
ity of the plasma membrane for both monovalent cations 
and small translation inhibitors suggests that pores or 
membrane lesions, rather than a specific ion pump, are 
formed By analogy with the lytic polypeptides, protein 
2B may form transmembrane cation-selective pores or ly 
collateral to the membrane, making the phospholipids 
more accessible to the action of phosphohpases Both 
mechanisms would account for the observed ion fluxes 
across the membrane, causing the ionic imbalances that 
may be responsible for a further destabilization of the 
membrane Many cytolytic viruses have been reported to 
increase phosphohpase activity In poliovirus infected 
cells choline and phosphorylchohne arc released in the 
culture medium and the levels of diacylglycerol and 
inositol triphosphate in the cytoplasma are increased 
from the third hour postinfection (21) Although this 
finding suggests that the membrane modification may be 
caused by phosphohpases, the possibilities that protein 
2B still forms transmembrane pores and that the integra­
tion of these pores is responsible for disturbing the integ­
rity of the membrane and the activation of the 
phosphohpases cannot be excluded 
Although protein 2B has a profound effect on the 
permeability of the plasma membrane, it should be em­
phasized that there is no experimental proof for an 
interaction of protein 2B with the plasma membrane 
Electron microscopic studies using immunocytochem-
ìstry have shown that proteins 2B, 2C, and 2BC of polio-
virus are contained exclusively at the endoplasmic retic-
ulum membrane or the surface of the endoplasmic 
reticulum-dcnved membrane vesicles that surround the 
\iral replication complexes (8) Intracellular localization 
of individual expressed poliovirus protein 2B in eucary-
otic cells showed a disseminated distribution throughout 
the cytoplasm (2) These findings suggest that protein 
2B interacts with intracellular membranes rather than 
with the plasma membrane On basis of these observa-
tions, an alternative mechanism for the induction of the 
plasma membrane modification may be proposed Be-
cause of its lonophonc or membrane perturbing proper-
ties, protein 2B may permeabilize endoplasmic reticu-
lum membranes and cause the leakage of stored calcium 
ions into the cytosol The consequences of a permanent 
increase in cytosohc calcium concentration for cellular 
metabolism and virus reproduction are unknown How-
ever, as calcium is a regulator of a broad spectrum of 
physiological processes, it is likely that an increased 
calcium level is highly toxic for an array of cellular 
structures and processes Increased cytosohc calcium 
levels in rotavirus (32), Semliki Forest virus (37), 
cytomegalovirus (34) and recently also in pohovirus-
infected cells (25) have been demonstrated The possible 
role of the alterations in calcium ion concentrations in 
viral replication, membrane permeabihzation, and cell 
lysis, however remains to be elucidated 
Mutations that disrupt the cationic amphipathic a-
helix in protein 2B cause primary defects in vRNA 
synthesis, suggesting that the initial consequence of the 
membrane modification (ι e, the efflux of potassium 
ions and the influx of sodium ions or, alternatively, the 
efflux of calcium) is a prerequisite for vRNA replication 
However, the possibility that the cationic amphipathic 
helix is also required for the second function that has 
been attributed to protein 2B, ι e , the inhibition of cellu­
lar protein secretion, cannot be excluded It has been 
proposed that this inhibition is involved in the accumu­
lation of membrane vesicles on which positive-strand 
RNA synthesis occurs (16) Permeabihzation of mem­
branes may be required for this function, by causing 
either an altered ionic environment that may be inhibito­
ry to protein transport or a nonspecific leakiness of 
intracellular organelle membranes and the loss of mole­
cules crucial for transport A disruption of the cationic 
amphipathic helix may interfere with the accumulation 
of the virus-induced membrane vesicles that are required 
for the formation of the viral replication complexes and 
thereby may be responsible for the defects in vRNA 
replication 
Although the results presented in this paper indicate 
that the cationic amphipathic α-hehx in protein 2B is an 
important requirement for its function in vRNA synthe­
sis, replacement of this structural motif with the cationic 
amphipathic helix of lytic peptide bombohtin II resulted 
in a nonfunctional protein 2B Both amphipathic helices 
contain a small hydrophihc face formed by three lysines, 
one negatively charged residue and two polar residues 
(Fig 2) The nonviabihty of this chimeric construct (2B-
bomll) suggests that the position of the charged residues 
in the helix may be crucial either for the formation of a 
cation specific pore or for the membrane-perturbing ca­
pacity Alternatively, alterations in amino acid sequence 
of this domain may interfere with a possible interaction 
of the putative amphipathic helix with another mem­
brane-interacting domain of CBV3 protein 2B Potential 
candidates for such an interaction are the N-terminal 16 
aa, which also have considerable potential to form an 
amphipathic α-hehx (Fig 1), and the hydrophobic do­
main, formed by aa 63 to 80, which contains an amino 
acid composition and hydrophobicity features that are 
characteristic of multimene transmembrane regions (46) 
Either of these domains may, together with the cationic 
amphipathic α-hehx, cooperatively be involved in the 
formation of a cation-specific pore Additional muta­
tional analysis and analysis of the effect of individually 
expressed mutant 2B proteins on membrane permeabil­
ity and protein secretion are required for a better under­
standing of the involvement of protein 2B in membrane 
modification and virus replication 
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KARLA K.IRKEGAARD2, AND JOHN R. DOEDENS2 
Department of Medical Microbiology', University of Nijmegen, The Netherlands 
Department of Molecular, Cellular, and Developmental Biology2, University of Colorado, USA 
Expression of poliovirus protein 2B in mammalian cells inhibits protein secretion and 
increases the susceptibility of the cells to hygromycin B, consistent with the increase in plasma 
membrane permeability seen during poliovirus infection (J. R. Doedens and K. Kirkegaard, 
EMBO J. 14, 894-907, 1995). We report here that expression of protein 2B of the closely related 
Coxsackie B3 virus (CBV3) leads to the same biochemical alterations. Analysis of several mutant 
CBV3 2B proteins that contain mutations in a predicted cationic amphipathic α-helix (F. J. M. 
van Kuppeveld, J. M. D. Galama, J. Zoll, P. J. J. C. van den Hurk, and W. J. G. Melchers, J. 
Virol. 70, 3876-3886, 1996) demonstrated that the integrity of this domain is crucial for both 
biochemical functions of 2B. Mutations in a second hydrophobic domain (F. J. M. van 
Kuppeveld, J. M. D. Galama, J. Zoll, and W. J. G. Melchers, J. Virol. 69, 7782-7790, 1995), on 
the other hand, are more disruptive to the ability of CBV3 2B to inhibit protein secretion than to 
increase membrane permeability. Therefore, inhibition of protein secretion is not merely a 
consequence of the membrane changes that increase uptake of hygromycin B. The existence of 
mutations that interfere with virus growth but do not impair the ability of 2B to inhibit protein 
secretion or increase membrane permeability argues for additional functions of protein 2B. 
The genus Enterovirus consists of the polioviruses, 
coxsackieviruses, echoviruses, and several enterovirus 
serotypes. Enteroviruses, like other picomaviruses, are 
small nonenveloped viruses which contain a 7.5-kb 
single-stranded RNA molecule of positive polarity that 
is translated into a large polyprotein (22, 34). This poly-
protein is processed by virally encoded proteinases to 
the PI region proteins, which form the viral capsid, and 
the P2 and P3 region proteins, most of which are re­
quired for viral RNA (vRNA) replication (reviewed in 
reference 42). The P2 region proteins have also been 
implicated in the structural organization of viral replica­
tion complexes and in the induction of several of the 
morphological and biochemical alterations that occur 
during infection. Protein 2A is a proteinase that, in addi­
tion to cleaving the viral polyprotein, induces the cleav­
age of the 220-kDa component of initiation factor 
eIF-4F (25), implicated in the inhibition of translation of 
cellular mRNAs (16, 18). Protein 2BC expression can 
induce the formation of membrane vesicles (4, 9) and 
therefore may be the viral protein responsible for the 
generation of the small membrane vesicles on which 
vRNA replication takes place (7-10). Protein 2C is a 
small NTPase with RNA binding properties (30, 36), 
located at the cytoplasmic surface of the virus-induced 
membrane vesicles where it may be involved in attach­
ing the vRNA to the membranous replication complex 
(7, 8, 10). 
Recently it was found that the expression of poliovi-
rus protein 2B or 2BC results in two of the major bio­
chemical alterations that occur during enterovirus infec­
tion: the inhibition of protein secretion (14) and the 
permeabilization of the plasma membrane (5, 14). The 
relevance of these activities to the viral life cycle re­
mains to be elucidated. The required residues and the 
mechanism of induction of these alterations are also 
unknown. The finding that protein 2B permeabilizes cel­
lular membranes in both mammalian cells and Escheri­
chia coli (27) suggests that it may function as an iono-
phore or otherwise disrupt membrane function. Proteins 
that display such properties often contain cationic am­
phipathic α-helical motifs (6, 17, 37). Enterovirus 2B 
proteins all contain two hydrophobic domains, the more 
NH2-terminal of which is predicted to form a cationic 
amphipathic α-helix (Fig. 1). Mutational analysis of Cox­
sackie B3 virus (CBV3) protein 2B argued that the cat­
ionic and amphipathic character of the predicted α-helix 
was indeed required for the function of 2B in vRNA 
replication and virus growth (39). Mutational analysis of 
the second hydrophobic domain of CBV3 protein 2B 
demonstrated that mutations that caused severe increases 
or decreases in the hydrophobic character of the domain 
also impaired the function of protein 2B in the viral 
replicative cycle (40). 
Here we report that CBV3 protein 2B, like poliovirus 
protein 2B, is able to inhibit transport through the cellu­
lar secretory pathway and to modify the susceptibility of 
cells to hygromycin B, a translation inhibitor that nor­
mally enters cells poorly, in the absence of other viral 
proteins. Analysis of the activities of several mutant 
CBV3 2B proteins (Fig. 1) in protein secretion inhibition 
and increased susceptibility to hygromycin В suggests 
that these two activities are separate functions of protein 
2B rather than that one of these effects is the conse­
quence of the other. Furthermore, the results indicate 
that the predicted cationic amphipathic α-helix is in-
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amphipathic α-helix hydrophobic domain 
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Figure 1. Sequences of wild-type and mutant 2B proteins used in this stud) Alignment of the complete amino acid sequences of 
poliovirus (PV) type 1 Mahoney and Coxsackie B3 virus (ГВ З) is shown in the top panel Numbering is with respect to CBV3 2B 
protein Solid lines indicate ammo acid identity colons indicate similarity dashes indicate gap;, in the alignment Periods indicate 
unchanged residues and parentheses indicate locations in which amino acids have been inserted, not substituted 
volved in both the inhibition of protein secretion and the 
permeabilizing activity, whereas mutation of the second 
hydrophobic domain has a greater effect on the secretion 
inhibition function 
MATERIALS AND METHODS 
Cells, antibodies, and reagents. COS-1 cells were grown 
as described (14) Affinity-purified rabbit polyclonal antibody 
to alpha-1 protease inhibitor (A1PI) was obtained from Os­
wald Pfenniger and Jerry Brown (University of Colorado 
Health Sciences Center) Hygromycin В was from Boehnnger 
Mannheim Fixed Staphylococcus aureus cells for collecting 
immune complexes were obtained from Gibco-BRL 
Construction of plasmids. The dicistronic plasmid 
p2BNCa6 containing the poliovirus 2B coding region as the 
first cistron and the A1 PI coding region as the second cistron 
has been described previously (14) pC2Bi6, containing the 
CBV3 2B sequence upstream of Al PI, was constructed by 
PCR amplification of the CBV3 2B coding sequence from 
pCB3/T7 (24) The oligonucleotide primers, 5 -GCAATGTCG 
ACCATGGGAGTGAAGGACTATGTG-3' and 5'-AAGCCA 
CCCGGGCTATTGGCGTTCAGCCATAGG-3', introduced a 
San site and an initiation codon upstream of the CBV3 2B 
coding region and a stop codon and a .Smal site downstream of 
the 2B coding region The 327-bp amplified fragment was cut 
with Sail and Smal and cloned into pLINKxé, a plasmid 
containing Sail and Sma\ sites upstream of the poliovirus 
5 -noncoding region and the Al PI coding region (14) The 2B 
coding region of the mutant pCB3/T7 plasmids carrying muta-
tions in either the hydrophobic domain (40) or the amphipathic 
α-helix (39) of protein 2B was amplified with the same prim­
ers Amplified products were cut with Spel and Smal and 
cloned into pC2Bo6 from which the corresponding fragment 
was deleted The 2B coding sequence of all constructs was 
confirmed by sequence analysis 
Secretion assays. COS-1 cells growing on 60-mm dishes 
were transfected using a standard calcium phosphate method 
(3) All labelings were performed 2 days posttransfection To 
radiolabel cells with ["S]methionine, transfected COS-1 cells 
were washed with phosphate-buffered salt solution (PBS) and 
incubated m 1 ml of methionine-free DMEM supplemented 
with 50 μΟ ot [J5S]methionme (Expre^S^S protein labeling 
mix, New Fngland Nuclear) for 30 min Following labeling, 
the cells were washed with PBS and placed in 1 ml fresh 
medium containing 0 23 mM unlabeled methionine for 2 h M 
the end of the chase period, the culture medium was removed 
and saved for further analysis Cells were harvested by scrap­
ing into 0 5 ml PBS at 4°C The cells were pelleted by centnf-
ugation at 300 χ g for 5 min and resuspended in 200 μΐ of PBS 
containing 1% Triton X-100, 0 5% sodium deoxycholate, and 
1 mM phenylmethylsulfonyl fluoride at 4°C After 30 mm on 
ice, detergent-insoluble material was pelleted in a microcentri­
fuge, and the supernatants were transferred to fresh tubes 
Immunoprecipitation of Al PI. Rabbit polyclonal anti­
body directed against Al PI was diluted in PBS containing 1% 
Triton X-100, 0 5% sodium deoxycholate, 0 5% SDS, and 1% 
bovine serum albumin An equal volume of antibody dilution 
was added to each lysate sample to be precipitated Two 
hundred microliters of antibody dilution was added to each 1-
ml sample of culture supernatant Immune precipitations were 
then incubated tor 2 h on ice, and antibody-antigen complexes 
were collected by incubation with fixed 5 aureus cells The 
cells and bound immune complexes were washed three times 
in ice-cold PBS containing 1% Triton X-100, 0 5% deoxy­
cholate, and 1% SDS Immunoprecipitated Al PI from cell 
lysales and culture supernatants was then displayed by 
SDS-PAGE and quantified on a phosphonmager (Molecular 
Dynamics) Relative amounts of AI PI secretion were deter­
mined from the ratio of Al PI detected in the supernatant to 
that detected in the cell extract This \alue was adjusted to I 0 
for cells expressing Al PI alone with no 2B protein, and the 
ratios for cells transfected with wild-type and mutant 2B 
proteins were normalized 
Hygromycin В sensitivity of transfected cells. Sensitivity 
of transfected COS-1 cells to hygromycin В was determined as 
described previously (14) except that the labeling period was 
increased to 1 h Preparation of lysates and immunoprecipita­
tion of Al PI was as described above Protein concentrations 
were determined using the Bio-Rad DC protein assay (Bio-
Rad) Al PI activities were calculated as Al PI phosphonmager 
counts/jig protein input into immunoprecipitation and the 
ratios of Al PI synthesized in the presence and absence of 
hygromyen В were determined When indicated this value 
was adjusted to 1 0 for cells expressing Al PI alone with no 2B 
protein, and the ratios for cells transfected with wild-type and 
mutant 2B proteins were normalized 
RESULTS 
The finding that poliovirus 2B protein inhibited 
transport through the cellular secretory pathway and 
increased plasma membrane permeability to hygromycin 
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В ¡η the absence of other viral proteins (14) led us to ask 
(i) whether this function is conserved among other enter-
oviral 2B proteins and (ii) which structural protein do­
mains are involved in these activities. We chose to test 
CBV3 protein 2B because the phenotypes of viruses 
containing a number of different mutations in each of 
two hydrophobic domains of this protein (Fig. 1) have 
been recently characterized (39,40). 
Inhibition of protein secretion by Coxsackie B3 
virus protein 2B. The CBV3 2B coding region was in­
serted into a dicistronic plasmid designed to express both 
a single viral protein and human Al PI, a secreted pro­
tein. The predicted mRNA from the dicistronic plasmids 
is diagramed in Fig. 2A. Because AI PI is not expressed 
in untransfected COS-1 cells, secretion of Al PI pro­
duced from dicistronic mRNAs can be used to measure 
effects of the coexpressed viral proteins on secretory 
pathway function (14). COS-1 cells were transfected 
with plasmids that encoded poliovirus protein 2B, CBV3 
protein 2B, or no viral protein in the first cistron, and 
secretion of the A1 PI encoded in the second cistron was 
assayed in a pulse-chase experiment (Fig. 2B). 
In cells that expressed only A1 PI, Al PI secretion can 
be observed both from the observation that most of the 
labeled protein was found in the medium after a 2-h 
chase and from the shift in electrophoretic mobility that 
resulted from modification of N-linked oligosaccharides 
on Al PI within the secretory pathway. In cells trans­
fected with the plasmid that expresses poliovirus protein 
2B as well as Al PI, only 36% of the amount of radio­
labeled Al PI was released into the culture medium in 
the 2-h chase period. Similarly, the expression of CBV3 
protein 2B reduced secretion of A1 PI to 59% of the 
control (Fig. 2B). The lower level of inhibition of Al PI 
secretion by CBV3 protein 2B may reflect either a lesser 
ability of this protein to inhibit secretory pathway func­
tion or a lower level of expression. Nevertheless, the 
ability of CBV3 protein 2B to inhibit Al PI secretion 
indicates that this activity is conserved among these two 
enteroviruses. 
Coxsackie B3 virus protein 2B increases the sensi­
tivity of cellular translation to hygromycin B. Hygro-
mycin В is an inhibitor of translation to which mam­
malian cells are ordinarily relatively insensitive, because 
the compound enters cells poorly. Increased sensitivity 
of translation to hygromycin В has been demonstrated in 
cells infected with poliovirus and several other viruses 
(5, 31, 32, 33). In poliovirus-infected cells, this in­
creased sensitivity correlates with increased efflux of 
86Rb (29) and is thus thought to reflect increased perme­
ability of the cellular plasma membrane to the drug. In 
addition, E coli that express poliovirus protein 2B show 
increased uptake of ONPG, increased efflux of ['H]uri-
dine, and increased sensitivity to hygromycin В (27), 
further suggesting that this protein can significantly alter 
membrane permeability and that these changes can be 
detected as increased sensitivity of translation to hygro­
mycin B. 
To determine whether expression of CBV3 protein 
A 
2B PV5'NC Al PI 
В 
A1 PI only PV2B CBV3 2B 
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Figure 2. Effect of expression of CBV3 2B protein on secre­
tion of A1 PI (A) Predicted dicistronic mRNA for coexprcssion 
of 2B proteins and A1PI Iranslation of A1PI in the second 
cistron is driven by the internal nbosome entry site (1RES) 
element wilhin the poliovirus 5'-noncoding region (PV5'NC) 
(B) COS-1 cells were transfected with dicistronic plasmids 
containing the indicated 2B coding region as the first cistron 
and AI PI sequence as the second Two days posttransrection. 
the cells were radiolabeled with [3,SJmethioninc for 30 mm and 
chased in unlabeled methionine for 2 h At the end of the chase 
period, culture supematants and cell lysates were harvested and 
A1P1 in each sample was quantified by immunoprecipitation 
followed by SDS-PAGE and phosphonmagcr analysis The 
phosphonmage shows radiolabeled Al PI immunoprecipitated 
from culture medium (med) and cell lysates (cells) derived from 
cells transfected with the indicated constructs The relative 
fraction of labeled A1PI secreted into the medium within the 
chase period is indicated below each pair of lanes, this normali­
zation eliminates any differences in transfcction efficiency 
between experiments The difference in migration between the 
intracellular and secreted forms of A1PI reflects incomplete 
glycosylation of the intracellular material (14) 
2B also increases sensitivity to hygromycin B, we meas­
ured the effect of hygromycin В on Al PI expression in 
transfected COS-1 cells (Fig. 3). In cells expressing no 
viral protein, hygromycin В had very little effect on 
A1PI accumulation in a 1-h labeling period, indicating 
that the cellular membranes were relatively impermeable 
to this inhibitor. In contrast, expression of either poliovi­
rus or CBV3 protein 2B increased sensitivity to hygro­
mycin В considerably. Al PI synthesis was reduced 
approximately threefold by hygromycin В in cells ex­
pressing either 2B protein, arguing that both proteins are 
capable of modifying membrane permeability. 
Effects of mutations in the amphipathic helix 
motif on secretion inhibition and hygromycin В sen­
sitivity. To investigate the contribution of the putative 
cationic amphipathic α-helix motif that comprises resi­
dues 37 to 54 of CBV3 protein 2B to secretion inhibition 
and hygromycin В sensitivity, several mutant alleles of 
CBV3 2B with amino acid changes within this domain 
(39) were cloned into the dicistronic Al PI expression 
plasmid. The amino acid changes of five mutations 
within this domain are shown in Fig. 1. Plasmids that 
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A1 PI only PV2B CBV3 2B 
hyg - + - + - + - + - + - + 
ι 1 
В 
m 
Plasmid Iransfected 
Figure 3. Effect of expression of CBV3 2B protein on hygro-
mycin В permeability COS-1 cells were Iransfected with dicis-
tronic plasmids containing the indicated 2B coding region as the 
first cistron and Al PI sequence as the second cistron Two days 
postlransfection, hygromycin В sensitivity was assayed (A) 
Phosphorimage of immunoprecipitated Al PI synthesized in the 
presence and absence of 0 5 mg/ml hygromycin В as indicated, 
results from duplicate plates are shown The bracketed pair of 
lanes for the CBV3 2B samples represents a single sample 
inadvertently divided between two lanes of the gel (B) Quantita­
tion of relative hygromycin В sensitivity for samples shown in 
(A), black and grey bars represent duplicate samples A1PI-
specific phosphonmager counts from (A) were normalized to the 
total protein input into the immunoprecipitation reactions The 
ratio of protein accumulation in the presence and absence of 
hygromycin В is shown 
encoded wild-type and mutant CBV3 2B proteins were 
transfected into COS-1 cells and assayed for the ability 
of the expressed mutant 2B proteins to inhibit Al PI 
secretion and to increase sensitivity to hygromycin В 
(Fig. 4). 
All mutant 2B proteins could still inhibit protein 
secretion and increase the permeability of cells to hygro­
mycin B. However, the ability of the mutant proteins to 
induce these alterations varied for the different muta­
tions. The relative effects on virus viability (Fig. 4) and 
on the two different biochemical activities correlated 
well for the individual mutant proteins. Each of the 
mutations K[41,44,481E, ins[41]L, and ins[44]L, which 
eliminated viral viability, reduced the ability to inhibit 
protein secretion and modify plasma membrane permea­
bility to a greater extent than did mutations K[41]L and 
K[41,44]L, which gave rise to viable, but slow-growing, 
viruses. Thus, mutant proteins that were the most defec­
tive in the virus were the least effective in secretion 
inhibition and also the least effective in increasing cell 
sensitivity to hygromycin B. Furthermore, mutations in 
this domain showed that the integrity of this domain is 
important for both the inhibition of protein secretion and 
the increase in membrane permeability caused by CBV3 
protein 2B. 
Effects of mutations in the second hydrophobic 
domain on secretion inhibition and hygromycin В 
sensitivity. We next tested the effects of mutations in the 
second hydrophobic domain of CBV3 protein 2B (40) 
on the two activities (Fig. 1). Little correlation between 
the relative effects of these mutations on the inhibition 
of protein secretion and the increase in membrane per­
meability was observed (Fig. 4). With the exception of 
mutation I[64]S/V[66]S, little effect on the ability of 
CBV3 2B to increase hygromycin В susceptibility was 
observed for any of the mutations in the second hydro­
phobic domain. Nevertheless, mutations C[75]M and 
S[77]M/C[75]M impaired the ability of protein 2B to 
inhibit protein secretion. Thus, the observed inhibition of 
protein secretion by CBV3 protein 2B is probably not 
caused by the increase in membrane permeability. 
Virus containing mutations S[77]M/C[75]V arose 
due to a reversion mutation in RNAs carrying mutations 
S[77]M/C[75]M, which destroy viral viability. Mutant 
2B protein that contained these S[77]M/C[75]V muta­
tions exhibited wild-type activity in both biochemical 
assays, although virus carrying the mutant 2B protein 
showed reduced growth compared to wild-type virus 
(Fig. 4). Similarly, virus that contained mutation A[71]E 
was nonviable, although the 2B protein carrying this 
mutation showed nearly wild-type ability both to inhibit 
protein secretion and to increase the susceptibility of 
cells to hygromycin B. These observations argue that 
protein 2B has other functions in the viral infectious 
cycle in addition to those we have assayed here. 
DISCUSSION 
Mutations in the 2B proteins of both poliovirus and 
coxsackievirus give rise to viruses with primary defects 
in RNA synthesis (23, 28, 39, 40). However, no bio­
chemical activity directly tied to viral genome replica­
tion has yet been demonstrated for 2B. The only activi­
ties identified for protein 2B in eukaryotic cells are the 
two tested here: the inhibition of protein secretion and 
modification of the plasma membrane permeability. In 
this study, we have shown that Coxsackie B3 virus pro­
tein 2B displays these two activities (Figs. 2 and 3), as 
previously demonstrated for poliovirus protein 2B (14). 
It was possible either that secretion inhibition and 
plasma membrane modification were two separate func­
tions of protein 2B or that one of these effects was the 
consequence of the other. For example, permeabihzation 
of the plasma membrane by 2B could cause the inhibi­
tion of protein secretion by altering the intracellular 
ionic milieu; increased intracellular calcium levels and 
changes in concentrations of monovalent cations have 
been documented in poliovirus-infected cells (13, 20, 
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Designation Virus growth3 
Inhibition of 
protein secretion (%)b 
Increase in susceptibility 
to hygromycin В (%)c 
Amphipathic Helix 
no viral proteins 
wild type CBV3 2B 
2B-K[41,44,48]E 
2B-K[41]L 
2B-K[41,44]L 
2B-ins[41]L 
2B-ins[44]L 
nonviable 
0.1 wt 
0.01 wt 
nonviable 
nonviable 
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Second Hydrophobic Domain 
no viral proteins 
wild type CBV3 2B 
2B-C[75]M 0 1 wt 
2B-S[77]M/C[75]M nonviable 
2B-S[77]M/C[75]V 0 2 wt 
2B-I[64]S/V[66]S nonviable 
2B-A[71]E nonviable 
0 20 40 100 120 0 20 40 60 80 100 120 
Figure 4. The effects of mutations in the putative cationic amphipathic α-helix and the second hydrophobic domain of CBV3 protein 2B 
on viral growth in a single-cycle infection, inhibition of protein secretion, and increase in susceptibility to hygromycin B. (a) Viral titer 
after 8 h growth (39, 40). (b) Ability of mutant CBV3 2B proteins to inhibit protein secretion, expressed as the percentage of the effect 
of wild-type 2B protein. COS-1 cells were transfected with dicistronic plasmids encoding the indicated viral protein as the first cistron 
and Al PI as the second cistron. At 2 days posttransfection, transfected cells were assayed for Al PI secretion. Values calculated for cells 
transfected with wild-type CBV3 2B were normalized to 100% inhibition. Values for cells expressing A1PI alone with no 2B protein 
were adjusted to 0% inhibition. Error bars represent standard deviations of measured values, (c) Ability of mutant CBV3 2B proteins to 
increase hygromycin В sensitivity, expressed as the percentage of the effect of wild-type 2B protein. COS-1 cells were transfected with 
dicistronic plasmids encoding the indicated viral protein as the first cistron and A1PI as the second cistron. At 2 days posttransfection, 
transfected cells were assayed for hygromycin В sensitivity. Values calculated for cells transfected with wild-type CBV3 2B were 
normalized to 100% increase in hygromycin В sensitivity. Values calculated for cells expressing A1PI alone with no 2B protein were 
adjusted to 0% increase. Error bars represent standard deviations of measured values. 
29). Such changes might affect a number of cellular 
processes, including secretory transport. Alternatively, if 
the direct effect of 2B were on protein transport, the 
protein and lipid composition of the plasma membrane 
could be altered, resulting in altered permeability. 
Analysis of mutations in CBV3 2B has helped to 
clarify the relationship between secretion inhibition and 
membrane permeabilization. Experiments examining 
mutations in the second hydrophobic domain of CBV3 
2B (Fig. 4) suggest that the two activities are separable. 
In particular, mutations C[75]M and S[77]M/C[75]M 
showed effects on membrane permeabilization similar to 
wild-type CBV3 2B, but less effective inhibition of 
protein secretion than the wild-type protein. Therefore, 
plasma membrane permeabilization, as measured by 
hygromycin В sensitivity, is insufficient to explain the 
secretion inhibition displayed by wild-type 2B. Other 
mutations in the second hydrophobic domain and those 
in the amphipathic helix motif affected permeability to 
hygromycin В and secretion inhibition to a similar extent 
(Fig. 4). The correlation between the two assays may 
result from losses in activity stemming from general 
disruption of 2B structure, a role for the cationic amphi­
pathic helix in both functions, or both. 
Does either the ability to inhibit protein secretion or 
the ability to modify plasma membrane permeability 
correlate well with the phenotype displayed by CBV3 
2B mutant viruses (Fig. 4)? The data are inconclusive on 
this point. Protein 2B carrying mutations S[77]M/ 
C[75]M, which rendered the virus nonviable, showed a 
wild-type ability to increase hygromycin В sensitivity 
but an impaired ability to inhibit protein secretion. A 
revertant of this mutant, which contained a Met to Val 
substitution to yield 2B protein S[77]M/C[75]V, also 
showed wild-type ability to increase hygromycin В 
sensitivity but increased the ability of the mutant 2B 
protein to inhibit protein secretion. Thus, a reversion 
from nonviability to viability correlated with an increase 
in ability to inhibit protein secretion. Although 2B pro­
tein carrying reversion mutation S[77]M/C[75]V showed 
wild-type abilities in inhibition of protein secretion and 
increasing hygromycin В sensitivity, viruses carrying 
this protein exhibited an impaired virus growth. Muta­
tion A[71]E, which rendered 2B able to inhibit protein 
secretion comparably to wild-type CBV3 2B and which 
caused only a slight reduction in the ability to induce 
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membrane permeabilization, even completely abrogated 
vRNA replication and virus growth (Fig. 4). These ob­
servations point to roles for viral protein 2B in the viral 
replicative cycle other than the interactions with host cell 
membranes studies here. Consistent with this, mutant 
poliovirus 2B proteins defective in vRNA synthesis due 
to mutations outside either the cationic amphipathic 
α-helical domain or the second hydrophobic domain 
(mutations 2B201 and 2B204 at residue 29) (23) exhib­
ited wild-type activities in inhibiting cellular protein 
secretion (15). 
The organization and structure of the cationic amphi­
pathic α-helix in enterovirus protein 2B is similar to that 
of "lytic" polypeptides, a group of cationic amphipathic 
α-helical peptides that exert cytolytic effects on mem­
branes (37). Two models of action have been proposed 
to explain the cytolytic action of these peptides. In one 
model, the cationic peptides form aqueous channels by 
traversing the membrane and forming multimers that 
expose their hydrophobic sides to the lipid bilayer and 
their hydrophilic faces to the aqueous pore. In a second 
model, the peptides perturb the membrane by lying 
parallel to the membrane, with their hydrophobic side 
inserted in the lipid bilayer, thereby making the phos­
pholipids more susceptible to the action of phospho-
lipases (6). Two putative structural models of 2B that are 
consistent with the need for processing at the 2A/2B and 
2B/2C cleavage sites by protein ЗСрт0, a cytosolic pro­
tein, are shown in Fig. 5. 
The increase in sensitivity to hygromycin В caused 
by expression of CBV3 protein 2B is sensitive to muta­
tions in the predicted cationic amphipathic α-helix. Cat­
ionic amphipathic α-helical peptides can form voltage-
gated and cation-selective channels in lipid bilayers (1, 
2, 19, 38). It is tempting to speculate that channels 
formed by multimene 2B proteins are responsible for the 
influx of the sodium ions, the efflux of potassium ions, 
and the alterations in calcium levels that are observed 
from the third hour postinfection by poliovirus (13, 20). 
Alterations in ionic milieu have been implicated in the 
shutoff of host cell translation, as high concentrations of 
sodium ions are inhibitory to host cell but not to viral 
translation (12), and the cleavage of the p220 component 
of initiation factor eIF-4F may not be sufficient for com­
plete inhibition of host cell protein synthesis (11, 21, 
35). Consistent with this, coxsackieviruses that produce 
reduced levels of 2B protein due to the presence of poor­
ly processed 2B/2C cleavage sites, failed to completely 
inhibit host cell protein synthesis (41). Modifications in 
membrane permeability may also be required for cell 
lysis, release of progeny virus, or both. 
Inhibition of cellular protein secretion by viral pro­
tein 2B requires both the cationic amphipathic helix and 
the hydrophobic domain, and is not a direct result of 
increased membrane permeability. The inhibition of pro­
tein secretion during enterovirus infection is likely to 
result from alteration or sequestration of membranes or 
proteins required for secretory transport. This could 
simply be a consequence of RNA replication complex 
aqueous channel 
membrane I І Г Т 1 
cytosol c~yf\ñ\~<' I -v 
N
 f\ « N 'Ш 
К 
Figure 5. Potential topologies of protein 2B. Putative multimers 
of 2B proteins that allow the formation of an aqueous channel 
are shown on the left Helices representing the membrane-
integral amphipathic α-helix (nearer the NH2-lcrminus) and the 
second hydrophobic domain (nearer the COOH-termmus) are 
shown The hydrophilic face of the cationic o-helix is darkly 
shaded An alternative model is shown on the right, in which the 
hydrophobic face of the α-helix perturbs the membrane by lying 
parallel to it 
assembly, or it may play an additional role in viral am­
plification such as blocking host antiviral réponses (14). 
The exact functions of protein 2B in both membrane 
permeabilization and inhibition of protein secretion 
await further investigation. 
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Mutagenesis of the Coxsackie B3 Virus 2B/2C Cleavage site: 
Determinants of Processing Efficiency and Effects 
on Viral Replication 
FRANK J. M VAN KUPPEVELD, PATRICK J J С VAN DEN HURK, JAN ZOLL, 
JOCHEM M D. GALAMA, AND WILLEM J. G MELCHERS 
Department of Medical Microbiology, University of Nijmegen, The Netherlands 
The enterovirus 2B/2C cleavage site differs from the common cleavage site motif AxxQiG by 
the occurrence of either polar residues at the PI' position or large aliphatic residues at the P4 
position. To study (i) the putative contribution of these aberrant residues to the stability of 
precursor protein 2BC, (ii) the determinants of cleavage site specificity and efficiency of ЗСрт°, 
and (lii) the importance of efficient cleavage at this site for viral replication, a mutational analysis 
of the Coxsackie B3 virus (CBV3) 2B/2C cleavage site (AxxQlN) was performed. Neither 
replacement of the PI' asparagine with a serine or a glycine nor replacement of the P4 alanine 
with a valine significantly affected 2B/2C cleavage efficiency, RNA replication, or virus growth. 
The introduction of a P4 asparagine, as can be found at the CBV3 3C/3D cleavage site, caused a 
severe reduction in 2B/2C cleavage and abolished virus growth. These data support the idea that 
a P4 asparagine is an unfavorable residue that contributes to a slow turnover of precursor 
protein 3CD but argue that it is unlikely that the aberrant 2B/2C cleavage site motifs serve to 
regulate 2B/2C processing efficiency and protein 2BC stability. The viability of a double mutant 
containing a P4 asparagine and а РГ glycine demonstrated that а РГ residue can compensate for 
the adverse effects of an unfavorable P4 residue. Poliovirus (or poliovirus-like) 2B/2C cleavage 
site motifs were correctly processed by CBV 3CP"\ albeit with a reduced efficiency, and yielded 
viable viruses. Analysis of the in vivo protein synthesis showed that mutant viruses containing 
poorly processed 2B/2C cleavage sites were unable to completely shut off cellular protein 
synthesis. The failure to inhibit host translation coincided with a reduced ability to modify 
membrane permeability, as measured by the sensitivity to the unpermeant translation inhibitor 
hygromycin B. These data suggest that a critical level of protein 2B or 2C, or both, may be 
required to alter membrane permeability and, possibly as a consequence, to shut off host cell 
translation. 
Enteroviruses contain a positive-strand RNA genome 
of 7 5 kb in length which encodes a single polyprotein 
This polyprotein is processed by three virus encoded 
proteinases, 2Ap,°, 3Cp,°, and 3CDpr° (Fig 1A), into the 
structural PI capsid proteins and the nonstructural P2 
and P3 proteins that are involved in viral RNA (vRNA) 
replication (reviewed m reference 50) Proteinase 2AP'° 
cleaves between the PI and P2 regions cotranslationally 
(45). The capsid proteins are processed in tram by pro­
teinase 3CDp,° (26, 51) Processing of the nonstructural 
proteins by proteinase 3Cp,° yields both the final cleav­
age products (2A, 2B, 2C, ЗА, 3B, 3C, and 3D) as 
well as relatively stable processing intermediates (2BC, 
ЗАВ, and 3CD) (22) These precursor proteins have 
functions in vRNA replication that are distinct from 
those of their cleavage products Protein ЗАВ is the 
membrane-bound precursor that delivers VPg (3B) to the 
membranous replication complex (42-44) Furthermore, 
protein ЗАВ stimulates 3Dpo1 activity and the autocata-
lytic processing of 3CDpm to 3CP'° and 3D1"1 (30, 34, 37) 
Protein 3CD not only is a proteinase but also is involved 
in the formation of a ribonucleoprotein complex at the 5' 
end of the RNA, which is required for the initiation of 
viral positive-strand RNA synthesis (2, 3, 23) Protein 
2BC has been proposed to play a role in the induction of 
the membrane vesicles at which viral positive-strand 
RNA synthesis occurs (7) Bienz et al. showed that in 
poliovirus (PV)-infected cells in which polyprotein 
processing was partially inhibited, the formation of these 
vesicles always coincided with the production of protein 
2BC (8) Consistent with this, Barco and Carrasco have 
demonstrated that the expression of PV protein 2BC, but 
not that of protein 2B or 2C, either individually or in 
combination, induced the formation of membrane vesi­
cles in yeast cells (5) The finding that protein 2C alone 
can induce vesicles in human cells (1, 14) may have 
been hampered by the use of vaccinia viruses, which 
modify vesicular traffic themselves 
The production and stability of proteins 2BC, ЗАВ, 
and 3CD require a finely tuned regulation of the tempo­
ral processing at different cleavage sites in the polypro­
tein Proteolysis may be regulated by the occurrence of 
less favorable recognition sequences. In PVs, all 3Cpr°-
mediated cleavages occur between glutamme-glycine 
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Figure 1. (A) Schematic structure of the 7 5-kb single-stranded RNA genome of CBV3 containing protein VPg at 5' end of the 
nontranslated region (NTR) and a polyadenylatc tract at the end of the 3' nontranslated region The pol>protein-encoding region is 
shown boxed The proteinase that is responsible for cleavage at a particular cleavage site (indicated by an arrow) is shown below the 
polyprotein (B) Alignment of ammo acid sequences that occur at the P4-P3-P2-P1/P1' of the 2A/2B, 2B/2C. 2C/3A, 3A/3B, 3B/3C, and 
3C/3D cleavage sites of enteroviruses for which complete sequences of the P2 and P3 regions arc known The enteroviruses are divided 
into a CBV-likc subgroup and a PV-like subgroup Fnteroviruses with distinct amino acid sequences are shown apart Only sequence 
motifs that differ from the most frequently occurring motif AxxQ/G are shown Abbcrant amino acids are in boldface Abbreviations 
ECHO, echovirus, CAV, Coxsackie A virus, SVDV, swine vesicular disease virus. PV1(S) and PV1(M). PV type I strains Sabin and 
Mahoney, respectively, PV2(S) and (L), PV type 2 strains Sabin and Lansing, respectively, PV3(S) and PV3(L), PV type 3 strains Sabin 
and Leon, respectively, EV70, enterovirus type 70, BEVI, bovine enterovirus type 1 
(Q-G) dipeptide pairs. Additional determinants in sub­
strate recognition, however, have been proposed because 
the PV polyprotein contains four Q-G amino acid pairs 
that are not cleaved and cleavage sites other than Q-G, 
as identified in other enteroviruses (15, 27, 32), were 
also cleavable by PV protein 3CP™ (17). The amino acid 
at the P4 position (i.e., the fourth residue proximal to the 
Q-G cleavage site), which is in most cases an alanine, 
seems to be a major determinant of the efficiency of 
cleavage. Data that support the role of the P4 amino acid 
in substrate recognition have been obtained by muta­
genesis of infectious PV cDNA clones (9). The impor­
tance of the P4 amino acid for the stability of precursor 
protein 3CDpro has been demonstrated by Pallai et al. 
(36), who found that a synthetic peptide containing the 
authentic PV 3C/3D cleavage site (TxxQiG) was resis­
tant to hydrolysis by 3CP'°, whereas a peptide containing 
a substitution of the threonine by an alanine was effi­
ciently cleaved. Other determinants that may affect sub­
strate processing are the recognition of secondary or 
tertiary structures and the accessibility to a potential 
cleavage site. Analysis of structural data suggests that 
cleavage sites must be correctly displayed at the surface 
in a flexible tum configuration at the end of an α-helix 
or ß-sheet to be recognized efficiently (4, 35, 36) Pro-
cessing at the 3A/3B cleavage site seems to be deter-
mined by structural rather than by sequence-specific 
determinants. Lama et al. found that only membrane-
associated protein ЗАВ, not solubilized ЗАВ, could be 
cleaved by 3Cp,°, indicating that either the recognition or 
exposure of the 3A/3B cleavage site, which lies in close 
proximity to the membrane-binding domain of protein 
ЗА, is dependent on a hydrophobic environment (30). 
Alignment of the 3CP'° cleavage sites of the enterovi­
rus nonstructural proteins (Fig. IB) shows that nearly all 
enteroviruses contain the sequence AxxQlG (P4-P3-P2-
Р1-РГ) at their 2A/2B, 2C/3A, 3A/3B, and 3B/3C junc­
tions. The 3C/3D cleavage sites differ from this se­
quence by the occurrence of unfavorable residues at the 
P4 position, which seem to be involved in the stability of 
protein 3CDpr° (see above). It is remarkable that also all 
2B/2C cleavage site motifs are aberrant from the se­
quence AxxQlG. Coxsackie В virus (CBV)-like viruses 
contain polair asparagine or serine residues at the PI' 
position rather than a neutral glycine residue. PV-like 
viruses, on the other hand, contain at the P4 position 
either a valine or an isoleucine, residues which are 
heavily branched at the B-carbon, rather than an alanine, 
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which has only a small methyl group as its side chain 
The only virus that contains the sequence AxxQlG at its 
2B/2C junction, PV type 2 strain Sabin, differs from all 
other enteroviruses by the occurrence of a negatively 
rather than a positively charged residue at its P2 posi­
tion The occurrence of aberrant sequence motifs at the 
2B/2C cleavage site of all enteroviruses may indicate a 
regulatory role in the kinetics of 2B/2C processing and, 
thereby, in the stability of protein 2BC To test this 
possibility and to gain more insight in the determinants 
of the 2B/2C cleavage site specificity and processing 
efficiency, eight mutant Coxsackie B3 virus (CBV3) 
cDNAs were constructed and the effects of the muta­
tions on in vitro polyprotein processing were analyzed 
To understand the importance of efficient cleavage at 
this site for viral replication, the effects of the mutations 
on virus viability and growth, RNA replication, and in 
vivo protein synthesis were assayed 
MATERIALS AND METHODS 
Cells and viruses. Virus propagations and vRNA transfec-
tions were performed with Buffalo green monkey (BGM) 
cells Plaque assays were performed with Vero cells The cells 
were grown in minimal essential medium (MEM) supple­
mented with 10% fetal calf serum After infection, cells were 
fed with MEM containing 3% serum After transfection, MEM 
containing 10% serum was added to the cells Viruses were 
titrated in 96-well plates with BGM cell monolayers as de­
scribed previously (46) Virus titers were calculated by the 
method of Reed and Muench and expressed in 50% tissue 
culture infective dose ( ГСЮ
М
) values (40) 
Site-directed mutagenesis. Ohgonucleotidc-directed site-
specific mutagenesis was performed with subgenomic phage-
mid pALTCB3/2080-4947 (46), using the Altered Sites in 
vitro mutagenesis system (Promega) according to the manu­
facturer's recommendations The nucleotide sequence of the 
synthetic oligonucleotides (Isogen Bioscience, Maarssen, The 
Netherlands) are 5'-CrrAAGCCAGCTATTGCTTGGCGTT 
CAGCCAT-3' (mutation 2B/2C-1'G), 5"-CTTAAGCCAGCTA 
TTTGGTTGGCGTTCAGCCAT-3' (2В/2С-ГР), 5'-CTTAAG 
CCAGCT ATTCG ATTGGCGTTC AGCCA Г-3' (2B/2C- l'S), 
5'-ATTGTTTTGGCGTTCGACCATAGGGATTCCGTA-3' 
(2B/2C-4V), 5'-ATTGTTTTGGCGCTCATTCATAGGGATT 
CCGTA-3' (2B/2C-4N), 5'-CTTAAGCCAGCTATTGCCTT 
GGCGCTCATTCATAGGGATTCCGTA-3' (2B/2C-4N, 1 'G), 
5'-CTTAAGCCAGCTATTGCCTTGGCGTlCGACCATAGG 
GATTCCGTA-3' (2B/2C-4V,1'G), 5'-CTTAAGCCAATTG 
CCTTGGCGGATCACCATAGGGATGATTCCGTAATA-3' 
(2B/2C-4V,3I,1 G) Each of these oligonucleotides created a 
novel endonucleasc restriction site Clones carrying the de­
sired mutation were identified by restriction enzyme analysis 
The nucleotide (nt) sequence around the 2B/2C junction of 
these clones was verified by dideoxy chain termination se­
quencing of plasmid DNA, using primer 5'-CCATTCAAT-
GAATTTC TG-3' (nt 4117 to 4134) From the mutant clones, 
the Spe\ (nt 3837)-Іо-ВмНІІ (nt 4238) fragment was cloned in 
Plasmids pCB3/T7, which contains a full-length tDNA of 
CBV3 Nancy behind a T7 RNA polymerase promoter (28), 
and pCB3/T7-LUC, a pCB3/T7-denved construct that contains 
the luciferase gene in place of the capsid coding region (46) 
In vitro translation reactions. іаЛ-linearized plasmid 
DNA (0 5 μg) was transcribed and translated in a single reac­
tion, using Г7 TNT rabbit reticulocyte lysate (Promega) sup­
plemented with HeLa cell initiation factors (kindly provided 
by J Flanegan, University of Florida) and Tran35S-label (a 
mixture of [J5S]methionine and [!!S]cysteine, ICN) Labeled 
proteins were analyzed by sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE) as described previous­
ly (47) 
Transfection of cells with RNA transcripts. Eighty 
percent confluent BGM cell monolayers were transfected with 
5 pg of full-length copy RNA transcripts, generated with T7 
RNA polymerase from Sa/I-lineanzed cDNA templates, using 
the DEAE-dextran method, as described previously (46) After 
transfection, the cells were grown at either 33 or 36°C When 
virus growth was observed, the cultures were incubated until 
cytopathic effect was complete Otherwise, the cultures were 
subjected to three cycles of freezing and thawing, and 200 μΙ 
was passaged to fresh BGM monolayers, which were incu­
bated for another five (33°C) or three days (36°C) 
Sequence analysis of 2B/2C junction of mutant viruses. 
vRNA extraction, cDNA synthesis and amplification by PCR 
using forward primer 5'-GCAATGGAACAGGGAGTGAAGG 
ACTATGTGGA-3' (nt 3733 to 3765) and reverse primer 5'-
TTGGGATGGCGCGCTCTGCTC-3' (nt 4231 to 4251) were 
performed as described (46) The resulting PCR products were 
purified from low-melting-point agarose, and the nucleotide 
sequence around the 2B/2C junction was determined as de­
scribed above 
Plaque assays and single-cycle yield analysis. Plaque 
assays were carried out with confluent monolayers of Vero 
cells on 10-cm2 dishes in six-well plates as described previous­
ly (46) To determine the virus yield in a single replicative 
cycle, 100% confluent BGM cell monolayers (5 χ IO6 cells) 
were infected with virus at a multiplicity of infection (MOI) of 
1 TCID,0 per cell and grown at either 33, 36, or 39°C At 8 h 
postinfection, viruses were released by three cycles of freezing 
and thawing and the virus titer was determined 
Analysis of positive-strand RNA synthesis. BGM cell 
monolayers were transfected with 0 5 pg of T7 RNA polymer­
ase generated full-length copy RNA transcripts of the mutant 
рСВЗЛП-LUC plasmids as described above At 1, 4, 6, 8, and 
10 h posttransfection, the cells were lysed and the luciferase 
production was measured as described previously (46) 
Analysis of viral protein synthesis in vivo. BGM cell 
monolayers were infected with virus at an MOI of 25 for 30 
mm at room temperature After infection, cells were supplied 
with new medium and incubated at 36°C At several times 
postinfection, protein synthesis was monitored by labeling 
with 10 μΟ of Tran15S-label in methionine- and serum-free 
MEM (Gibco) After 30 mm, the medium was discarded, the 
ceils were lysed in cold lysis buffer, and labeled proteins were 
analyzed by SDS-PAGE as described previously (46) 
In experiments in which the permeability of cells to hygro-
mycm В was assayed, the same procedure was followed ex­
cept that cells were incubated in methionine- and serum-free 
MEM, in the presence or absence of 500 μg of hygromycin В 
(Sigma) per ml, for 15 mm prior to the addition of 10 μΟ of 
Tran35S-label to the medium 
To determine the ["SJmcthionine incorporation, sample 
lanes were cut from the gel and measured in a liquid scintila-
tion counter following SDS-PAGE and autoradiography 
RESULTS 
Construction and description of CBV3 2B/2C 
cleavage site mutants. Substitution mutations at the 
2B/2C cleavage site were generated by oligonucleotide-
directed mutagenesis and introduced in infectious CBV3 
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cDNA clone pCB3/T7 and subgenomic replicón рСВЗ/ 
T7-LUC. The mutants fall into three categories. Within 
the first group are four mutants that were constructed to 
examine the importance of the aberrant PI' or P4 resi­
dues that occur at the enteroviral 2B/2C cleavage site 
(Fig. IB). For this, the PI' asparagine was replaced with 
a glycine (mutation 2B/2C-1O), a proline (2В/2С-ГР), 
or a serine (2B/2C-1'S) or the P4 alanine was replaced 
with a valine (2B/2C-4V). The second group consists of 
two mutants that were constructed to examine the effect 
on 2B/2C cleavage efficiency of a P4 asparagine, as can 
be found at the 3C/3D cleavage site of CBV-like viruses. 
The P4 asparagine was introduced either alone (2B/2C-
4N) or, in order to create a site that resembles the 3C/3D 
cleavage site, together with a PI' glycine (2B/2C-4N; 
I 'G). The third group consists of two mutants that were 
engineered to examine the cross-species substrate speci­
ficity of CBV3 3CP'°. In one mutant, a valine was intro­
duced at the P4 position and a glycine was introduced at 
the PI ' position to create a motif with P4, PI, and Ρ Г 
residues that occur at the 2B/2C junction of most PV-
like viruses (2B/2C-4V;1'G). The other mutant con­
tained an additional replacement of the P3 glutamic acid 
with an isoleucine (2B/2C-4V;3I;1'G) to create a P4 to 
Ρ Г sequence that is identical to that found at a PV 
2B/2C junction (PV type 3). 
In vitro polyprotein processing of 2B/2C cleavage 
site mutants. The effect of the mutations on the 3Cp,°-
mediated processing at the 2B/2C cleavage site was 
studied by in vitro translation of copy RNA transcripts 
of the mutant pCB3/T7 plasmids. Figure 2A shows the 
protein patterns generated after 3 h. This figure shows 
that some of the mutations affected the efficiency of 
2B/2C processing, but not the 2B/2C cleavage site speci­
ficity, as shown by a correct migration of protein 2C. 
Remarkably, no accumulation of protein 2BC or any 
other potential precursor protein was observed. None of 
the mutations affected any of the other proteolytic pro­
cessing events in the viral polyprotein, as shown by the 
normal production of other viral proteins, including 
protein 2A (Fig. 2C), to levels similar to those produced 
by wild-type RNA. Protein 2B (11 kDa) could not be 
visualized because it migrated in the heavily overloaded 
globin spot. 
To determine the relative efficiency of 2B/2C cleav­
age, autoradiograms from three independent translation 
experiments were analyzed by densitometric scanning 
and the ratio of protein 2C/3CD was calculated (to cor­
rect for variations in total protein yield). The amount of 
protein 2C produced by RNA transcripts carrying muta­
tions 2B/2C-1'G and 2B/2C-1'S was similar to that pro­
duced by wild-type pCB3/T7 RNA. Mutation 2В/2С-ГР 
completely abolished 2B/2C cleavage. Even after pro­
longed exposure of the gels, no protein 2C could be 
detected. Mutation 2B/2C-4V slightly impaired 2B/2C 
cleavage, and approximately 85% of the wild-type pro­
tein 2C amount was produced. The introduction of 
asparagine residues at the P4 position (single mutation 
2B/2C-4N and double mutation 2B/2C-4N;1'G) reduced 
Figure 2. Effects of 2B/2C cleavage site mutations on polypro­
tein processing in vitro. In vitro translation reactions of RNA 
transcripts of the wild-type and mutant pCB3/T7 plasmids (A 
and C) and RNA transcripts carrying nonviable mutation 
2B/2C-4N and reversion mutation 2B/2C-4S, which was 
identified at the 2B/2C junction of revenant viruses isolated 
from cells transfected with RNA transcripts carrying mutation 
2B/2C-4N (B). RNA transcripts were synthesized and translated 
in a single reaction using T7 TNT rabbit reticulocyte lysate. 
Reactions were incubated for 3 h at 30°C. ["Sjmethionine 
labeled translation products were analyzed by SDS- PAGE on 
12.5% (A and B) or 15% (C) Polyacrylamide minigels. An 
extract from cells infected with wild-type virus, labeled with 
C"S]methionine for 1 h at 4 h postinfection, was used as a 
marker (vivo). 
2B/2C cleavage efficiency to about 10% of the wild-type 
level. Mutations 2B/2C-4V;1'G and 2B/2C-4V;3I;1'G 
reduced the cleavage efficiency to about 25% of that of 
the wild-type. 
Effects of 2B/2C cleavage site mutations on RNA 
replication. To study the effects of the mutations on 
positive-strand RNA replication, BGM cells were trans­
fected with copy RNA transcripts of wild-type and mu­
tant pCB3/T7-LUC constructs, and the luciferase activi­
ty was measured at several times posttransfection. Figure 
3 shows that none of the mutations interfered with the 
initial increase in luciferase activity (between 1 and 4 h) 
that reflects translation of the input RNA (46). However, 
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Figure 3. Effects of 2B/2C cleavage site mutations on RNA 
replication RNA transcripts were synthesized from both mutant 
and wild-type luciferase replicón pCB3/T7-LUC BGM cells 
were transfectcd with both mutant and wild-type RNA tran-
scripts (0 5 μg), and the luciferase activity was determined at the 
indicated time points posttransfection as described in Materials 
and Methods 
some mutations interfered with the second increase in 
luciferase activity, which occurs from the fourth hour 
and reflects the replication of the input RNA and subse­
quent translation of the newly synthesized RNA strands 
(46, 47). Replicons carrying mutations 2B/2C-TG and 
2B/2C-TS, which had virtually no effect on 2B/2C clea­
vage, displayed an increase (about 10- to 15-fold) in 
luciferase activity similar to that of wild-type pCB3/T7-
LUC (data not shown). Mutation 2B/2C-4V, which 
caused a minimal reduction in 2B/2C cleavage, reduced 
RNA replication and yielded an increase in luciferase 
accumulation that was only fourfold. Mutations that 
either abrogated (2В/2С-ГР) or severely reduced (2B/ 
2C-4N, 2B/2C-4N;1'G, 2B/2C-4V;1'G, and 2B/2C-4V; 
3I;1'G) 2B/2C cleavage caused severe defects in RNA 
replication, as shown by the absence of an increase in 
luciferase activity above the initial translation level. 
Effects of 2B/2C cleavage site mutations on virus 
viability and growth. The effects of the mutations on 
virus viability were determined by transfection of BGM 
cells with copy RNA transcripts from the mutant 
pCB3/T7 plasmids. For each mutation, two independent­
ly made constructs were tested. Four transfections were 
performed with RNA from each construct. After trans­
fection, two cell cultures were incubated at 33 °C and 
two were incubated at 36°C. Viruses were obtained con­
sistently upon transfection of cells with RNA transcripts 
carrying mutations 2B/2C-1'G, 2B/2C-1'S, 2B/2C-4V, 
2B/2C-I'G;4N, 2B/2C-1'G;4V and 2B/2C-1'G;3I;4V, 
albeit virus growth was severely delayed with RNA 
transcripts carrying the three latter mutations. Sequence 
analysis demonstrated that all viruses had retained the 
introduced mutation at the 2B/2C junction. The mutant 
viruses were named vCB3-2B/2C-l'G, vCB3-2B/2C-
l'S, VCB3-2B/2C-4V, vCB3-2B/2C-4N;l'G, vCB3-2B/ 
2C-4V;1'G, and vCB3-2B/2C-4V;3I;l'G, respectively. 
No virus growth was observed in any of the cell cultures 
transfected with RNA transcripts carrying mutation 
2В/2С-ГР. Upon transfection of cells with RNA tran­
scripts carrying mutation 2B/2C-4N, a revertant virus 
was isolated (see below). 
Viral growth characteristics were examined both by 
plaque assay and measuring the virus yield at 8 h postin­
fection in a single-cycle infection (Table 1). СВЗ-
2B/2C-1'G and vCB3-2B/2C-l'S showed wild-type 
growth characteristics. СВЗ-2В/2С-4 produced 16% 
of the wild-type virus yield and displayed a small-plaque 
phenotype. vCB3-2B/2C-4N;l'G and vCB3-2B/2C-4V; 
l'G produced about 2% of the wild-type virus yield and 
exhibited a minute-plaque phenotype. Minute-plaque 
virus vCB3-2B/2C-4V;3I;l'G produced only 0.3% of the 
wild-type virus yield. The relative virus yield of all 
mutants was the same at 33, 36, and 39°C. 
Isolation of revertant virus vCB3-2B/2C-4S. Upon 
transfection of cells with RNA transcripts carrying muta­
tion 2B/2C-4N, virus growth was observed in only one 
of the eight transfected cell cultures. Sequence analysis 
of the 2B/2C junction and the region surrounding this 
cleavage site showed that this virus contained a rever­
sion of the introduced asparagine (AAU) to a serine 
(AGU). This mutant virus was named vCB3-2B/2C-4S. 
To examine whether this reversion mutation was suffi­
cient to confer virus viability, mutation 2B/2C-4S was 
introduced in pCB3/T7, and BGM cells were transfected 
with RNA transcripts of the resulting plasmid. The sys-
Table 1. Effects of mutations on 2B/2C cleavage efficiency, 
plaque size, and single-cycle virus yield. 
Mulation 
None (ut) 
2B/2C-IG 
2B/2C-IT 
2B'2t-l 'b 
2B/2C-4V 
2D/2C-4N 
2B/20-4S (revenant) 
2B/2C-4N 1 G 
2B/2C-4V 1 G 
2B72C-4V.31 l'G 
2П/2С 
junction" 
AerQ/N 
AerQ/C 
AerQ/P 
AerQ/S 
\crG7N 
NcrQ/N 
SerQ/N 
NerQ/G 
VerQ/G 
\ irQ/G 
2B/2C 
deavage' 
+++ 
+++ 
+++ 
+++ 
++ 
± 
± 
+ 
+ 
Plaque 
size' 
Sing!e-c\lce 
virus vield 
1 "Bin 
T O D
w
, m l 
wt 
wt 
nonviable 
wt 
small 
nonviable 
mimile 
minute 
minute 
minute 
8 9 
9 0 
8 8 
8 1 
7 2 
7 1 
7 2 
64 
% oí wt 
>ield 
15 8 
2 0 
1 7 
2 0 
0 3 
" Amino acids at the Р4-РЗ-Р2-Р1/РГ positions, respectively 
Mutated ammo acids arc in boldface 
* Relative efficiency of cleavage at the 2B/2C |unction based on 
the densitometnc analysis of (he cell-free cleavage assay shown 
in Fig 2 
' Relative plaque size at 96 h postinfection of confluent Vero 
cell monolayers 
J
 Confluent BGM cell monolayers were infected with virus at an 
MOI of 1 TCID,o per cell and grown at 36°C At 8 h postinfec­
tion, viruses were released by freezing and thawing and the 
virus titer was determined by endpoint titration 
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tematic isolation of viruses carrying this mutation indi­
cates that the reversion of the asparagine to the serine at 
the P4 position of the 2B/2C cleavage site was indeed 
sufficient to confer virus viability. This mutant virus 
displayed a minute-plaque phenotype and produced 
about 2% of the wild-type virus yield in single-cycle 
infections at different temparatures. 
To examine whether the viability of reversion muta­
tion 2B/2C-4S correlated with an increased 2B/2C 
cleavage, the in vitro processing profiles of pCB3/T7 
Plasmids carrying mutations 2B/2C-4N and 2B/2C-4S 
were compared. Figure 2B demonstrates that the effi­
ciency of 2B/2C cleavage was indeed increased by re­
version mutation 2B/2C-4S; RNA transcripts carrying 
mutation 2B/2C-4S generated about 25% of the wild-
type protein 2C level, whereas RNA transcripts carrying 
mutation 2B/2C-4N produced only 10% of the wild-type 
protein 2C level. 
In vivo protein synthesis of mutant viruses. The 
time course and pattern of viral proteins synthesized in 
vivo was examined by infection of BGM cells with 
either wild-type virus or mutant viruses at an MOI of 25 
and pulse-labeling with [35S]methionine at several times 
postinfection. The production of viral proteins in cells 
infected with vCB3-2B/2C-l'G and vCB3-2B/2C-l'S 
was similar to that produced in wild-type virus-infected 
cells (data not shown). The protein patterns generated in 
cells infected with mutant viruses vCB3-2B/2C-4V, 
VCB3-2B/2C-4S, vCB3-2B/2C-4N;l'G, vCB3-2B/2C-
4V;1'G, and vCB3-2B/2C-4V;3I;l'G are shown in Fig. 
4A. This figure shows that in wild-type ν i rus-infected 
cells, cellular protein synthesis was completely shut off 
at 4 h postinfection and that viral protein synthesis 
reached a maximum level at 5 h postinfection. In cells 
infected with small-plaque virus vCB3-2B/2C-4V, viral 
protein synthesis was delayed and reached a maximum 
level at 6 and 7 h postinfection, reflecting the reduced 
growth rate of this virus. Remarkably, cellular protein 
synthesis was reduced but not completely shut off. This 
feature was also observed with minute-plaque viruses 
VCB3-2B/2C-4S, vCB3-2B/2C-4N;l'G, and vCB3-2B/ 
2C-4V;1'G, which produced viral proteins in a large 
background of cellular proteins. Even at 10 h postin­
fection, no complete inhibition of cellular translation 
was observed (data not shown). In cells infected with 
minute-plaque virus vCB3-2B/2C-4V;3I;l'G, virtually 
no shutoff of host cell translation occurred. For a com­
parison of the protein patterns, lysates of cells infected 
with the different mutant viruses were concurrently 
electrophoresed on a single gel (Fig. 4B). 
Ability of mutant viruses to increase plasma 
membrane permeability. PV-infected cells show an en­
hanced permeability to monovalent cations and other 
low-molecular-weight compounds, including the nonper-
meant translation inhibitor hygromycin B, from the third 
hour postinfection (6, 12). It has been suggested that this 
membrane modification and the resulting alterations in 
ionic milieu may be involved in the shutoff of host cell 
protein synthesis (12). 
pulse-label ing after (hours) 
2 3 4 5 6 7 8 2 3 4 5 6 7 8 2 3 4 5 6 7 
*»--
vCB3wt СВЗ 2B/2C 4V VCB3-2B/2C-4S 
2 3 4 5 6 7 8 2 3 4 5 6 7 8 2 3 4 5 6 7 
В 
vCB3-2B<2C-4N 1 G СВЗ 2B/2C-4V 1 G СВЗ 2B/2C-4V.31 1'G 
.0 .о J> 
^ Ρ Ρ Ρ Ρ' 
f $ $ $ $ 4 
Figure 4. (A) Time course of appearance of viral proteins after 
infection of BGM cells with wild-type recombinant virus ( СВЗ 
ut) and viruses carrying 2B/2C cleavage site mutations 2B/2C-
4V, 2B/2C-4S, 2B/2C-4N;I'G, 2B/2C-4V;1'G, and 2B/2C-4V: 
3I;l'G. BGM cells (2 χ IO5) were infected at an equal MOI of 25 
TCID50 per cell and incubated at 36°C. At Ihe indicated limes 
postinfection, the cells were washed and incubated for 30 min in 
methionine- and serum-free medium containing 10 цСІ of 
Tran35S-label as source of [35S]methionine. Labeled proteins 
were analyzed by SDS-PAGE on a 12.5% Polyacrylamide 
minigel. (В) Comparison of labeled proteins in lysates of cells 
infected with the wild-type СВЗ (labeled at 5 h postinfection) 
and the mutant viruses (labeled at 7 h postinfection) shown in 
panel A. 
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pulse labeling after (hours) 
2 4 6 8 2 4 6 8 2 4 6 
+ - + . + . + . + . + 
vCB3wt vCB3-2B/2C-4V;1'G vCB3-2B/2C-4V:3l;1'G 
Figure 5. Ability of mutant viruses to increase the plasma membrane permeability to the unpermeant translation inhibitor hygromycin B. 
BGM cells were infected with either wild-type virus or mutant virus vCB3-2B/2C-4V;l'G or vCB3-2B/2C-4V;3I;l'G at an MOI of 25 
TC1D50 per cell. Pulse-labeling and analysis of proteins were performed as described in the legend to Fig. 4 except that the cells were 
incubated in methionine- and serum-frcc MEM for 15 min in the presence (+) or absence (-) of 500 μg of hygromycin (hyg) В per ml 
prior to the addition of 10 μΟ of Tran"S-label to the medium. 
To examine whether the failure of the mutant Cox­
sackie B3 viruses to shut off cellular translation corre­
lated with a decreased ability to modify membrane per­
meability, the sensitivity of translation to hygromycin В 
was assayed. Cells were infected with wild-type virus, 
vCB3-2B/2C-4V;l'G, or vCB3-2B/2C-4V;3I;l'G and 
pulse-labeled in the presence or absence of hygromycin 
В at 2, 4, 6, and 8 h postinfection. In wild-type virus-
infected cells, hygromycin В reduced translation about 
70% at both 4 and 6 h postinfection, time points at 
which cellular translation was indeed shut off and when 
only viral proteins were synthesized (Fig. 5). In contrast, 
hygromycin В had little effect on translation in cells 
infected with the mutant viruses. No inhibition of trans­
lation was observed at 4 and 6 h postinfection, when 
protein synthesis was suppressed to about 40% ( СВЗ-
2B/2C-4V;1'G) and 55% (vCB3-2B/2C-4V;3I;l'G) of 
the level observed at 2 h postinfection. At 8 h post­
infection, when translation was suppressed to about 20% 
(vCB3-2B/2C-4V;l'G) and 40% (vCB3-2B/2C-4V;3I; 
l'G), some inhibition of translation (about 40%) by 
hygromycin В was observed in cells infected with 
vCB3-2B/2C-4V;l'G but not in cells infected with 
vCB3-2B/2C-4V;3I;l'G. 
DISCUSSION 
Enterovirus protein 2BC is a proteolytic processing 
intermediate that exerts a specific function in vRNA 
replication (5, 8). Protein 2BC is a poor substrate for 
3Cpro and is only very slowly processed into proteins 2B 
and 2C in vitro (20, 21, 34). The stability and function of 
this protein require a subtle regulation of processing 
efficiency at the 2B/2C cleavage site. One mechanism to 
regulate the kinetics of proteolysis is the occurrence of 
unfavorable residues at the scissile bond or positions 
surrounding this amino acid pair. The enterovirus 2B/2C 
cleavage site differs from the common motif AxxQlG 
by the occurrence of either polar PI' residues or large 
aliphatic P4 residues (Fig. IB). We have constructed 
several CBV3 2B/2C cleavage site mutants (i) to exam­
ine the importance of these aberrant residues for the 
efficiency of 2B/2C cleavage and, thereby, the stability 
of protein 2BC, (ii) to gain more insight in the determi­
nants of cleavage site specificity and efficiency of CBV3 
3CP'°, and (iii) to analyse the effects of alterations in the 
2B/2C cleavage efficiency, leading to altered levels of 
proteins 2B and 2C, on virus viability and growth, 
vRNA replication, and protein synthesis in vivo. 
The mutants that were generated fell into three 
groups. The first group was designed to investigate the 
importance of the aberrant Ρ Г and P4 residues. Replace­
ment of the Ρ Г asparagine neither with a glycine (2B/ 
2C-1O), which created the common AxxQlG motif, nor 
with a serine (2B/2C-VS) affected 2B/2C cleavage, as 
shown by the production of wild-type levels of proteins 
2BC and 2C. RNAs containing these mutant cleavage 
site motifs replicated efficiently and gave rise to viruses 
that produced viral proteins and exhibited growth similar 
to that of the wild-type virus. These results suggest that 
it is unlikely that the polar PI' residues occurring in 
CBV-like viruses serve to regulate 2B/2C processing 
efficiency and, thereby, protein 2BC stability. This is 
irrespective of whether all 2B and 2C proteins are pro­
duced exclusively by trans cleavage of protein 2BC or 
whether a substantial amount of these proteins are pro­
duced by successive cw-cleavage events from larger 
precursors (e.g., 2BC-P3 or 2BC-3ABC). This latter 
possibility should be considered given the relative ineffi-
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ciency of cleavage of 2BC in trans (20, 21, 34) and the 
finding that insertion of internal nbosome entry site 
elements between nonstructural proteins or mutations at 
specific cleavage sites may interfere with processing at 
upstream located sites (11, 50) The efficient cleavage of 
3Cp,° at a Q-S dipeptide pair and the wild-type growth of 
these mutant viruses are consistent with the occurrence 
of this residue at the 2B/2C cleavage site of several other 
enteroviruses (Fig IB) and also with the wild-type 
growth of PVs containing a Q-S dipeptide pair at their 
3C/3D cleavage site (27) The relative efficient 2B/2C 
processing observed at sites containing a P4 valine (2B/ 
2C-4V) argues that it is also unlikely that the large ali­
phatic P4 amino acids occurring in PV-like viruses are 
unfavorable residues that provide the stability of protein 
2BC Based on these results, we propose that alternative 
determinants such as inefficient recognition of secondary 
and tertiary protein structures surrounding the cleavage 
site or decreased accessibility of 3Cpr° to the cleavage 
site contribute to the stability of protein 2BC and that a 
conformational change is required to improve recogni­
tion or exposure of the cleavage site Such a change may 
be induced by an interaction with a specific target (e g , 
membrane or another protein) The observation of Molla 
et al that the addition of protein ЗАВ significantly en­
hanced proteolysis of PV protein 2BC by 3Cpr" in vitro 
lends support to such a hypothesis (34) 
The introduction of a PI' proline (2В/2С-ГР) com­
pletely abolished 2B/2C cleavage The nonviabihty of 
this mutation may be due to an adverse effect on the 
function of protein 2BC in vRNA replication However, 
it seems more likely that efficient vRNA replication 
requires the production of either protein 2B or protein 
1С or both The activities that have been ascribed to 
protein 2B, ι e, inhibition of protein secretion and 
permeabilization of the plasma membrane (16), and 
protein 2C, which is endowed with nucleoside triphos­
phatase and RNA binding activities (31, 41), however, 
can also be fulfilled by protein 2BC (16, 41) The re­
quirement for either mature protein 2B or 2C suggests 
that one of these proteins, or both, exerts a yet unidenti­
fied function in vRNA replication that cannot be ful­
filled by protein 2BC Alternatively, protein 2BC may 
be not be able to exert these activities when engaged 
with other viral proteins 
In the second group of mutants, the effect of P4 
asparagine on 2B/2C cleavage and viral replication was 
examined This polar residue has been identified at the 
P4 position of the 3C/3D cleavage site of CBV-like 
viruses Introduction of this residue (2B/2C-4N) reduced 
the efficiency of 2B/2C cleavage to about 10% ofthat of 
the wild-type This finding provides experimental evi­
dence for a role of this polar residue in determing a slow 
turnover rate of protein 3CD, analogous with the role of 
the unfavorable polar threonine occurring at the P4 
position of the PV 3C/3D cleavage site (36) The non-
viability of this mutation argues that critical levels of 
protein 2B or 2C, or both, are required for efficient virus 
growth Alternatively, mutation 2B/2C-4N may abolish 
a function of protein 2B in vRNA replication The muta­
tion did not completely abolish vRNA synthesis, as 
shown by the isolation of a revertant virus carrying a P4 
serine The viability of this reversion mutation is most 
probably due to the increase in 2B/2C cleavage efficien­
cy (to about 25% of that of the wild-type) and, as a 
consequence, the production of increased levels of pro­
teins 2B and 2C These data fit well with the crystal 
structure of 3Cpro of human rhinovirus 14, a Picornavirus 
closely related to enteroviruses (31) It was found that 
the S4 substrate pocket of this proteinase is small and 
hydrophobic and that it best accommodates small and 
hydrophobic amino acids Any change in the P4 position 
from a small aliphatic to a polar residue results in strong 
energetic constraints Our data suggest that these con­
straints are more severe with a polar residue containing a 
large side chain (asparagine) than with a small polar 
residue (serine) Impaired processing efficiency was also 
observed in PV genomes that contained a serine, threo­
nine, or glutamic acid residue at the P4 position of the 
cleavage site between two genetically engineered VPg 
coding units (11) 
In contrast to nonviable mutation 2B/2C-4N, simulta­
neous introduction of a P4 asparagine and a PI' glycine 
(2B/2C-4N,1'G) yielded viable viruses That a P I ' resi­
due (ι с, the first amino acid of protein 2C) can ìntra-
molecularly compensate for a nonviable mutation at the 
P4 position (ι e , amino acid 96 of protein 2B) makes it 
unlikely that the nonviabihty of mutation 2B/2C-4N was 
due to an impaired function of protein 2B in vRNA 
replication It seems unlikely that the rescuing effect of 
the РГ glycine is due to an effect on the function of 
protein 2C in vRNA replication, because viruses carry­
ing a PV asparagine (wild-type) or a PV glycine (2B/2C-
l'G) replicated equally well Two alternative explana­
tions must be considered First, the P4, PI, and РГ resi­
dues may play a synergistic role in determining the 
cleavage site conformation, and the compensating effect 
of the PI' glycine may be due to a more efficient 2B/2C 
cleavage All enterovirus 2B/2C cleavage sites contain 
small amino acids at either the P4 position, the PI' posi­
tion, or both Cleavage sites carrying mutation 2B/2C-
4N contain asparagine residues at both the P4 and Ρ Г 
positions The simultaneous occurrence of such large P4 
and PI' residues may interfere with the cleavage site 
conformation and, as a consequence, the recognition of 
the substrate or its accessibility to the active center of 
3C"° However, no profound differences in processing 
efficiency at sites carrying mutations 2B/2C-4N and 
2B/2C-4N,1'G were observed Densitometrie scanning 
of autoradiograms, however, may not be sensitive 
enough to detect minor quantitative differences It can 
therefore not be excluded that the additional introduction 
ot a PV glycine causes a subtle enhancement of 2B/2C 
cleavage, leading to levels of proteins 2B and 2C that are 
sufficient to enable virus growth Another possibility is 
that mutation 2B/2C-4N disrupts the structure and, as a 
consequence, the function of precursor protein 2BC in 
vRNA replication, and that the compensating effect of a 
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PI' glycine is due to stabilization of the protein confor­
mation. 
The third group consisted of two mutants that were 
engineered to examine the ability of CBV3 3Cp,° to 
process PV (or PV-like) 2B/2C cleavage sites. Cleavage 
sites carrying P4, PI, and Ρ Г residues that occur at the 
2B/2C cleavage site of most PV-like viruses (2B/2C-
4V;1'G) or P4 to PI' residues that are identical as those 
found at the 2B/2C cleavage site of PV type 3 (2B/2C-
4V;3I;1'G) were correctly processed by CBV3 3Cpro, 
albeit with a reduced efficiency (about 25% of that of 
the wild-type). These findings are consistent with the 
impaired cleavage of P2 proteins observed with a chi­
meric PV polyprotein containing CBV3 protein 3C'° 
(15). The cross-species substrate specificity of CBV3 
3C1"" confirms the existence of both conformational and 
sequence-specific cleavage determinants. The finding 
that double mutation 2B/2C-4V;1'G reduced cleavage 
efficiency to a much greater extent than each of the 
single mutations did supports the proposed synergistic 
action of the P4, PI, and РГ residues in determining the 
cleavage site conformation (see above). The P3 residue 
seems to be of less importance for the cleavage site 
conformation, as mutations 2B/2C-4V;1'G and 2B/2C-
4V;3I;1'G had similar effects on cleavage efficiency. 
The finding that mutation 2B/2C-4V;3I;1'G reduced 
virus growth to a greater degree than mutations that 
caused reductions in cleavage efficiency that were simi­
lar (2B/2C-4V;1'G and 2B/2C-4S) or even more severe 
(2B/2C-4N;1'G) suggests that the P3 glutamic acid is a 
determinant of the structure and function of protein 2B, 
or 2BC, in vRNA synthesis rather than of 2B/2C cleav­
age efficiency. This view is consistent with structural 
data for human rhinovirus 14 3Cpr°, which suggested that 
the side chain groups of residues at the P5 and P3 posi­
tions are pointing away from the active center of 3Cp,° 
(31). 
Analysis of the viral protein synthesis in vivo showed 
that none of the minute-plaque viruses containing poorly 
processed 2B/2C cleavage sites was capable to com­
pletely inhibit cellular protein synthesis. A reduced but 
significant amount of cellular proteins was continuously 
synthesized in cells infected with viruses carrying the 
mutations 2B/2C-4S, 2B/2C-4N;1'G, and 2B/2C-4V; 
l'G, while viruses carrying mutation 2B/2C-4V;3I;1'G 
caused virtually no shutoff of host cell translation. The 
simultaneous synthesis of viral and cellular proteins late 
in infection is remarkable and has, to our knowledge, not 
been demonstrated previously. It is unlikely that this 
situation is due to the reduced growth rate of these vi­
ruses, since it was not observed with other mutant CBV3 
viruses that exhibited a similar or an even more severe 
decrease in growth (47, 48). The mechanism by which 
enteroviruses shut off host cell translation is still de­
bated. According to the traditional view, the shutoff of 
cellular translation relies only on the protein 2Ap,0-medi-
ated cleavage of the 220-kDa component (p220) of 
eucaryotic initiation factor 4F (18, 19, 29). The integrity 
of p220 seems to be required for the translation of cellu­
lar mRNAs but not for the initiation of translation at 
vRNA, which occurs by internal entry of ribosomes to 
internal ribosome entry site elements in the 5' nontrans-
lated region (25, 38). However, several reports have 
described that substantial levels (25 to 45%) of cellular 
protein synthesis can take place in cells in which all 
p220 has been degraded (10, 24, 39). It has therefore 
been suggested that the p220 cleavage is necessary but 
not sufficient to completely inhibit host cell protein 
synthesis and that a second event, which requires RNA 
replication, is required to block cellular translation. The 
permeabilization of the plasma membrane and the result­
ing influx of sodium ions have been suggested as poten­
tial second events. High concentrations of sodium ions 
are inhibitory to host mRNA translation but not to the 
translation of vRNAs (12). The reversal of the shutoff 
and the continuous synthesis of cellular proteins that 
occur in sodium-free medium are further indicative for a 
role of sodium ions in the inhibition of cellular protein 
synthesis (13). 
Recently, it has been shown that of the PV nonstruc­
tural proteins, protein 2B has the highest intrisic capacity 
to modify the plasma membrane permeability to hygro-
mycin В in human cells (16). This capacity was found to 
be conserved in CBV3 protein 2B (49), which contains a 
cationic amphipathic α-helical motif that is required for 
vRNA replication and that is typical for so-called lytic 
polypeptides (47). In this study, we have shown that the 
failure of mutant coxsackieviruses containing poorly 
processed 2B/2C cleavage sites to completely shut off 
host cell translation coincided with a reduction of levels 
of mature proteins 2B and 2C, but not of protein гА1™, 
and a reduced ability to modify the plasma membrane 
permeability. These data suggest that the permea­
bilization of the plasma membrane by protein 2B may 
indeed be the second event required for the shutoff of 
cellular translation. Reduced levels of protein 2B may be 
responsible for a poor permeabilization of the plasma 
membrane and, as a consequence, a reduced influx of 
sodium ions. The failure to increase the intracellular 
sodium concentration could account for the maintenance 
of host cell translation, the reduction in viral protein 
synthesis, and the reduced virus yield. However, it 
should be emphasized that normal levels of protein 2A 
were demonstrated in vitro but not yet in vivo. Fur­
thermore, as it remains to be established that an in­
creased membrane permeability contributes to the inhibi­
tion of cellular translation, it cannot be excluded that the 
accumulation of either protein 2B or 2C, or both, is 
required for another, yet unidentified process that is 
neccessary to fully suppress cellular protein synthesis. In 
addition, the mutations introduced near the 2B/2C cleav­
age site may not only affect the relative amounts of 2BC, 
2B, and 2C, but also their functions. Additional studies 
on the functions of the P2 region proteins are required to 
shed more light on the possible participation of these 
proteins in the shutoff of host cell protein synthesis. 
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The nonstructural 2B proteins of coxsackievirus and poliovirus (PV) sbare a significant 
similarity in structure and exhibit similar biochemical activities, namely inhibition of protein 
secretion and modification of membrane permeability. Both proteins contain two hydrophobic 
domains in the carboxy-terminal two-third of their sequence, of which one has the potential to 
form a cationic amphipathic α-helix and one displays characteristics typical for transmembrane 
domains. To gain more insight into the structural requirements of enterovirus protein 2B for its 
functioning in viral RNA replication, a chimeric cDNA approach was used. Chimeric Coxsackie 
B3 virus (CBV3) genomes were constructed that expressed either the entire PV 2B protein or 
hybrid proteins in which specific segments of CBV3 protein 2B were substituted by their 
corresponding PV counterparts. In vitro synthesis and processing of the chimeric polyproteins 
showed no abnormalities. СВ З genomes carrying the entire PV 2B gene exhibited a defect in 
viral RNA replication and were nonviable. A chimeric genome that expressed a hybrid 2B protein 
consisting of the amino-terminal one-third of PV and the remainder of CBV3 yielded viable 
viruses. In contrast, a hybrid genome that produced a 2B protein consisting of the amino-
terminal one-third of CBV3 and the remainder of PV failed to replicate. These data argue that a 
sequence-specific interaction with another viral replication protein is required to drive viral RNA 
replication and suggest that the proposed sites of contact reside in the carboxy-terminal two-third 
of 2B. Hybrid genomes in which either the amphipathic α-helix or the other hydrophobic domain 
was replaced failed to replicate. The potential contribution of these domains to the structure and 
functioning of protein 2B is discussed. 
The genus Enterovirus of the family of Picornaviri-
dae, a large group of plus-strand RNA viruses, com­
prises polioviruses (PV), Coxsackie A viruses, Coxsackie 
В viruses, echoviruses, and several distinct enterovirus 
serotypes. These enteroviruses are closely related and 
share marked similarities with respect to virus structure, 
genomic organization, and replicative cycle (29). The 
main differences between these viruses are observed in 
the clinical syndromes they produce in humans, growth 
in particular cell lines, and the illness and pathology they 
produce in monkeys and suckling mice (18). The differ­
ences in tropism are predominantly based on the ability 
to bind to specific receptors for cell entry, reflecting 
differences in the structural capsid proteins encoded by 
the PI region of the genome, and the occurrence of host-
specific as-acting translational control elements in the 
genomic RNA (1, 19). 
The enteroviruses can be divided into two major 
subclasses, namely a CBV-like group and a PV-like 
group. The nonstructural proteins encoded by the P2 and 
P3 regions of the genomes of CBV-like and PV-like 
enteroviruses share 50 to 65% amino acid homology. 
Despite the differences in primary sequence, there is a 
high degree of conservation of important structural do­
mains and sequence motifs, suggesting that these pro­
teins share similar functions in viral reproduction. Stud­
ies towards the functional exchangeability of these pro­
teins have provided experimental evidence for this 
suggestion. Chimeric PV genomes containing the Cox­
sackie B3 virus (CBV3) counterpart of protein ЗСрг°, a 
proteinase that is responsible for the majority of the 
processing events that give rise to the production of the 
nonstructural proteins, demonstrated a correct processing 
of the PV P2 and P3 region proteins (10). In addition, 
PV genomes carrying СВ 4 protein 2Apr°, a multifunc­
tional protein that acts as a proteinase, a frans-activator 
of viral translation, and as a component in viral RNA 
(vRNA) replication, gave rise to viable viruses (17). 
Enterovirus protein 2B is a small hydrophobic pro­
tein that is localized at the outer surface of the mem­
brane vesicles on which vRNA replication takes place 
(6). The phenotypes of 2B mutants of both PV and 
СВ З have implicated a role of protein 2B, or possibly 
its precursor 2ВС, in vRNA amplification (12, 16, 23, 
24, 26). The exact function of this protein is yet unclear 
but seems to be related to its effects on cellular mem­
branes. Expression of the 2B proteins of both PV and 
CBV3 in mammalian cells caused a modification in 
permeability of the plasma membrane and inhibition of 
vesicular protein transport (11, 27), two phenomena that 
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also occur during enterovirus infection (8, II) The 
interaction of enterovirus protein 2B with membranes is 
most likely provided by the two conserved hydrophobic 
domains, of which one has the potential to form a cano­
nic amphipathic α-helix (23) and one (which will further 
be referred to as "the second hydrophobic domain") 
shows characteristics typical for multimene trans­
membrane helices (24) The relevance of these domains 
for the ability of CBV3 2B to increase membrane 
permeability and inhibit protein secretion has recently 
been confirmed by individual expression of 2B proteins 
carrying mutations in these regions (27) 
The aim of this study was to gain more insight into 
the structural requirements of enterovirus protein 2B for 
its functioning in viral reproduction To this end, we 
have constructed chimeric CBV3 cDNAs that contained 
either the entire PV 2B protein or hybrid proteins in 
which specific segments of CBV3 protein 2B were 
substituted by the corresponding PV regions The ability 
of PV 2B and the hybrid 2B proteins to drive vRNA 
replication and virus growth was assayed by transfection 
of cells with copy RNA transcripts of the chimeric 
cDNAs Polyprotein synthesis and processing were 
studied by translation of RNA transcripts in a cell-free 
extract The potential contribution of the distinct do­
mains to the structure and function of protein 2B are 
discussed 
MATERIALS AND METHODS 
Construction of unique endonuclease restriction sites in 
pCB3/T7. For the introduction of PV sequences in plasmid 
pCB3/T7 (13), which contains a cDNA of CBV3 (strain Nan­
cy) behind a T7 RNA polymerase promoter, unique restriction 
sites were introduced, either alone or in combination, by site-
directed mutagenesis Mutagenesis was performed with a 
subgenomic pALTER phagemid clone containing the EcoRV 
fragment of pCB3/T7 (nucleotide [nt] 918 to 6177) using the 
Altered Sites in vitro mutagenesis system according to the 
instructions of the manufacturer (Promega) The nucleotide 
sequence of the antisense synthetic oligonucleotides (Isogen 
Bioscience, The Netherlands) used for the introduction of 
unique restriction sites (which are underlined) immediately 
upstream or downstream of the 2B-encoding sequence are, 5'-
TTCCArAAGTCCTTCAAGGCCTGTTCCATTGCATC-3' 
{Stul site at nt 3743) and 5'-TTTCTT\AGCCAGCTGTTAA. 
ÇTTGGCGTTCGCCAT-3 (Hpa\ site at nt 4042) Nucleotide 
sequences of the oligonucleotides used for the introduction of 
unique restriction sites at 2B amino acids (aa) 57 to 59 are, 5'-
TAGTGTGGCAGTCACAGTGATCAGGTCGTGGTT££G_ 
GACCACAATTACTAAGGCTGATATO (ЛссІІІ site at nt 
3913) and 5'-GATCAGGTCATCGTGGTTAACCACCACA 
ATTACTAAGGC-3' (Hpal site at nt 3915) Mutant pAl TER 
clones were identified by restriction enzyme analysis The 
nucleotide sequence of the mutant clones was verified by 
dideoxy chain termination sequencing of plasmid DNA using 
the Ampli Cycle sequencing kit according to the instructions 
of the manufacturer (Perkin-Elmer) The unique restriction 
sites were intro-duced in pCB3/T7 by cloning of the Bglll (nt 
2040>to-SijHII (nt 4238) fragments in plasmids from which 
the corresponding fragment was deleted In this way, plasmids 
рСВЗЛ7-ЛиІ(Э743), рСВЗ/Т7-ЯраІ(4042), рСВЭЛ7-ЯраІ 
(3915), рСВЗГГ7-5№І(3743)/Я/?аІ(4042), рСВЗЛ7-5гиІ 
(3743)//7ραΙ(3915), and рСВЭАГ7-ЛссШ(Э913)/ЯраІ(4042) 
were generated 
Construction of chimeric cDNAs. Chimeric cDNAs were 
constructed by PCR amplification and cloning of PV 2B-
encoding segments into pCB3/T7 plasmids from which the 
corresponding segment was deleted Plasmid pXpA (generous­
ly provided by R Andino, University of California), which 
contains a cDNA of PV type 1, was used as template for PCR 
A total of 4 forward primers (fl to f4) and 5 reverse primers 
(rl to г5) containing restriction sites (which are underlined) at 
their 5' end were used for amplifying PV sequences PCR was 
performed using SuperTaq DNA polymerase (HT Biotechnol­
ogy) according to the instructions of the manufacturer The 
chimeric cDNAs were named according to the CBV3 amino 
acids that were replaced by the corresponding residues of PV 
The construction of each of the chimeric plasmids is briefly 
summarized 
2B/PV1-99, A DNA fragment containing the coding se­
quence of PV aa 1 to 99 was generated by PCR using primers 
fl (5'-ATGGAACTGCGCATCACCAATTACArA-3'. A\ill 
site) and rl (5'-CCAACTMTATTTTGCTTGATGACATAA 
GG-3, Sspl site), digested with A\Al and Sspl, and cloned m 
рСВЗЛ7-5;иІ(3743)/Я/;аІ(4042) from which the SjuI-to-ЯраІ 
fragment was deleted 
2B/PV1-94, A DNA fragment containing the coding se­
quence of PV aa 1 to 94 was generated by PCR using primers 
Π and r2 (5 -CCAACTMIâTTTTGGCGTTCAGCCATA 
GGTATCTCCAGAACATCGCA3, Sspl site), digested with 
Л /ll and Sspl, and cloned in рСВЗ/Т7-9ги1(3743)/ЯраІ(4042) 
from which the Stul-lo-Hpal fragment was deleted 
2B/PV1-30, A DNA fragment containing the coding se­
quence of PV aa 1 to 30 was generated by PCR using primers 
fl and r3 (5-GGTACTGA£TAGJOAATTGGTCAACTCT 
GTTAT-3', Spel site), digested with 4vxII and Spel, and cloned 
in pCB3/T7-S/ul(3743) from which the Stul-to-Spel (3837) 
fragment was deleted 
2B/PV1-59, A DNA fragment containing the coding se-
quence of PV aa 1 to 59 was generated by PCR using primers 
fl and г4 (5 -TTCATAAGGCCTAGTTATAATAACTAG-3 , 
Siiti site), digested with Ίν/ΙΙ and Stul, and cloned in 
рСВЗ/Т7-ЛнІ(3743)/Я/?а1(3915) from which the Stul-to-Hpal 
fragment was deleted 
2B/PV60-99, A DNA fragment containing the coding 
sequence of PV aa 60 to 99 was generated by PCR using 
primers f2 (S'-ATTATAATCCGGAACTATGAAGACACC-
3, Acclll site) and rl, digested with ЛссІІІ and Sspl, and 
cloned in рСВЗ/Т7-4ссІ1І(3913)/ЯроІ(4042) from which the 
Acclll-to-llpal fragment was deleted 
2B/PV60-94, A DNA fragment containing the coding 
sequence of PV aa 60 to 94 was generated by PCR using 
primers f2 and r2, digested with 4cclII and Sspl, and cloned in 
рСВЗ/Т7-Л<.<ЛІІ(3913)/ЯраІ(4042) from which the Acclll-to-
Hpal fragment was deleted 
2ВФ 34-59, A DNA fragment containing the coding 
sequence of PV aa 34 to 59 was generated by PCR using 
primers f3 (5 -AATATGCTAGCCAGTACCATCACTGAA-
3 , V/;d site) and r4, digested with VAel and Stul, and cloned 
in рСВЗ/Т7-Яра1(3915) from which the Spel (nt 3837)-to-
ЯраІ fragment was deleted Due to the occurrence of a Spel 
site in the amplicon, a VAel site (compatible ends with Spel) 
was build in the 5' end of primer f3 As a result of this, valine 
33 is altered into an alanine 
2B/PV34-99, A DNA fragment containing the coding 
sequence of PV aa 34 to 99 was generated by PCR using 
primers D and rl, digested with \hel and Sspl, and cloned in 
рСВЗ/Т7-Я/?а1(4042) from which the Spel (nt 3837)-іо-Я/70І 
fragment was deleted Due to the occurrence of a VAel site 
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rather than a Spel site in primer D (see above), valine 33 is 
changed into an alanine 
2B/PV34-94, A DNA fragment containing the coding 
sequence of PV aa 34 to 94 was generated by PCR using 
primers D and r2, digested with Khe\ and Ssp\, and cloned in 
pCB3/T7-tfpoI(4042) from which the ¿pel (nt 3837)-to-tfpaI 
fragment was deleted Due to the occurrence of a Nhel site 
rather than a Spel site in primer О (see above), valine 33 is 
changed into an alanine 
2B/PV37-54, A DNA fragment containing the coding 
sequence of PV aa 37 to 54 was generated by PCR using 
primers f4 (5 -GAGTTGTCACTAGTGGGTCAAGACACCA 
TCACTGAAAAGCTACTTAAG-3, ¿pel site) and r5 (5-
1TCATAMJGC_CJCACCACAATAACTAGGGAGGATATG 
АТСТТ-3, 5/мІ site), digested with ¿pel and Srul, and cloned 
in рСВЗ/Т7-Яра1(3915) from which the Spel (nt 3837)-to-
Hpal fragment was deleted Primer r5 was designed such that 
the ¿pel site occurring m the PV sequence was deleted while 
leaving the amino acid sequence intact 
brom all mutant constructs, the entire PV segment that was 
introduced was confirmed by sequence analysis 
Transfection of cells with copy RNA transcripts. In vitro 
transcription of Sa/I-lineanzed plasmids by phage T7 RNA 
polymerase and transfection of 75% confluent Buffalo green 
monkey (BGM) cell monolayers with RNA transcripts (5 μg) 
using the DEAh-dextran method were performed as described 
previously (24) After transfection cells were fed with minimal 
essential medium (MEM) containing 10% fetal bovine serum 
(FBS) and incubated at either 33 or 36°C In case virus growth 
was observed, cultures were incubated until cytopathic effect 
(CPE) was complete, followed by three cycles of freezing and 
thawing to release intracellular viruses Viruses were aliquoted 
and stored at -80°C 
Analysis of RNA synthesis by dot blot hybridization. 
BGM cell monolayers were transfected with wild-type and 
mutant RNA transcripts as described above At various times 
posttransfection, the medium was discarded and the cells were 
washed with phosphate-buffered saline (PBS) for three times 
Total RNA was isolated by a single extraction procedure with 
guanidium thiocyanate-phenol-chloroform as described by 
Chomczynski and Sacchi (9) RNAs were denatured with 
formamide and formaldehyde and spotted onto Hybond nylon 
membranes (Amersham) according to standard procedures (3) 
cDNA clone рСВЗЛГ7 was labeled with [o-32P]dATP by nick-
translation Membranes were prehybndized, hybridized, 
washed, and analyzed by autoradiography according to stand­
ard procedures(3) 
In vitro translation reactions. Copy RNA transcipts were 
synthesized and translated in a single reaction using 17 TNT 
rabbit reticulocyte lysate (Promega) supplemented with 20% 
(vol/vol) HeLa cell initiation factors (kindly provided by J 
Flanegan, University of Florida) The translation reactions (20 
μΙ) contained 0 5 μg of circular plasmid DNA and 20 μ& of 
Tran"S-label (a mixture of [3,S]methionme and ["S]cysteme, 
1CN) and were incubated for 3 h at 30°C Translation products 
were analyzed on a sodium dodecyl sulfate (SDS) containing 
12 5% Polyacrylamide gel (14) Gels were fixed, fluoro-
graphed and exposed to Kodak XAR film at -80°C 
Sequence verification of virus. RNA extraction, synthesis 
of cDNA, amplification of the 2B coding region by PCR using 
primers 5 -TGGTGTCATTGGCATTGTGACCATGGGGGG-
3 (nt 3648 to 3677) and 5 -TTGGGATGGCGCGC1CTGCTC 
-3 (nt 4231 to 4251), purification of the PCR products, and 
sequence analysis with reverse primer 5-CCATTCAATGA 
ATTTCTG-3' (nt 4117 to 4134) were all performed as de­
scribed previously (23) 
Virus titrations Virus titers were determined by endpoint 
titration as described previously (24) and expressed in 50% 
tissue culture infective doses (TCIDS0) according to the meth­
od of Reed and Muench (20) 
Single-cycle growth analysis. Confluent BGM cell 
monolayers grown in 25-cm2 flaks (5x10' cells) were infected 
with virus at a multiplicity of infection (MOI) of I TCID,0 per 
cell for 30 mm at room temperature The cells were fed with 
MEM containing 3% FBS and grown at 33, 36, or 39°C At 
various times postinfection, cells were disrupted by three 
cycles of freezing and thawing, and the virus titers were 
determined 
Analysis of viral protein synthesis in vivo. Confluent 
monolayers of BGM cells were infected with virus at a MOI of 
25 for 30 mm at room temperature After infection, cells were 
fed with MEM containing 3% FBS and grown at 36"C At 
various times postinfection, the cells were washed with PBS 
and incubated in methionine- and serum-free MEM (Gibco) 
containing 10 μΟ of Tran"S-label for 30 min Lysis of cells 
and analysis of the [3SS]methionine-labeled proteins by SDS-
polyacrylamide gel electrophoresis were performed as de­
scribed previously (24) 
RESULTS 
Construction of heterologous CBV3 cDNAs. To 
allow the construction of chimeric CBV3 genomes, 
unique restriction sites were introduced, either alone or 
in combination, at the 2A/2B and 2B/2C junctions and 
within the 2B coding sequence of plasmid pCB3/T7 PV 
sequences were amplified by PCR and cloned in these 
constructs PCR primers were designed such that no 
additional ammo acid changes outside the substituted 
fragment were introduced A total of ten chimeric con­
structs, schematically diagrammed in Fig 1, was gener­
ated In construct 2B/PV1-99, the complete 2B coding 
region of CBV3 was replaced by that of PV In the other 
constructs, the amino-terminal region (ι e , the first 30 to 
35 amino acids), the amphipathic o-hehx, or the second 
hydrophobic domain were replaced, either alone or in 
combination, by their corresponding PV counterparts 
Because the borders of the amphipathic α-helix were not 
exactly known, two different constructs (2B/PV34-59 
and 2B/PV37-54) were generated Constructs 2B/PV1-
99, 2B/PV60-99, and 2B/PV34-99 contained at the P4 
position of the 2B/2C cleavage site a valine rather than 
an alanine (which occurs in wild-type CBV3) There­
fore, three additional constructs (2B/PVK94, 2B/PV60-
94, and 2B/PV34-94) containing the last five amino 
acids of CBV3 2B were generated as well 
Viability of chimeric CBV3 genomes. To examine 
whether PV protein 2B and the hybrid PV-CBV3 2B 
proteins could functionally replace the 2B protein of 
CBV3 in vivo, BGM cells were transfected with in vitro 
synthesized RNA transcripts from wild-type pCB3/T7 
and the chimeric constructs Four transfections were 
performed for each construct Two transfected cell cul­
tures were grown at 33 °C and two were grown at 36°C 
In case no virus growth was observed after 5 days, the 
cultures were subjected to three cycles of freezing and 
thawing, and passaged to fresh cell cultures, which were 
incubated for an additional 3 days 
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2B/PV1-30 | | | | | | | 
2B/PV1-59 | | I I I I I 
2B/PV60-99| | I I I I I 
2B/PV60-94 | | I I I I I I 
2B/PV34-57 | | | | | | | 
2B/PV34-99| | | | | | | 
2B/PV34-94 | | | | | I I I 
2B/PV37-54 | | I I I I 
Figure 1. Schematic representation of the chimeric CBV3 genomes. At the top of the figure is shown the 7.5-kb single-stranded RNA 
genome of CBV3 with the polyadenylate tract at (he end of the 3' nontranslated region (NTR). The boxed region shows the polyprotein 
and vertical lines within the box indicate proteinase cleavage sites. The complete amino acid sequence of protein 2B, containing the 
cationic amphipathic α-helix and the second hydrophobic domain, is enlarged. The polioviras 2B encoding segments are shaded. 
Transfection of cells with RNA transcripts derived 
from the wild-type plasmid gave complete CPE within 
two days. RNA transcripts from construct 2B/PV1-30 
produced CPE in all transfected cell cultures at 5 days 
posttransfection. Sequence analysis of the 2B coding 
region of this virus (vCB3-2B/PVl-30) showed that the 
introduced PV segment was retained and that no other 
mutations had occurred. No CPE was observed in any of 
the cell cultures that were transfected with RNA of the 
other chimeras. Passage of cytoplasmic extracts to fresh 
BGM cell monolayers also failed to reveal virus growth. 
Analysis of the virus growth of vCB3-2B/PVl-30 in 
a single-cycle infection showed a delay in virus produc­
tion relative to wild-type virus (Fig. 2). This delay was 
most apparent at 6 h postinfection when mutant virus 
production was only 1% ofthat of wild-type virus. At 8 
h postinfection there was only a 10-fold difference in 
virus yield, whereas at 12 h postinfection virus produc­
tion was similar. The delay in virus growth was not 
temperature sensitive; the kinetics of virus reproduction 
of VCB3-2B/PV1-30 relative to that of wild-type virus 
was similar at 33, 36, and 39°C (data not shown). 
Analysis of vRNA replication. To examine whether 
the reduced growth of vCB3-2B/PVl-30 and the non-
viability of the other chimeric genomes were due to a 
defect in vRNA replication, a dot blot hybridization was 
9 η 
virus yield (log TCID50/ml) 
5 -
tvCB3-2B/PV1-30 
- СВЗ wild-type 
4 6 θ 
hours postinfection 
10 12 
Figure 2. One-step growth curves of wild-type virus and mutant 
virus vCB3-2B/PVl-30. BGM cell monolayers were infected at 
a multiplicity of I TCID<„ per cell and incubated at 36°C. At the 
indicated times postinfection, the cells were disrupted by three 
cycles of freezing and thawing, and the virus production was 
determined by endpoint titration. TCID,„, 50% tissue culture 
infective dose. 
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Figure 3. Analysis of wild-type and mutant vRNA replication. 
BGM cell monolayers were transfected with equal amounts of 
genomic transcripts derived from the indicated plasmids linear­
ized by Sal]. At the indicated times posttransfection, total RNA 
was isolated. The RNA was denatured, bound to nylon mem­
brane, and hybridized to a [a-32P]-labeled cDNA probe. 
performed. BGM cells were transfected with in vitro 
synthesized copy RNA transcripts and at various times 
posttransfection total cellular RNA was isolated, dena­
tured, immobilized on nylon membranes, and hybridized 
<r t» ту ту 
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Figure 4. In vitro translation of wild-type and mutant RNAs in 
a cell-free extract. RNA transcripts were synthesized and trans­
lated in TN Τ rabbit reticulocyte lysatc, a coupled transcription-
translation system, supplemented with HeLa cell initiation 
factors. Reactions were programmed with 0.5 μg of circular 
plasmid DNA and incubated for 3 h at 30"C. The ["S]-
methionine-labeled translation products were analyzed on an 
SDS-12.5% Polyacrylamide gel. An extract from wild-type 
virus-infected cells, labeled with ["SJmethionine at 4 h postin­
fection, was used as a marker (vivo). 
with a [a-32P]dATP-iabeled CBV3 cDNA probe. Figure 
3 shows that there was no detectable vRNA synthesis in 
cells transfected with any of the nonviable chimeras. 
From the hybridization signals obtained with construct 
2B/PV1-30 it is evident that vRNA synthesis is delayed. 
Synthesis and processing of hybrid polyproteins. 
To examine whether the chimeric genomes were able to 
correctly generate all nonstructural and structural pro­
teins required to replicate and assemble vRNAs, copy 
RNAs of the mutant constructs were synthesized and 
translated in a reticulocyte lysate. Figure 4 shows that all 
mutant RNAs produced cleavage products to levels 
similar to those produced by RNA derived from 
pCB3/T7. Protein 2B (11 kDa) could not be visualized 
because it migrated in the heavily overloaded globin 
spot. Nevertheless, the efficient production of proteins 
2A and 2C indicated that none of the introduced PV 
segments interfered with cleavage site specificity and 
processing efficiency of 3CP'° at either the 2A/2B or 
2B/2C junction. Thus, the defects in vRNA replication 
and virus growth of the chimeric genomes are unlikely 
to be due to impaired processing of the viral polyprotein. 
To examine the possibility that the defect in vRNA 
replication of vCB3-2B/PVl-30 was due to a reduction 
in the rate of viral protein synthesis in vivo, we com­
pared protein synthesis following infection of BGM cells 
with either wild-type or the chimeric virus. Cells were 
infected at an equal multiplicity of infection and pulse-
labeled with [35S]methionine at various times postinfec­
tion. Analysis of the cell lysates shows that the chimeric 
virus has retained the ability to shut off cellular protein 
synthesis (Fig. 5). In chimeric virus-infected cells, viral 
protein synthesis was maximal at 7 h postinfection. The 
amount of viral proteins produced at this time point was 
similar to that observed in wild-type virus-infected cells 
at 5 h postinfection, when wild-type protein synthesis 
pulse labeling after (hours) 
-2BC 
- VPO 
-2C 
VP1 
VCB3-2B/PV1-30 
СВЗ wi ld-type 
Fig. 5. Protein synthesis in wild-type virus and vCB3-2B/PVl-
30-infected cells. BGM cells were infected at a multiplicity of 
25 Теш,,, per cell and grown at 36°C. At the indicated times 
postinfection, cells were radioactively labeled in 30-min pulses 
with [3,S]methionine. Cellular extracts were prepared and 
analyzed on an SDS-12.5% Polyacrylamide gel. 
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was maximal This suggests that it is unlikely that the 
defect in vRNA replication is due to an impaired rate of 
viral protein synthesis in vivo 
DISCUSSION 
The construction of chimeric viral genomes is a 
suitable approach to dissect multiple functions of specif­
ic genetic elements Hybrid Picornavirus genomes have 
provided interesting information on the occurrence of 
independent functional domains essential for vRNA 
replication and translation in both the 5' nontranslated 
region (2, 21, 30) and nonstructural protein 2Apro (17) 
We have employed a chimeric cDNA approach to dis­
sect the structural requirements of enterovirus protein 2B 
for its functioning in vRNA replication Chimeric CBV3 
genomes were constructed that expressed either the 
entire PV 2B protein, which is 50% homologous to the 
2B protein of CBV3, or hybrid proteins in which specif­
ic structural elements of CBV3 2B were substituted by 
their PV counterpart All hybrid polyproteins were effi­
ciently synthesized and correctly processed Defects in 
vRNA replication are therefore primarily attributable to 
impaired functioning of the 2B protein 
A chimeric CBV3 genome that expressed the entire 
PV 2B protein failed to replicate That PV 2B cannot 
functionally replace CBV3 2B is remarkable because 
these proteins are endowed with the same biochemical 
activities Expression in mammalian cells of the 2B 
proteins of both PV (11) and CBV3 (27) results in 
modification of plasma membrane permeability and 
inhibition of protein secretion Modification of mem­
brane permeability is also observed when these 2B pro­
teins are expressed in Escherichia coli cells (15, 25) 
The exchangeability of the 2Apro and 3C™ proteins of 
PV with those of Coxsackie В viruses (10, 17) and the 
overall similarity in structure of the nonstructural entero­
virus proteins, are further indicative for a conservation 
of the functions of these proteins A'ternative expla­
nations for the nonexchangeabihty of protein 2B must 
therefore be considered A possible cause for the defect 
in vRNA replication of this chimera may be the heter­
ologous nature of protein 2BC, a relatively stable pro­
cessing intermediate that is required for the induction ot 
the membrane vesicles on which vRNA amplification 
takes place (4, 7) Impaired functioning of a heterolo­
gous precursor protein was also observed with poliovirus 
chimeras that contained 3C*° of either human rhinovirus 
14 or CBV3 These 3C proteinases were able to cleave 
the nonstructural precursor polypeptides, but the hybrid 
3CDp,° proteins were unable to process the poliovirus 
capsid proteins (10) Another possible explanation for 
the inability of PV 2B to drive vRNA synthesis may be a 
failure to recognize and contact other CBV3 replication 
proteins Thus, apart from its abilities to modify mem­
brane permeability and inhibit protein secretion, protein 
2B may play a direct role in vRNA replication in which 
interactions with other viral proteins are essential This 
suggestion is consistent with the existence of mutations 
that interfere with vRNA replication but that do not 
impair the ability of 2B to increase membrane permea-
bilty or inhibit protein secretion (27) 
Only one of the hybrid 2B proteins was functional in 
vRNA replication This hybrid protein (2B/PV1-30) 
contained the ammo-terminal one-third of PV 2B, ι e , 
the region upstream of the hydrophobic domains, and the 
remainder of CBV3 2B Remarkably, a hybrid protein 
that contained the ammo-terminal one-third of CBV3 2B 
and the remainder of PV 2B (2B/PV34-99), was non­
functional The loss of activity of this protein may be 
due to a general disruption of the structure of either 2B 
or 2BC However, this possibility seems unlikely in 
view of the well functioning of protein 2B/PV1-30 The 
explanation that the carboxy-terminal two-third of the 
protein contains the sequence-specific determinants re­
quired for an intramolecular interaction with 2C (in 
precursor 2BC) or for intermolecular contacts with other 
viral replication proteins seems more plausible and is in 
agreement with the nonfunctioning of PV 2B in vRNA 
replication as discussed above 
Hybrid genomes that contained the carióme amphi-
pathic α-helix of PV 2B (2B/PV34-59, 2B/PV37-54, 2B/ 
PV1-59) failed to replicate This is in agreement with the 
previously described defect in vRNA replication of 2B-
bomll, a chimeric CBV3 genome that produced a 2B 
protein in which the cationic amphipathic helix was 
replaced with a similar motif of lytic peptide bombohtin 
II (23) The amphipathic helix motif in CBV3 2B is a 
major determinant for the ability to modify membrane 
permeability and inhibit protein secretion (27) The 
occurrence of such a motif is characteristic for mem­
brane-disrupting proteins Two models of action have 
been proposed to explain the membrane-perturbing 
activities of these proteins (4, 22) According to the first 
model, the amphipathic helix lies colateral to the mem­
brane and inserts a few Angstrom into it, thereby making 
the membrane phospholipids more susceptible to degra­
dation by phosphohpases The second model suggests 
that the amphipathic helices form aqueous pores by 
spanning the membrane and forming oligomers, ex­
posing their hydrophobic faces to the lipid bilayer and 
their hydrophihc faces forming the aqueous interior 
That the cationic amphipathic helices of both PV 2B and 
bombohtin II cannot functionally replace that of CBV3 
2B argues against an independent role (i e, the first 
model) of this domain in the structure and function of 
2B A possible explanation for the nonexchangeabihty 
of the amphipathic helix is that both this helix and the 
second hydrophobic domain traverse the lipid bilayer 
and that contacts between these two domains are re­
quired for the formation of an aqueous pore The obser­
vation that individually expressed protein 2B-bomII is 
unable to modify plasma membrane permeability and 
inhibit protein secretion (28) lends support to this idea 
Further support for this suggestion comes from the find­
ing that, in addition to mutations targeted to the 
amphipathic helix, also mutations in the second hydro-
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phobic domain can disrupt the ability of 2B to modify 
membrane permeability and inhibit protein secretion 
(27) Disturbances of contacts between these two do­
mains may also account for the nonviabihty of the con­
structs that contained the amphipathic helix of CBV3 2B 
but the second hydrophobic domain of PV 2B (2B/PV 
60-99, 2B/PV60-94) 
In conclusion, these studies have allowed us to sepa­
rate the contribution of distinct domains to the function 
of protein 2B in vRNA replication We have shown that 
the ammo-terminal one-third of CBV3 2B, but not the 
middle one-third or the carboxy-terminal one-third of the 
protein, neither alone nor in combination, can be func­
tionally replaced with its PV counterpart In contrast to 
the cdrboxy-terminal two-third of the protein, the role of 
the amino-terminal region in the function of 2B protein 
is yet unclear Mutations in this region caused defects in 
vRNA replication (12), but did not interfere with the 
ability of protein 2B to inhibit protein secretion (27) 
Recently it has been shown that deletion of the first 30 
amino acids of protein 2B abolished the ability of poho-
virus protein 2BC to induce membrane proliferation and 
to interfere with the exocytic pathway in yeast cells (4) 
The importance of this region for a function of protein 
2B, or 2BC, in mammalian cells awaits further inves­
tigation 
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Digital-imaging microscopy was performed to study the effect of Coxsackie B3 virus infection 
on tbe cytosohc free Ca1* concentration and the Ca14 content of the endoplasmic reticulum (ER). 
During the course of infection a gradual increase ш the cytosohc free Ca1* concentration was 
observed, due to the influx of extracellular Ca1*. The Ca2* content of the ER decreased in time 
with a kinetics in\ersely proportional to that of viral protein synthesis. Individual expression of 
protein 2B was sufficient to induce the influx of extracellular Ca2* and to release Ca2* from ER 
stores. Analysis of mutant 2B proteins showed that both a cationic amphipathic α-helix and a 
second hydrophobic domain in 2B were required for these activities. Consistent with a presumed 
ability of protein 2B to increase membrane permeability, viruses carrying a mutant 2B protein 
exhibited a defect in virus release. We propose that 2B is a viroporin that gradually enhances 
membrane permeability, thereby disrupting the intracellular Ca2* homeostasis and ultimately 
causing the membrane lesions that allow release of virus progeny 
The genus Enterovirus of the family of Picornaviri-
dae comprises polioviruses, Coxsackie group A and В 
viruses, ECHO viruses, and several unnamed enterovi­
ruses The molecular biology of these cytolytic animal 
viruses is relatively well known, mainly from the exten­
sive studies on pohovirus Enteroviruses are nonenve-
loped viruses that contain a single-stranded RNA ge­
nome of positive polarity After cell entry and virion 
uncoating, the RNA molecule acts as a mRNA directing 
the synthesis of a single polyprotein This polyprotein is 
subsequently processed by virus-encoded proteases to 
produce the structural capsid proteins and the non­
structural proteins that have been implicated in viral 
RNA (vRNA) replication (for review see references 29 
and 48) For replication, the genomic RNA is used as a 
template to synthesize a complementary minus-strand, 
whiLh, in tum, is transcribed into new molecules of 
RNA Plus-strand RNA synthesis occurs at the outer 
surface of virus-induced, membranous vesicles that pro­
liferate and accumulate m the cytoplasm of infected cells 
(6) During infection, enteroviruses induce a number of 
alterations in metabolic functions and morphological 
structures of the cell, most of which serve to facilitate 
viral replication These include inhibition of host cell 
protein and RNA synthesis (13, 17), stimulation of lipid 
synthesis (26), and inhibition of vesicular protein trans­
port (12) 
The molecular mechanism employed by enterovi­
ruses to induce cell lysis and release of virion progeny is 
largely unknown Cell lysis is presumably the ultimate 
result of the increase in plasma membrane permeability 
that occurs from the third hour postinfection (9) This 
modification is such that gradients of monovalent ions 
are gradually destroyed and compounds that normally do 
not pass the membrane leak out of the cell or flow into 
the cytoplasm (9) It has long been thought that either 
the bulk of viral gene expression or the formation and 
accumulation of virus particles is responsible for en­
hancing membrane permeability and lysis of the cell 
However, recent data suggest that a single viral protein 
may be responsible for the enhancement of plasma 
membrane permeability individual expression of the 2B 
proteins of both pohovirus and coxsackievirus in mam­
malian cells led to an increased permeability of the plas­
ma membrane to the nonpermeative translation inhibitor 
hygromycin В (12, 46) Increased membrane permea­
bility was also observed in Escherichia coli cells that 
expressed protein 2B (20) The mechanism of this activi­
ty and its relevance to the viral life cycle remain to be 
established No experiments have yet directly addressed 
the role of 2B, or any other viral protein, in virus release 
or cell lysis 
Enterovirus 2B is a small hydrophobic protein that 
has been localized at the rER membrane and the outer 
surface of the ER-denved membranous vesicles at which 
plus-strand RNA replication takes place (5, 6) Bio­
chemical analysis of the isolated vesicles confirmed that 
the membranes are derived at least in part from the ER 
(37) The ER is the major intracellular store of Ca2* ions 
(8) Based on its localization and proposed potential to 
modify membrane permeability, we hypothesized that 
protein 2B might release Ca2* from internal stores To 
examine this, we measured the intracellular Ca2+ concen­
tration ([Ca2*] ) and the Ca2* content of the ER in Coxsac­
kie B3 virus (CBV3)-infected cells Here, we demon­
strate that the Ca2* gradients maintained by the plasma 
membrane and ER membrane are disrupted during infec­
tion Individual expression of protein 2B appeared tobe 
sufficient to induce these effects Analysis of mutant 2B 
proteins showed that both a cationic amphipathic o-hehx 
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and a second hydrophobic domain were required for 
these activities The ability o f protein 2B to enhance 
membrane permeability served to facilitate virus release 
The increase in [Ca2*], further potentiated virus release 
We propose that protein 2B by forming membrane-em­
bedded pores accounts for the disturbance of the intra­
cellular Ca2* homeostasis and, ultimately, the formation 
of the membrane lesions that allow virus release Based 
on this ability, protein 2B is recognized as a new mem­
ber of the family of viroponns Protein 2B represents the 
first example of a viroporm of a naked virus A putative 
function of the release o f ER-stored Ca2* in the assembly 
of the viral replication complex is proposed 
MATERIALS AND METHODS 
Cells, media, virus infections and titrations. COS-1 cells 
were grown in Dulbecco s modified Eagle's medium (Gibco) 
HeLa Ohio cells were grown in minimal essential medium 
(МЬМ) (Gibco) Media were supplemented with 10% fetal 
bovine serum (FBS), 100 units penicillin per ml, and 100 mg 
streptomycin per ml Cells were grown at 37°C in a 5% C 0 2 
incubator 
Ca2*-free MEM was the same as regular MEM except that 
it lacked CaCl2 In experiments in which the effects of 
extracellular Ca2* were assayed, as Ca2*-containing medium 
we used Ca2*-free medium to which CaCl2 was added to a final 
concentration of 1 8 mM Both media were adjusted to pH 7 3 
To Ca21-free MEM, 0 5 mM ethylene glycol-bis(ß-ammo ethyl 
etherbV,AyV',JV'-tetraacetic acid (EGTA) (pH 7 3) was added 
immediately before use 
All viruses used in this study are recombinant CBV3 
viruses derived from plasmid pCB3/T7 (19), which contains a 
full-length cDNA of CBV3 strain Nancy behind a T7 RNA 
polymerase promoter HeLa Ohio cell monolayers were in-
fected with virus at the indicated multiplicity of infection 
(MOI) for 30 min at room temperature After this, cells were 
washed three times with phosphate-buffered saline (PBS), 
supplied with MFM (with or without Ca2*) containing 3% 
FBS, and grown at 37°C 
Virus yields were determined by endpoint titration Serial 
10-fold dilutions were tested in 8 replicative wells of 96-well 
plates as described (44) Virus titers were calculated and 
expressed in 50% tissue culture infective dose (TCID50) values 
(31) 
Measurement of |Ca2*],. [Ca2*], was measured by using 
the fluorescent Ca2* indicator ftira-2 essentially as described 
previously (47) Briefly, at 30 min before measurement, the 
cells were incubated in new medium containing 2 5 μΜ fura-2 
in its membrane-permeant acetoxymethyl (AM) ester form 
(Molecular Probe, lnc, Eugene, Oreg ) Cells were incubated 
for 30 mm at 37°C and then washed three times with medium 
to remove extracellular probe Cells were supplied with pre­
heated medium and the coverslip was introduced to a thermo-
stated (37°C) incubation chamber on the stage of an inverted 
fluorescence microscope (Nikon Diaphot) Routinely, an epi-
fluorescent x40 magnification oil immersion objective was 
used, allowing simultaneous monitoring of about 25 to 50 
single cells Dynamic video imaging was carried out using the 
MagiCal hardware and TARDIS software (Joyce Loebl, UK) 
Fluorescence was measured every 2 s with the excitation 
wavelength being altered between 340 and 380 nm and the 
emission fluorescence being recorded at 492 nm (binding of 
Ca2* shifts the absorbance spectra from 380 to 340 nm) At the 
end of each experiment, a region free of cells was selected and 
one averaged background frame was collected at each excita­
tion wavelength The averaged background frames were sub­
tracted from the corresponding experimental frames After 
this, the fluorescence ratio R, which equals FuJFiS<„ where 
F,
w
 and F
no
 are the emission intensities at 340 and 380 nm 
excitation, respectively, was calculated [Ca2*], was calculated 
using the equation [Ca2*] - Kd χ (R-R^R^-R) x (FmJFmJ, 
where R
mn
 and A„„ are the minimum and maximum fluores­
cence ratios, obtained in the presence of 10 mM EGTA and 1 
μΜ îonomycin (Sigma), respectively, and Fmm and F^ are the 
emission fluoresence values at 380 nm at these two extreme 
conditions The equilibrium dissociation constant {К
л
) for the 
Ca2*-fiira-2 complex at 37"C was taken to be 224 nM (14) 
Measurement of Ca2* release from endoplasmic reticu­
lum stores. Cells on covershps were loaded with ftira-2 as 
described above and placed on the stage of the microscope 
After recording cells in Ca2*-containing medium, the medium 
was replaced with 200 μΙ of Ca2*-free medium After 10 min, 
800 μΙ of Ca2*-free medium containing 1 μΜ (final concen­
tration) thapsigargin (LC Services, Wobum MA, USA) was 
added The [Ca'*], was measured as described above 
Plasmids. Гог the expression ot both the wild-type CBV3 
2B protein and the mutant 2B proteins, we made use of pre­
viously described pC2Ba6 plasmids (46) These dicistromc 
plasmids were constructed by cloning of the coding region of 
2B with an additional methionine at its 5' end and a stopcodon 
at its 3 end, as the first cistron in plasmid pLINKné The 
plasmids contain a SV40 origin of replication to allow their 
amplification in COS-1 cells and a SV40 late promoter to 
drive transcription of RNA 
Transfections. COS-1 cell monolayers grown to conflu-
ency of 70% were harvested by trypsinization, collected by 
centrifugation for 5 mm at 1,500 χ g, and resuspended in PBS 
to a density of I χ 10' cells per ml 2 χ 106 COS-1 cells were 
transfected with 15 pg of plasmid DNA by eleclroporation at 
300 Volts and 125 μFaπ·aday using the Gene Puiser (Bio-
Rad) After electroporation, cells were resuspended in fresh 
medium and seeded onto covershps (diameter, 2 4 cm) placed 
inside the wells of 6-well plates Cells were seeded at a density 
of 2 χ 10^ cells per well and grown at 37°C until further analy­
sis 
Transfection of HeLa cell monolayers with in vitro tran­
scribed copy RNA of chimeric replicón pCB3/T7-LLC and 
measurement of the luciferase activity were performed as 
described (44) 
Indirect immunofluorescence. Transfected COS-1 cells 
grown on covershps were fixed by treatment with cold metha-
nol, followed by treatment with cold aceton, each for 2 mm 
The covershps were incubated for 1 h at 37°C with rabbit 
polyclonal serum raised against CBV3 protein 2B (kind gift 
from the laboratory of R Kandolf, University of Tübingen, 
Germany) that was 1 40 diluted in PBS After 2 washes with 
PBS, the covershps were incubated for 1 h at 37°C with 
fluorescein isothiocyanate-conjugated goat-anti-rabbit IgG 
(Cappel laboratories, Cochranville PA, USA), which was 1 40 
diluted in 0 2% evans blue/PBS The covershps were washed 
with PBS, dried, overlaid with a 1 1 mixture of glycerol and 
PBS, and viewed with a Leitz dialux 20 EB microscope The 
percentage of protein-expressing cells was determined de visu 
of 500 cells 
Immuno-electron microscopy. ГВ З-infected HeLa cells 
and transfected COS-1 cells were harvested by scraping in 
MEM without FBS and collected by centrifugation for 5 mm 
at 1,500 χ g After fixation in penodate-lysine-2% parafor­
maldehyde for 2 h at room temperature, cells were pelleted in 
15% gelatin Gelatin pellets were cut in small blocks, 
cryoprotected in 2 3 M sucrose for 45 mm, and snap frozen in 
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liquid nitrogen Cryostat sections (25 цт) were washed with 
PBS and incubated in 50 mM glycine (pH 7 4) for 10 min 
After two washes in PBS, the sections were incubated over­
night at 4°C with anti-2B serum (see above) that was 1 40 
diluted in 1% bovine serum albumin (BSA)/PBS Sections 
were washed in PBS and incubated for 1 h with goat-anti-
rabbit antibodies, coupled to colloidal gold of 1 nm (Nano-
probes Immunosource, Stony Brook, NY, USA), that were 
1 50 diluted in 1% BSA/PBS This was followed by a 1 h 
incubation in PBS and postfixation with 1% glutaraldehy-
de/PBS After three washes in distilled water, the gold signal 
was enhanced using HQ silver (Nanoprobes Immunosource) 
for 7 mm Sections were incubated overnight in distilled water 
and treated with 1% Os04 for 30 min After this, they were 
dehydrated m alcohol, embedded in Epon 812, and viewed 
with a JEOL 1200 EX II electron microscope 
Analysis of viral protein synthesis in vivo. HeLa cell 
monolayers were infected at a MOI of 25 TCID50 per cell 
After infection, cells were supplied with MEM with or without 
Ca2* and incubated at 37°C At various times ρ ι, protein 
synthesis was monitored by pulse labeling with 10 цСі of 
Tran"S-label (a mixture of [3!S]methiomne and ["SJcysteine, 
ICN) in methionine- and serum free MEM or methionine- and 
serum-free MFM without CaCI2 for 30 min Lysis of cells and 
analysis of labeled proteins by sodium dodecyl sulfate (SDS)-
polyacrylamide gel electrophoresis was performed as de­
scribed previously (44) 
In experiments in which the permeability of cells to hygro-
mycin В was assayed, cells were incubated in methionine- and 
serum-free MEM, with or without Ca2t and in the presence or 
absence of 500 μg hygromycin В (Sigma) per ml, for 15 min 
prior to the addition of 10 μΟ of Tran"S-label to the medium 
Viral growth curves. Confluent HeLa cell monolayers in 
Ti25 flasks were infected with virus at a MOI of 5 TC1DM per 
cell After infection, cells were supplied with 5 ml of MEM 
with or without Ca2* and grown at 37°C At the indicated 
times ρ ι, flasks were subjected to three cycles of freezing and 
thawing to release intracellular viruses Viruses contained in 
these flasks represented the total virus population (ι e , extra­
cellular plus intracellular virus) Virus titers were determined 
by endpoint titration 
In experiments in which the release of viruses from the 
cells was studied, 1 ml of medium was removed prior to freez­
ing of the flasks This sample was microcentnfuged for 5 min 
at 1,500 χ g to remove intact cells The titer of extracellular 
viruses maintained in the supernatant was determined as de­
scribed above 
Propidium iodide uptake. HeLa cell monolayers were 
infected with CBV3 at a MOI of 5 TCID50 per cell After 
infection, cells were supplied with MEM with or without Ca2* 
and grown at 37°C At the desired time ρ ι, the medium was 
collected Cells remaining at the surface of the flask were 
harvested by incubating in I ml of PBS containing 50 mM 
EDTA and combined with the medium Cells were collected 
by centrifugation for 5 mm at 1,500 χ g and resuspended in 
300 μΐ of medium Propidium iodide (Sigma) was added to a 
final concentration of 5 μg Cells were incubated for 10 mm at 
room temperature The number of permeable cells was 
determined using a Coulter XL flow cytometer (Coulter corp , 
Hialeah FL, USA) 
RESULTS 
Enhanced intracellular Ca1* concentration during 
Coxsackie B3 virus infection. To monitor the [Ca2*], 
during CBV3 infection, we carried out digital-imaging 
microscopy using the fluorescent Ca2+ indicator fura-2 
HeLa cells grown on coverslips were infected with wild-
type CBV3 at a MOI of 25 TCID5 0 per cell At various 
times postinfection (p t ), the [Ca2*], in 250 individual 
cells was determined The basal [Ca2*], in uninfected 
HeLa cells was about 20 nM Figure 1 shows that the 
[Ca2*], in infected cells gradually increased from 2 h ρ ι 
Cells that showed the highest [Ca2*], which were also 
those that exhibited the most severe cytopathic effects 
(e g , rounding and granulation), started to detach from 
the covershp from 10 h ρ ι The few cells that were still 
attached to the covershp at 14 h p i all exhibited an 
enormous increase in [Ca2*], 
Two possible mechanisms may explain the nse in 
[Ca2*], One possibility is that the virus induces the in­
flux of extracellular Ca2* Alternatively, the virus may 
release Ca2* from intracellular stores To examine this, 
the [Ca2*], in СВ З-infected HeLa cells that were sup­
plied with medium without Ca2* was measured In the 
absence of extracellular Ca2*, no increases in [Ca2*], 
were observed (data not shown) Moreover, lowering of 
the external Ca2* concentration of cells exhibiting an 
increase in [Ca21], resulted in an immediate decrease in 
[Ca2'] (see Fig 2B, lower pannel) From this it follows 
that the Ca2* responsible for increasing the [Ca2*], comes 
mainly from the external medium 
Leakage of Ca2* from the endoplasmic reticulum 
during infection. We have measured the inducible Ca2* 
release of ER stores at various times during infection 
using thapsigargin, a specific inhibitor of the ER Ca2*-
ATPase (22) This Ca2*-ATPase transports Ca2* from the 
cytoplasma into the ER, an activity that is required to 
compensate for the continuous leakage of stored Ca2* 
through channels in the ER membrane (8) When this 
ATPase is inhibited, Ca2* that leaks from the ER is not 
resequestered and accumulates in the cytosol In Ca2*-
free medium, this accumulation is transient (minutes) 
because the Ca2* ions that leak out of the ER are rapidly 
pumped out of the cell by Ca2h-ATPases present in the 
plasma membrane (8) Under the latter condition (Ca2*-
free medium), the size of the thapsigargin-induced peak 
increase in [Ca2*], may be considered as a reflection of 
the Ca2* content of the ER 
Hel a cells grown on coverslips were infected with 
wild-type CBV3 at a MOI of 25 TCID5 0 per cell At 
various times ρ ι, first the average [Ca2*], of groups of 
fura-2-loaded cells was determined Then, the cells were 
incubated in Ca2*-free medium and challenged with 
thapsigargin after 10 min Figure 2A shows that the 
average [Ca2*], gradually increased and that there is 
about a 2-fold increase at 4 h, a 5-fold increase at 6 h, 
and a 10-fold increase at 8 h ρ ι The average Ca2* con­
tent of ER was calculated relative to that of mock-in­
fected cells (0 h ρ ι ) In these cells, the thapsigargin-
induced Ca2* release caused a peak increase in [Ca2*], of 
130 ± 10 nM (mean ± SEM) (Fig 2B, upper panel) 
Representative traces measured at 4 and 8 h ρ ι are 
shown in Figure 2B (middle and lower panel, respective­
ly) The relative responses to thapsigargin measured 
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Figure 1. [Ca2*], during CBV3 infection IleLa cells grown on covershps were infected with CBV3 at a MOI of 25 TCID,„ per cell for 
30 mm at room temperature and grown at 37°C The cells were loaded with the fluorescent Ca2* indicator fura-2 (2 5 μΜ) for 30 min at 
37°C, starting at 30 min before the indicated times At each time, the [Ca2*], in 250 individual cells was determined using digital-
imaging microscopy, focusing on independently chosen cells lying in different areas of the coverslip The [Ca2*], was calculated from 
the fluorescence ratio of the emission intensities measured at 340 and 380 nm as described in Materials and Methods 
hourly between 1 h and 10 h p.i. are shown in figure 2C. 
From this figure it can be seen that the virus-induced 
decrease in the ER Ca2* content followed a triphasic 
kinetics. Infected cells showed a decrease in the amount 
of releasable Ca2* already at 1 h p.i. (phase I). At this 
time, the thapsigargin-induced peak increase in [Ca2*], 
was only 65% ofthat of control cells. From 2 to 5 h p.i., 
a relative constant response to thapsigargin (about 40% 
of that of control cells) was observed (phase II). 
Thereafter, the inducible Ca2* release rapidly declined 
and from 7 h p.i. virtually no response to thapsigargin 
was observed anymore (phase III). 
The kinetics of Ca2+ depletion from the ER was com­
pared with that of viral protein synthesis. Viral transla­
tion was visualized by transfection of HeLa cells with 
copy RNA transcripts of pCB3/T7-LUC, a chimeric 
CBV3 replicón that contains the luciferase gene in place 
of the capsid coding region (44). In transfccted cells, the 
replicón RNA drives translation of a chimeric polypro-
tein that is processed to yield luciferase and all non-
structural proteins involved in RNA replication. The 
monocistronic nature of the RNA guarantees that lucif-
erase accumulation faithfully represents levels of viral 
proteins produced. Figure 2D shows that in transfected 
cells a triphasic pattern of luciferase accumulation was 
observed; luciferase activity initially increased as a result 
of translation of the input RNA (phase I), remained 
constant between the second and fifth hour (phase II), 
and showed a second increase as a result of translation 
of newly synthesized chimeric RNA strands (phase III). 
The triphasic kinetics of Ca2t depletion from the ER and 
that of viral protein synthesis are inversely proportional. 
This suggests that a viral protein is directly responsible 
for the leakage of ER-stored Ca2*. 
Expression of protein 2B is sufficient to increase 
[Ca2+|¡. Transient expression of each nonstructural pro-
tein of poliovirus indicated that protein 2B, and also its 
precursor 2BC, strongly enhanced membrane permea-
bility to the hydrophilic antibiotic hygroinycin В (1, 12). 
This ability was found to be conserved in CBV3 protein 
2B (46). To examine whether expression of CBV3 pro­
tein 2B was also sufficient to increase [Ca2*],, COS cells 
were transfected with plasmids that allowed efficient 
expression of this protein or that encoded no protein. At 
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Figure 2. (A-C) [Ca2*]¡ and the Ca2* contení of the ER in СВ З-infected cells at various times p.i. HeLa cells grown on coverslips were 
infected with CBV3 al a MOI of 25 TCID,0 per cell for 30 min at room temperature and grown at 37"C. At the indicated times, first the 
average [Ca2*], in groups of fura-2-loaded cells was determined (A). Then the cells were stimulated with Ι μΜ thapsigargin following a 
10 mm incubation in Ca2*-free medium and the average thapsigargin-induced peak increase in [Ca2*],, a reflection of the ER Ca2* 
content, was determined. Representative traces measured at 0, 4, and 8 h p.i. are shown in (B). Peak increases in response to thapsigargin 
measured hourly between the I and 10 h p.i. relative to that of noninl'ected cells are shown in (C). Data in panels (A) and (C) are means 
± standard errors of measurements of two independent experiments. Five groups of cells (5 to 10 cells per group, all groups lying in the 
same area of the covcrslip) were analyzed in each experiment. (D) Kinetics of viral protein synthesis. HeLa cell monolayers were 
transfecled with 1 μg of copy RNA transcripts of pCB3/T7-LUC, a subgenomic CBV3 replicón that contains the luciferase gene in place 
of the capsid coding region. At various times posttransfection, cells were lyscd and the luciferase activity was determined. 
2 days posttransfection, the [Ca2*], in 250 individual 
cells was determined and expression of 2B was tested by 
immunofluorescence microscopy. 
Figure ЗА shows that in the cell cultures transfected 
with the 2B-encoding plasmid, about 20% of the cells 
exhibited an increased [Ca2*], (> 500 nM). A similar 
percentage of cells showed reactivity with a polyclonal 
antiserum against 2B (Fig 3B). No immuno-reactivity 
was observed in cell cultures that were transfected with 
the plasmid that encoded no protein. These latter cells 
displayed a [Ca2*], of about 40 nM, which is similar to 
that of nontransfected COS cells. The small portion 
(about 3%) of the cells that displayed an elevated [Ca2*], 
([Ca2< 500 nM) probably represented necrotic, 
membrane-permeable cells, the occurrence of which is 
most likely due to the electroporation procedure. That 
protein 2B is expressed in about 20% of the cells and 
that a similar percentage of cells exhibited an increase in 
[Ca2*],, strongly suggests that 2B is sufficient to increase 
[Ca2*],. Figure 3C shows the [Ca2*], in COS cells 
transfected with the 2B-encoding plasmid as a function 
of time posttransfection. 
Protein 2B causes leakage of Ca1* from the endo­
plasmic reticulum. To examine whether protein 2B 
could also induce leakage of ER-stored Ca2+, we com­
pared the ER Ca2* content of COS cells exhibiting an 
increased [Ca2i], (> 500 nM), which were considered as 
2B-expressing cells, to that of cells present at the same 
coverslip and displaying a normal [Ca2*],. The latter cells 
most likely represented nontransfected and non-2B-
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Figure 3. (A) Effect of CBV3 protein 2B on [Ca2*], COS cells 
were transacted with plasmids containing the coding sequence 
of 2B (plasmid pC2i6) or no viral protein (plasmid pLINKa6) 
and grown at 37°C At 2 days posttransfection, the [Ca2*], in 
individual cells was determined (B) Immunofluoresence mi­
crograph of 2B-expressing COS cells Protein 2B was detected 
using rabbit polyclonal serum raised against 2B and fluorescein 
isothiocyanale-conjugated goat-anti-rabbit IgG Bar, 10 μηι 
(magnification xl.000) (С) Determination of [Ca2*], in individu­
al cells following transfection of COS cells with the CBV1 2B-
protein encoding plasmid At each time, the [Ca2"], in 250 
individual fura-2-loaded cells was determined 
expressing cells and were further used as control cells. 
Fura-2-loaded cells were stimulated with thapsigargin 
following a 10 min incubation in Ca2*-free medium. At 
the end of each experiment, the thapsigargin-induced 
peak increase in [Ca2*], in individual 2B-expressing cells 
and control cells was determined and the average peak 
increase was calculated. Because Ca2* releases on differ­
ing [Ca2+], are not comparable, 2B-expressing cells that 
had not been able to lower their [Ca2*], to control levels 
during the 10 min incubation in Ca2*-free medium were 
not considered. A total of 6 experiments was performed 
(between 32 and 48 h posttransfection). In control cells, 
the basal [Ca2*], in Ca2*-free medium was about 20 nM 
and the thapsigargin-induced net change in [Ca2*], was 
50 ± 15 nM (mean ± SEM). The net change in [Ca2*], in 
2B-expressing cells relative to that of control cells, 
which was adjusted to 100% in each experiment, was on 
average 41 ± 13% (Fig. 4). These results provide evi­
dence that protein 2B indeed induces leakage of Ca2* 
from ER stores (P < 0.02). 
A cationic amphipathic α-helix in protein 2B is 
required to elevate [Ca2*],. CBV3 protein 2B contains 
two hydrophobic domains. One of these domains (aa 37 
to 54) has the potential to form a cationic amphipathic 
α-helix with a structural arrangement typical for lytic 
polypeptides (43). The second domain (aa 63 to 80) dis­
plays characteristics of multimene transmembrane do­
mains (44). To examine the importance of these structur­
al motifs for the ability of protein 2B to increase [Ca2*],, 
five 2B proteins carrying mutations in these domains 
were tested. Three proteins contained mutations in the 
amphipathic α-helix (Fig. 5A). In protein 2B-K[41,44, 
thapsigargin-induced Ca release (%) 
-2B +2B 
Figure 4. Protein 2B causes release of Ca!* from ER stores 
COS cells were transfected with a 2B-encoding plasmid and 
grown at 37°C Fura-2-loaded cells were stimulated with Ι μΜ 
thapsigargin following a 10 min incubation in Ca2*-free me­
dium 25 to 50 cells were monitored Al the end of the experi­
ment, the average thapsigargin-induced peak increase in [Ca2*],, 
a reflection of the Ca2 ' content of the ER, was calculated from 
the 2B-expressing cells that had been able to discharge their 
Ca2* content during the 10 min incubation in Ca2*-free medium 
(for explanation, see text) and an equal amount of control cells 
The average net change m [Ca2*], in control cells was adjusted 
to 100% in each experiment A total of 6 experiments was per­
formed I he relative response of the 2B-exprcssing cells rep­
resents the mean ± standard error Experiments were performed 
between 32 and 48 h posttransfection 
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48]E, the cationic character of the helix is disturbed by 
the replacement of the three lysines with glutamic acid 
residues. In protein 2B-ins[44]L, the amphipathic char­
acter of the helix is disturbed by the insertion of a leu­
cine. In protein 2B-K[41,44]L, the amphipathy is dimin­
ished, but not abolished, due to the substitution of two of 
the lysines with leucines. Two proteins contained muta­
tions in the second hydrophobic domain. These muta­
tions either severely increased (2B-S[77]M/C[75]M) or 
decreased (2B-I[64]S/V[66]S) the hydrophobicity of this 
domain. 
COS cells were transfected with plasmids that ex­
pressed either wild-type or mutant 2B. It seemed possi­
ble that the mutant 2B proteins might increase [Ca2h], in 
a delayed manner. Therefore, the [Ca2+], was measured 
(in 250 individual cells) after both 30 h (Fig. 5B) and 50 
h (Fig. 5C), the 30 h time point being the time at which 
the number of cells displaying a marked increase in 
[Ca2'], (> 500 nM) first reached its maximum (Fig 3C). 
The 2B proteins carrying mutations K[41,44,48]E and 
2B-ins[44]L were unable to elevate [Ca2*],. Protein 2B 
carrying mutation K[41,44]L was still able to increase 
[Ca2l]„ but its activity was considerably delayed. The 2B 
proteins that carried mutations in the second hydrophob­
ic domain exhibited different abilities in increasing 
[Ca2+],; protein 2B-I[64]S/V2[66]S was unable to elevate 
[Ca2+]„ whereas protein 2B-S[77]M/C[75]M showed a 
wild-type 2B activity in elevating [Ca2+],. Using immu­
nofluorescence, it was confirmed that all mutant 2B 
proteins were expressed in about 20% of the cells, simi­
lar as wild-type 2B (data not shown). These data demon­
strate that both the cationic amphipathic α-helix and the 
second hydrophobic domain are required to increase 
[СаП· 
Intracellular distribution of protein 2B. To gain 
more insight in the mechanism by which CBV3 protein 
2B affects Ca2+ homeostasis, we examined its subcellular 
localization in both transfected COS cells and infected 
HeLa cells. Immuno-electron microscopic analysis of 
2B-expressing COS cells showed intense immunolabel-
ing of the plasma membrane and, to a lesser extent, of 
ER membranes (Fig. 6A-C). 2B did not have an indis­
criminate affinity to all membranes, since the nuclear 
and mitochondrial membranes were not labeled. In 
СВ З-infected HeLa cells (Fig. 6D-F), protein 2B 
predominantly occurred in the cytoplasm, where it has 
been localized at the outer surface of the virus-induced, 
ER-derived membranous vesicles that surround the viral 
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Figure 5. Ability of mutant 2B proteins to increase [Ca2"], (A) Helical wheel diagrams of mutants that cany alterations in the putative 
cationic amphipathic α-helix formed by 2B amino acids 37 lo 54 Charged residues are underlined Hydrophobic amino acids are boxed 
(B and C) [Ca2*], measured at 30 h (В) and 50 h (С) after transfection of COS cells with plasmids that direct the synthesis of wild-type 
2R or the indicated mutant 2B proteins At each time, the [Ca2*], in 250 individual fura-2-loaded cells was determined 
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Figure 6. Immunoelectron microscopic localization of protein 2B in 2B-expressing COS cells (Α-C) and СВ З-infectcd HeLa cells (D-
F). COS cells were transfected with a CBV3 2B-cncoding plasmid and grown at 37°C for 40 h. HeLa cells were infected with CBV3 at a 
MOI of 25 TCID50 per cell and grown at 37
DC for 5 h. Cryostat sections (25 μιτι) were generated and processed as described in Materials 
and Methods. The arrows in (Λ) and (D) point to the places that arc shown enlarged in sections (B) and (C), and in sections (E) and (F), 
respectively. Bar in section (A), 0.5 μιη (magnification ХІ9.000). Bar in sections (B) and (C), 0.25 μιτι (magnification x40,000). Bar in 
section (D), 1 μπι (magnification x9,100). Bar in sections (E) and (F), 0.25 μιη (magnification хЗО.ООО). 
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replication complex (6). In addition to its cytoplasmic 
localization (Fig. 6F), a small fraction of the 2B proteins 
seemed to occur at the plasma membrane level (Fig. 6E). 
No immunolabeling was found in mock-infected HeLa 
cells or COS cells that were transfected with a plasmid 
that encoded no protein (data not shown). 
Protein 2B promotes release of virus progeny 
from infected cells. Based on its observed potential to 
enhance membrane permeability, we reasoned that a 
function of protein 2B might be to release virion proge­
ny from infected cells. To establish such a role, virus 
release of vCB3-2B-K.[41,44]L-infected cells was exam­
ined. This virus produces 2B-K[41,44]L, i.e., the mutant 
2B protein that showed a delay in increasing [Ca2+]„ 
most likely as a result of an impaired ability to increase 
membrane permeability. 
HeLa cells were infected with either wild-type virus 
or vCB3-2B-K[41,44]L and the production and release 
of viruses was compared. In the same experiment, we 
also tested vCB3-3'UTR-A[7335]C, a mutant virus that 
exhibits a reduction in virus growth and yield due to a 
nucleotide substitution in its 3' untranslated region (23). 
This virus was included to allow a comparison of the 
kinetics of virus release of vCB3-2B-K[41,44]L with 
that of a mutant virus that produces a wild-type 2B pro­
tein and which accumulates virion progeny to considera­
ble lesser levels. Figure 7 shows the amounts of viruses 
released at various times p.i. In cells infected with wild-
type virus or vCB3-3'UTR-A[7335]C, nearly all virion 
progeny was released at 16 h p.i. At this time, roughly 
only 1 % of the progeny of vCB3-2B-K[41,44]L was 
released. With the latter mutant, virus release was not 
complete before 32 h p.i. These results support the idea 
that virus release is dependent on the membrane-disturb­
ing action of protein 2B, rather than on the accumulation 
of virion particles (which in vCB3-2B-K[41,44]L-
infected cells is more than 100-fold higher than in 
vCB3-3'UTR-A[7335]C-infected cells). 
Do increased [Ca2*], levels contribute to certain 
stages of the viral replicative cycle? The question of 
whether the virus-induced increase in [Ca2*], serves to 
modulate a viral process or function, or is just a side-
effect of the enhanced permeability of the plasma mem­
brane, was addressed. For this, we compared the effi­
ciency and course of several stages of the viral replica­
tive cycle taking place in СВ З-infected cells supplied 
with medium with or without Ca2*. 
The importance of Ca2" for the shutoff of cellular 
protein synthesis and the efficiency of viral translation 
was examined by pulse-labeling of infected cells at 
various times p.i. Figure 8A shows that extracellular 
Ca2* is dispensable for the inhibition of host cell protein 
synthesis (which is evident at 3 h p.i.). In the absence of 
extracellular Ca2*, a small delay in the onset of viral 
protein synthesis was observed. However, once initiated, 
the rate of viral translation was not affected. 
The role of Ca2* in virus amplification was analyzed 
by measuring the virus titer at several times p.i. Figure 
8B shows that virus growth is largely independent of 
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Figure 7. Release of virion progeny from cells infected with 
wild-type CBV3, vCB3-2B-K[41,44]L, or СВЗ-3'UTR-
Л[7335]С HeLa cell monolayers were infected at a MOI of 5 
TCID5„ per cell and grown at 37°C At the indicated times ρ ι, a 
small portion of the medium was removed the flasks Cells and 
the remainder of the medium were subjected to three cycles of 
freezing and thawing to release intracellular viruses The 
medium sample that was kept apart was microcentnfuged for 5 
min at 1,500 χ g to remove intact cells The number of viruses 
present in the medium (containing extracellular viruses only) 
and the flasks (containing total virus, i.e., extracellular and 
intracellular viruses) was determined by endpoint titration 
TCIDS„, 50% tissue culture infective dose One of two represen­
tative experiments is shown 
[Ca24],. In the absence of extracellular Ca2+, a small 
reduction in virus titer was observed at 6 h p.i., but vi­
ruses grew to similar titers at 8 h p.i. That viruses repli­
cated efficiently in the absence of extracellular Ca2 ' 
implies that increases in [Ca2+], are dispensable for pro­
cesses like viral minus and plus-strand RNA synthesis 
and virion assembly. 
The possibility was investigated that the elevated 
[Ca2*], might aid in increasing plasma membrane perme­
ability. First, the sensitivity of translation to hygromycin 
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Figure 8. Importance of Ca2* for several stages of the viral replicative cycle. In all panels, HeLa cell monolayers were infected with 
CBV3 at the indicated MOI (given in TCID;0 per cell), supplied with medium with or without Ca2*, and grown at 37'C until further 
analysis. (A) Pulse-labeling of infected cells (MOI 25) at various times p.i. (indicated above each lane). At the indicated times, cells 
were incubated for 30 min in methionine-free MEM, with or without Ca2*, in the presence of 10 цСі of Tran"S-label (a mixture of 
["SJmethtonine and [35S]cysteine). Labeled proteins were analyzed on an SDS-12.5% Polyacrylamide gel. Viral proteins are indicated. 
(B) Single-cycle growth curves of infected cells (MOI 5). At the indicated times, cells were subjected to three cycles of freezing and 
thawing. Virus titers were determined by endpoint titration. (C) Permeability of the plasma membrane of infected cells (MOI 25) to 
hygromycin B. At 6 h p.i., cells were pulse-labeled with 10 цСі of Tran35S-label for 30 min in methionine-free MEM, with or without 
Ca2*, and in the presence or absence of 500 μgl hygromycin В (hyg B) per ml. (D) Permeability of infected cells (MOI 5) and mock-
infected cells to propidium iodide (PI). At the indicated times, cells were processed for propidium iodide uptake and flow cytometric 
analysis as described in Materials and methods. (E) Release of virion progeny from infected cells (MOI 5). Tilers of total and 
extracellular virus were determined as described in the legend of Figure 7. One of two representative experiments is shown. 
В in infected HeLa cells was assayed. The effect of 
hygromycin В was tested at 6 h p.i., a time at which host 
cell translation is shut off and only viral translation takes 
place. Figure 8C shows that the inhibition of translation 
by hygromycin В occurred irrespective of the [Ca2*],. 
We also tested the permeability of the plasma membrane 
at increasing times p.i.. Now, permeability was assessed 
by the uptake of propidium iodide, a membrane-
impermeable, fluorescent DNA stain. The percentage of 
permeable cells was then determined by flow cytometry. 
Figure 8D shows that during infection the number of 
permeable cells rapidly increased independent of the 
presence of extracellular Ca2*. These findings suggest 
that it is unlikely that the 2B-induced increase in plasma 
membrane permeability is facilitated by the increase in 
tCa^,. 
To examine whether the increase in [Ca2*], contrib­
utes to the release of virus progeny, the amount of total 
virus and extracellular virus produced and released in 
the presence or absence of extracellular Ca2' was com­
pared (Fig. 8E). The amount of total virus produced in 
the absence of Ca2+ was found to be similar to that pro­
duced in the presence of Ca2+ and is therefore not shown. 
In the presence of Ca2*, it took about 16 h before all 
viruses were released from the cells, i.e., when the 
amount of total virus and extracellular virus were the 
same. In the absence of Ca2*, however, virus release was 
not complete before 24 h p.i. Between 8 and 14 h p.i., 
the amount of virus that was released in the absence of 
Ca2+ was 5 to 10-fold lower than that released in the 
presence of Ca2*. Thus, increases in [Ca2*], facilitate the 
release of virus progeny. 
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DISCUSSION 
Protein 2B is a viroporin that facilitates virus 
release by modifying membrane permeability. Cyto­
lytic animal viruses need to modify membrane permea­
bility in order to release their progeny. This may be 
particularly important for nonenveloped viruses that do 
not leave the cells by budding but that need to lyse the 
membrane. The molecular mechanisms employed to 
disturb the membrane are yet poorly understood. It has 
been suggested that membrane permeability is due to the 
expression of a single or a limited number of virus genes 
rather than to the bulk of viral gene expression or the 
formation and accumulation of virus particles (9). Sever­
al results presented here provide ample evidence for this 
suggestion. First, we have shown that CBV3 infection 
leads to disruption of the Ca2+ gradients maintained by 
the plasma membrane and ER membrane, and that pro­
tein 2B is sufficient to induce these effects. Second, 
viruses carrying a mutant 2B protein exhibited an im­
pairment in the release of virion progeny. Third, mutant 
viruses that showed a 100-fold reduction in accumula­
tion of virion particles, but which produced a wild-type 
2B protein, showed a wild-type efficiency of virus re­
lease. These findings strongly suggest that 2B is a pro­
tein targeted to enhance plasma membrane permeability, 
and that a function of this activity is to facilitate the 
release of virion progeny. 
The recognition of virus proteins capable of enhanc­
ing membrane permeability is currently leading to the 
description of a new family of virus proteins; the 
viroporins (9). Until now, only two of such proteins 
have been identified; influenza virus protein M2 and 
togavirus 6K. protein, small proteins that contain a pre­
dicted amphipathic α-helix. Both proteins are able to 
modify membrane permeability in the absence of other 
viral proteins (15, 28, 36) and deletion or blockage of 
the function of these proteins caused a decrease in the 
release of virions due to a defect in budding from the 
cell surface (21, 33). CBV3 protein 2B represents the 
first example of a viroporin of a naked virus. An under­
standing of the mechanism by which 2B affects mem­
brane permeability will be of great interest in under­
standing how cytolytic viruses release their progeny and 
will contribute to our knowledge on the structure of 
proteins designed to lyse cellular membranes. 
Destabilization of the lipid bilayer by membrane-
disturbing proteins is a wide-spread strategy used in 
nature to lyse cells. Among these proteins are the holins, 
proteins from bacteriophages that lyse bacteria by form­
ing holes in their membranes (49, 50), hemolysins, cyto­
lytic toxins of bacterial origin (3), cecropines, peptides 
that occur in the venom of several insect species (38), 
magainins, antibiotic peptides that occur in the skin of 
amphibia (51), and defensins, vertebrate antimicrobial 
peptides (11). A general feature of these membrane-
disturbing proteins is the occurrence of amphipathic 
α-helices, mostly containing cationic amino acids in 
their hydrophilic faces. Two molecular models of action 
have emerged from structural and functional studies on 
these proteins (3, 39). According to the first type of 
model, the helices form aqueous pores by spanning the 
membrane and forming oligomers, exposing their hydro­
phobic sides to the lipid bilayer and their hydrophilic 
faces forming the aqueous interior. The second model 
suggests that the amphipathic helix is lying parallel to 
the membrane plane and penetrates a few Angstroms 
into it, thereby making the phospholipids more suscepti­
ble to degradation by phospholipases. The distinction 
between these models may not be so clear because 
membrane-embedded pores may also activate phospho-
lipase activity (50). 
Analysis of mutations in individually expressed 2B 
proteins confirmed that the predicted cationic amphi­
pathic α-helix in 2B is a major determinant for its ability 
to increase [Ca2+],. In addition to the amphipathic helix, 
however, also the second hydrophobic domain appeared 
to be involved in this ability. This argues against an 
independent role of the amphipathic α-helix (i.e., the 
second model) in increasing membrane permeability. It 
should therefore be considered that multimers of 2B 
form membrane-embedded pores and that the formation 
of these pores depends on a correct positioning of the 
second hydrophobic domain in the membrane. When 
considering the mechanism by which protein 2B in­
creases plasma membrane permeability, however, the 
subcellular localization of the protein should be taken 
into account. Studies examing the localization of polio-
virus 2B showed that the protein is contained exclusive­
ly central in the cytoplasm, where is it is associated with 
the ER-derived, membranous vesicles that surround the 
viral replication complex (6). The possibility that the 
2B-induced release of ER-stored Ca2+ is indirectly re­
sponsible for the increase in plasma membrane permea­
bility seems unlikely, because the enhancement of plas­
ma membrane permeability did not rely on the presence 
of Ca2+ ions. In addition, the thapsigargin-induced evac­
uation of ER-stored Ca2+ in noninfected cells had no 
effect on plasma membrane permeability to hygromycin 
В (unpublished data). Another possibility is that a small 
fraction of the 2B proteins directly associate with the 
plasma membrane. The immunocytochemical studies 
reported here provide a first indication for this possibili­
ty. In СВ З-infected cells, protein 2B was not only 
observed central in the cytoplasm, but also at the plasma 
membrane level. Whether these 2B proteins actually 
represent membrane-associated proteins or, alternatively, 
proteins that are associated with viral replication com­
plexes that lie in close vicinity to the plasma membrane 
remains to be established. That protein 2B is able to 
associate with the plasma membrane, however, is strong­
ly suggested by the plasma membrane labeling observed 
in 2B-expressing cells. 
A second activity identified for protein 2B is the 
ability to interfere with protein trafficking through the 
vesicular system (12). It could be postulated that this 
activity is indirectly responsible for the increase in plas­
ma membrane permeability by altering the protein and 
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lipid composition of the membrane. However, this possi­
bility seems unlikely because of two reasons. First, 
expression of enterovirus protein ЗА, which is an even 
more potent inhibitor of vesicular protein transport than 
2B, does not lead to enhanced plasma membrane perme­
ability (12). Second, analysis of the abilities of mutant 
CBV3 2B proteins to increase membrane permeability 
and inhibit protein transport suggested that these two 
activities are separate functions of protein 2B rather than 
that one of these effects is the consequence of the other 
(46) 
It is tempting to speculate that by forming pores in 
both the ER membrane and the plasma membrane, 2B is 
responsible for the disturbance of ionic gradients and the 
activation of phospholipases. Increased phospholipase С 
activities have indeed been reported in poliovirus-in-
fected cells (16) and it is likely that these contribute to a 
further disruption of the membrane, resulting in in­
creased pore sizes. A progressive recruitment of 2B 
proteins may also cause widening of the pore. The idea 
that 2B forms pores that gradually increase in size is 
consistent with the phenomenology observed in polio-
virus-infected cells: initially ionic gradients are disrupted 
in both directions, then low-molecular-weight com­
pounds can pass the membrane, and finally enzymes 
leak out of the infected cells (9). It is likely that this 
membrane damage will ultimately allow release of new­
ly formed viruses. The observation that polioviruses are 
released exclusively from the apical surface of polarized 
human intestinal epithelial cells (42) may be due to a 
focal distribution of 2B proteins at the apical plasma 
membrane. 
Disruption of intracellular CaI+ homeostasis by 
protein 2B. CBV3 infection gradually enhances [Ca2*],, 
similar as recently reported in poliovirus-infected cells 
(18). The increase in [Ca2*], in both СВ З-infected 
HeLa cells and 2B-expressing COS cells is mainly due 
to the influx of extracellular Ca2*. This influx may be 
explained by the increased plasma membrane permeabil­
ity. However, the influx of Ca2* may also be triggered by 
the partial emptying of the ER. Reductions in the state of 
filling of intracellular Ca2+ stores stimulate the influx of 
Ca2+ by opening specific Ca2* channels in the plasma 
membrane, a phenomenon known as capacitative Ca2' 
entry (reviewed in reference 4). The capacitative Ca2* 
entry mechanism is present in many cells and can be 
switched on by a great variety of stimuli all of which 
share a common property of releasing stored Ca2* (30). 
Capacitative Ca2* entry is therefore likely to occur in 
both СВ З-infected HeLa cells and 2B-expressing COS 
cells. The relative contribution and importance of the 
capacitative Ca2+ entry in increasing the [Ca2*],, how­
ever, is difficult to define because the time at which the 
[Ca2*], starts to increase in infected cells (i.e., from 4 h 
p.i.) is the same as that at which the permeability of the 
plasma membrane starts to increase (9). Besides, the 
capacitative Ca2* entry channel has not been identified 
and specific inhibitors are yet unknown. 
It seems plausible that protein 2B releases Ca2+ from 
the ER by increasing the permeability of the ER 
membrane. However, alternative mechanisms should be 
considered. The release of ER-stored Ca2* could be 
caused by (i) the enhanced activity of phospholipases, 
generating increased levels of inositol-1,4,5-trisphos-
phate (IP,), (ii) a direct inhibition of the ER Ca2+-ATPa-
se, or (iii) a direct stimulation of the ER IP3 receptor. 
The first possibility seems unlikely because increased 
levels of IP3 in poliovirus-infected cells were detected 
only at 3 to 4 h p.i. (16), whereas the Ca2* content of the 
ER is already decreased at 1 h p.i. Direct interactions of 
protein 2B with the ER Ca2+-ATPase or the ER IP, re­
ceptor also seem unlikely, since we have demonstrated 
that mutations that abrogate the membrane-disturbing 
potential of 2B also abolish its ability to increase [Ca2*],. 
The possibility that membrane-embedded 2B proteins 
sterically hinder the functioning of these proteins, how­
ever, cannot be excluded. 
Until now, only one other viral protein capable of 
mobilizing Ca2* from the ER has been identified; rotavi­
rus NSP4. This nonstructural ER transmembrane glyco­
protein contains a predicted amphipathic α-helix and this 
helix has been shown to be involved in the mobilization 
of Ca2* from the ER (40). The formation of cation chan­
nels has been proposed as a possible mechanism by 
which NSP4 alters the ER permeability. Thus, rotavirus 
NSP4 and 2B may release ER-stored Ca2* by a common 
mechanism. 
A model that may account for the alterations in Ca2+ 
homeostasis that take place in time during CBV3 infec­
tion, and the release of virus progeny from infected cells 
is illustrated in Fig. 9. We propose that early in infection 
(during the first 2 hours) the 2B protein is produced and 
inserted into the ER membrane, where it promotes a 
partial release (of about 50%) of stored Ca2+ by forming 
membrane-embedded pores. As a consequence, capaci­
tative Ca2* entry will be induced. However, the [Ca2+], 
remains constant during the first 3 to 4 h p.i., as a result 
of the action of the plasma membrane Ca2+-ATPase. A 
small fraction of the 2B proteins is transported to the 
plasma membrane, where it causes the influx of Ca2* 
(evident from 4 h p.i.). Between 2 h and 5 h p.i., the Ca2* 
content of the ER remains constant. This steady-state 
phase probably reflects the time needed to replicate the 
plus-strand genomic RNA via a complementary minus-
strand RNA intermediate. Translation of these newly 
synthesized plus-strand RNAs (between 5 and 6 h p.i.) 
gives rise to the production of large numbers of 2B 
protein, which cause a rapid evacuation of ER-stored 
Ca2+ by further disturbing the ER membrane. Progres­
sive insertion of 2B proteins in the plasma membrane 
results in a further collapse of ionic gradients. An in­
creased influx of Ca2' ions through both capacitative 
Ca2* entry channels and pores formed by 2B will be the 
result. A rapid increase in [Ca2*], occurs from 6 h p.i., 
most likely because from this time the Ca2* influx ex­
ceeds the pumping capacity of the plasma membrane 
Ca2*-ATPase. Progressive membrane disruption ulti­
mately allows the release of virus progeny. 
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through the formation of membrane-embedded pores Early events (up to 4 h ρ ι ) in the viral replicative cycle involve (1) production of 
protein 2B and insertion in the F.R membrane, leading to a release of Ca2* and, as a consequence, opening of capacitative Ca2* entry 
channels, (2) transport of 2B to the plasma membrane where it is inserted and causes influx of extracellular Ca2*, (3) induction of the 
membranous vesicles by protein 2BC that are required for viral plus-strand RNA replication (possibly through the release of CR-stored 
Ca2 ') Late events (from 5 h ρ ι ) in the viral replicative cycle involve (4) translation of newly formed plus-strand RNAs yielding large 
numbers of protein 2B, insertion of these proteins in the hR membrane causes a rapid evacuation of Caz* and gives rise to an increased 
capacitative Ca2t entry, (5) collapse of Ca2* gradient maintained by the plasma membrane by massive insertion of 2B proteins, (6) 
progressive increase in the size of the pores formed by 2B causes disruption of the membrane and results in the membrane lesions thai 
allow virus release For details, the reader is directed to the text RC. replication complex 
Studies towards the potential contribution of the 
enhanced [Ca2*], to different stages of the viral life cycle 
showed that increases in [Ca2+], were dispensable for the 
shutoff of cellular translation, the rate of viral transla­
tion, viral minus-strand and plus-strand RNA replica­
tion, virion assembly, and virus release. This latter pro­
cess, however, appeared to be potentiated by increases in 
[Ca2*],. The reason for this is unknown. A possible ex­
planation is that the elevated [Ca2*], is cytotoxic and 
enhances cell lysis. Increases in [Ca2+], have been shown 
to be involved in animal virus-induced cytopathic effects 
and cell killing (24, 27, 35, 41). Whether the increase in 
[Ca2*], in СВ З-infected cells also contributes to cytopa-
thology, and whether this contributes to virus release, 
remains to be established. 
Putative function of the mobilization of Ca2* from 
the ER in viral genome replication. We have shown 
that CBV3 protein 2B enhances membrane permeability 
and that this activity serves to release virus progeny. 
However, it seems unlikely that this is the only function 
of 2B. Mutations in the 2B gene that disrupt essential 
structural domains abolish vRNA replication and virus 
growth (43-45). However, if the only function of 2B 
were to modify plasma membrane permeability in order 
to release virus progeny, then genomic RNAs carrying 
mutations in their 2B gene would be expected to be 
replicated and encapsidated to produce viruses that 
accumulate in the cell. Additional functions of 2B con­
nected with its ability to disturb membrane integrity 
should therefore be considered. A possible explanation 
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is that the release of ER-stored Ca2* is required for 
vRNA replication. Viral plus-strand RNA synthesis 
takes place at the outer surface of virus-induced mem­
brane vesicles that originate from the ER (6). Protein 
2BC has been identified as the viral protein responsible 
for the induction of these vesicles (2, 7, 10). The func­
tion of 2B in precursor 2BC may involve its ability to 
release ER-stored Ca2*. The ER contains a gel of Ca2* 
binding proteins that is responsible for the sequestration 
of Ca2* ions. These Ca2h binding proteins form coordina­
tion complexes with Ca2* ions that are bound to the 
negatively charged phospholipid head groups on the 
luminal face of the ER membrane, thereby stabilizing 
the underlying membrane and preventing its vesiculation 
(34). It has been predicted that transport vesicles derived 
from the ER normally bud from regions of membrane 
that are not stabilized by the Ca2*-protein gel. The artifi­
cial evacuation of Ca2* ions from the lumen of the ER 
that occurs when cells are treated with Ca2* ionophores 
has been proposed to destabilize the entire Ca2*-protein 
gel and its associated membrane, leading to a mass 
vesiculation (34). By analogy with the effect of the iono­
phores, the release of ER-stored Ca2h by the 2B polypep­
tide in protein 2BC may be involved in the massive 
induction of ER-derived membrane vesicles by 2BC 
(Fig. 9). According to this model, mutations that disrupt 
the ability of 2B to enhance membrane permeability will 
interfere with the ability of protein 2BC to induce these 
membrane vesicles and thereby account for defects in 
vRNA replication and virus growth. 
The exact mechanism by which protein 2BC induces 
membrane proliferation and vesicle accumulation is still 
puzzling. The release of ER-stored Ca2* may be in­
volved, but is clearly not sufficient for these activities, as 
protein 2B alone is unable to account for these structural 
alterations. Therefore, a function of protein 2C in pre­
cursor 2BC seems to be required as well. Protein 2C has 
been identified as an NTPase that shares structural simi­
larities with the group of small GTPases involved in the 
regulation of vesicle transport (25, 32), but its exact 
function is unknown. Further investigations are required 
to define the contribution of proteins 2B and 2C to the 
ability of protein 2BC to rearrange membranes and to 
induce membranous vesicles. 
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The genus Enterovirus, which belongs to the family 
of the Picornavindae, comprises pohoviruses, Coxsackie 
A and В viruses, ECHO viruses, and a number of dis­
tinct enterovirus serotypes Enteroviruses are human 
pathogens that cause a broad spectrum of diseases Cox­
sackie В viruses usually cause acute infections that are 
either subclinical or so mild that they do not come to 
attention These viruses may, however, be involved in 
several chronic diseases such as idiopathic dilated car­
diomyopathy, polymyositis/denmatomyositis, and juve­
nile (type I) diabetes mellitus A possible explanation for 
the involvement of Coxsackie В viruses in these chronic 
diseases is that the virus causes a persistent infection 
However, coxsackievirus reproduction usually results in 
cell death within a short time This excludes a chronic 
course of infection A persistent infection may therefore 
reflect an alteration in viral reproduction The process of 
viral replication is still incompletely understood This 
thesis was undertaken to gain more insight in the mole­
cular mechanism of viral replication 
Enteroviruses are small cytolytic viruses that contain 
a single-stranded RNA genome of plus-strand polarity 
(15) After cell entry and virion uncoating, the genomic 
RNA serves as a messenger RNA to direct the synthesis 
of a single polyprotein Initiation of translation occurs 
via a cap-independent mechanism The polyprotein is 
processed by virally encoded proteases to yield four 
structural capsid proteins and ten nonstructural proteins, 
seven mature proteins (2A, 2B, 2C, ЗА, 3B, 3C, and 
3D) and three cleavage intermediates (2BC, ЗАВ, and 
3CD) (15) Replication of the viral RNA (vRNA) starts 
with the synthesis of a complementary minus-strand 
RNA which, in turn, serves as a template to transcribe 
new plus-strand RNA molecules Plus-strand RNA 
synthesis takes place in a replication complex at the 
outer surface of virus-induced, membranous vesicles that 
originate from the endoplasmic reticulum (ER) (3, 12) 
Newly formed plus-strand RNAs are packaged into the 
structural capsid proteins to produce new virions During 
infection, enteroviruses induce a number of alterations in 
cellular functions and structures, most of which serve to 
facilitate viral translation, RNA replication, and virus 
release These alterations include inhibition of host cell 
transcription and translation, rearrangement of intracel­
lular membranes, inhibition of vesicular protein trans­
port, and modification of the plasma membrane permea­
bility (10) All of these activities must be directed by the 
ten nonstructural proteins The genetic organization of 
the viral RNA genome and the putative roles of the each 
of the nonstructural proteins in vRNA replication and 
modification of host cell functions and structures are re­
viewed in chapter 1 
The investigations described in this thesis have fo-
cussed on the nonstructural 2B protein of Coxsackie B3 
virus (CBV3), a small protein that had been identified at 
the outer surface of the ER-denved membrane vesicles 
at which viral plus-strand RNA synthesis takes place, 
but whose function was completely unknown 
SUMMARY OF THE MAIN FINDINGS 
To gain more insight into the structure and function 
of protein 2B, first an extensive computer analysis was 
performed Alignment studies revealed no similarity 
with any cellular protein Analysis of the hydropathy 
showed the hydrophobic nature of the protein and al­
lowed the identification of two hydrophobic domains 
Both domains are well conserved in the 2B proteins of 
all enteroviruses One of these domains (which will 
further be referred to as "the hydrophobic domain") 
contained a moderate degree of hydrophobicity, a fea­
ture that is typical of multimene transmembrane helices 
The other domain displayed a high hydrophobic moment 
and had the potential to form a cationic amphipathic a-
helix 
Chapter 2 describes a molecular genetic approach to 
define the role of the hydrophobic domain of CBV3 2B 
in virus reproduction, and to examine the structural and 
hydrophobic requirements of the domain Defined muta­
tions were introduced in a full-length cDNA clone of 
CBV3 The effects of the mutations on virus viability 
and growth were assayed by transfection of cells with in 
vitro transcribed copy RNA transcripts Furthermore, the 
effects of the mutations on RNA replication, polyprotein 
synthesis and processing, and protein synthesis in infec­
ted cells were examined The results support the idea 
that a moderate degree of hydrophobicity of this domain 
is required for the structure and function of the protein 
Mutations that caused a major increase or decrease in 
hydrophobicity disrupted vRNA replication and virus 
growth, but did not interfere with the synthesis and 
processing of the polyprotein 
A detailed genetic analysis of the putative cationic 
amphipathic o-helix in CBV3 2B is described in chap­
ter 3 This amphipathic α-helix contains a narrow hy-
drophilic face and an arrangement of cationic residues 
that is characteristic for the so-called lytic polypeptides, 
small cationic peptides that modify the permeability and 
integrity of cellular membranes (2, 13, 14) Both the 
amphipathy of the helix and the presence of cationic 
residues in the hydrophilic face of the amphipathic helix 
in protein 2B were found to be required for vRNA repli­
cation and virus growth This supports the idea that a 
cationic amphipathic α-helix is formed and that this 
structure is involved in a function of protein 2B 
In chapter 4 it is shown that individual expression of 
CBV3 2B in COS cells leads to (ι) inhibition of protein 
secretion, as shown by the impaired secretion of a co-
expressed, secreted reporter protein, and (n) an increase 
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in the permeability of the plasma membrane, as shown 
by the increased sensitivity of cellular translation to 
hygromycin B, an inhibitor of translation that normally 
enters cells poorly. Analysis of mutant CBV3 2B pro­
teins showed that both the cationic amphipathic α-helix 
and the hydrophobic domain contribute to these activi­
ties. Some mutant 2B proteins exhibited an impaired 
ability to inhibit protein secretion but not to increase 
membrane permeability. This suggests that both activi­
ties represent distinct functions of 2B rather than that 
one is the consequence of the other. 
In chapter 5 it is shown that mutant viruses contain­
ing poorly processed 2B/2C cleavage sites, and that, as a 
consequence, produced reduced levels of proteins 2B 
and 2C, were unable to completely shut off cap-depend­
ent cellular protein synthesis. The failure of the mutant 
viruses to completely inhibit host cell translation co­
incided with an impaired ability to increase the permea­
bility of the plasma membrane to hygromycin B. These 
data are again indicative for a role or protein 2B in in­
creasing plasma membrane permeability. Furthermore, 
they suggest that by modifying the plasma membrane 
permeability, protein 2B may participate in the shutoff 
of cap-dependent cellular translation. 
To further dissect the structural requirements of pro­
tein 2B for its function in vRNA replication, the ap­
proach of constructing chimeric coxsackievirus-polio-
virus genomes was followed in chapter 6. CBV3 ge­
nomes that expressed poliovirus 2B, a protein that has a 
similar structure and function as CBV3 2B (7) but which 
differs significantly in its amino acid sequence , failed to 
replicate. This suggests that a sequence-specific interac­
tion between 2B and another viral protein is required for 
a function in vRNA replication. Only a hybrid 2B pro­
tein that contained the amino-terminal one-third of 
poliovirus 2B and the remainder of CBV3 2B was func­
tional in vRNA replication and gave rise to virus growth. 
This argues that the proposed sequence-specific contacts 
reside in the carboxy-terminal two-third of 2B. The 
failure to drive vRNA replication of the hybrid 2B pro­
teins that contained either the amphipathic helix or the 
hydrophobic domain of poliovirus 2B suggests that the 
functioning of 2B depends on a mutual interaction of 
these domains. 
The ability of protein 2B to modify membrane per­
meability and its localization at the ER and the virus-
induced, ER-derived membranous vesicles suggested 
that 2B might release Ca2* from ER stores. In chapter 7, 
digital-imaging microscopy was performed to study the 
effect of CBV3 infection on the cytosolic free Ca2+ con­
centration and the Ca2* content of the ER. It is shown 
that CBV3 infection leads to the influx of extracellular 
Ca2 + and the release of ER-stored Ca2+. The individual 
expression of protein 2B appeared to be sufficient to 
induce these effects. Analysis of mutant 2B proteins 
showed that both the cationic amphipathic α-helix and 
the hydrophobic domain are required for these functions. 
Electron microscopy argued that protein 2B not only 
occurs at the ER membrane but also at the plasma 
membrane. A mutant virus that carried a defective 2B 
protein exhibited an impairment in the release of virus 
progeny. These findings support the idea that protein 2B 
increases the permeability of the cellular membranes 
with which it interacts, resulting in a disruption of ionic 
gradients and, ultimately, the membrane lesions that 
allow virus release. 
PROPOSED STRUCTURAL MODEL OF 
PROTEIN 2B 
A cationic amphipathic α-helix is crucial for a func­
tion of protein 2B in vRNA replication (chapter 3) and 
its abilty to increase membrane permeability (chapters 4 
and 7). The occurrence of cationic amphipathic helical 
motifs is typical for membrane-perturbing proteins and 
peptides (13). Two mechanisms have been proposed to 
explain the action of these proteins (2, 14). According to 
the first model, the amphipathic helix perturbs the mem­
brane by lying collateral to it and penetrating a few 
Angstroms into it, thereby making the membrane phos­
pholipids more susceptible to degradation by phospho-
lipases. The second model suggests that the amphipathic 
helices form aqueous channels by spanning the mem­
brane and forming oligomers, exposing their hydrophob­
ic faces to the lipid bilayer and their hydrophilic faces 
forming the aqueous interior of the pores. 
Two observations argue against an independent role 
(i.e., the first model) of the amphipathic α-helix of 
CBV3 2B in increasing membrane permeability. First, 
this activity appeared to be sensitive to mutations in the 
hydrophobic domain (chapters 4 and 7). Second, a chi­
meric 2B protein in which the α-helix was replaced with 
another cationic amphipathic α-helix failed to modify 
aqueous channel 
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Figure 1. Proposed membrane topology of protein 2B. Helices 
representing the amphipathic α-helix (nearer the N-lerminus) 
and the second hydrophobic domain (nearer the C-tcrminus) are 
depicted. An aqueous channel can be formed by multimers of 
2B that expose the hydrophobic faces of their amphipathic 
helices to the lipid bilayer and the hydrophilic laces (darkly 
shaded) to the aqueous inner surface of the channel. 
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plasma membrane permeability (chapter 6) The forma­
tion of aqueous channels should therefore be considered 
A possible explanation for the importance of the hydro­
phobic domain and the nonexchangeability of the amphi-
pathic α-helix is that both domains occur cooperatively 
associated within the lipid bilayer and that intimate 
contacts are required for the formation or stabilization of 
such a channel A putative structural model of the mem­
brane-embedded pores formed by multimers of protein 
2B is shown in Fig 1 Transmembrane positioning of 
both the amphipathic helix and the hydrophobic domain 
is in agreement with the lack of glycosylation of poten­
tial glycosylation sites engineered in the NH2- and 
COOH-termini of 2B (van Kuppeveld et al, unpublished 
results), a finding that suggests that both termini reside 
on the cytosolic rather than on the luminal side of the 
membrane The cooperative association of hydrophobic 
domains in the membrane is compatible with the obser­
vation that a moderate degree of hydrophobicity of this 
domain is required for the well functioning of protein 2B 
(chapter 2), which suggests that the domain forms a 
multimene rather than a monomenc transmembrane 
helix 
R O L E OF PROTEIN 2B IN VIRAL REPLICATION: 
IMPLICATIONS AND SPECULATIONS 
The expression of protein 2B in COS cells leads to an 
increased permeability of the plasma membrane and the 
release of Ca2* from the ER (chapter 7), probably 
through the formation of membrane-embedded pores 
Another ability of protein 2B is to inhibit protein trans­
port through the vesicular pathway (chapter 4) It is yet 
unknown whether each of these activities represent true 
functions that contribute to virus reproduction Until 
now, only one activity has been directly tied to the viral 
replicative cycle, the ability of protein 2B to facilitate 
virus release from infected cells, which is presumably a 
direct effect of its ability to increase the permeability of 
the plasma membrane It seems unlikely, however, that 
this is the only function of 2B Mutations in the 2B 
protein that disrupt essential structural domains abolish 
vRNA replication and virus growth (chapters 2, 3, and 
6) If the only function of 2B were to modify plasma 
membrane permeability in order to release virus proge­
ny, then genomic RNAs carrying mutations in their 2B 
gene would be expected to replicate and to be encapsi-
dated to produce viruses that accumulate in the cell 
Additional functions of protein 2B should therefore be 
considered 
A second function of the increase in plasma mem­
brane permeability may be the inhibition of the host cell 
protein synthesis Mutant viruses that produced reduced 
levels of protein 2B failed to completely inhibit host cell 
translation and showed an impaired ability to modify 
membrane permeability (chapter 5) 1 he mechanism by 
which enteroviruses shut off host cell translation is still 
debated According to the traditional view, the shutoff of 
cap-dependent translation of host mRNAs relies only on 
the protein 2Apn>-mediated cleavage of the 220-kDa 
component (p220) of eucaryotic initiation factor eIF-4F 
(10) However, several reports have described that sub­
stantial levels of cellular protein synthesis can take place 
in cells where all p220 has been degraded (4, 8, 9) It has 
therefore been suggested that the p220 cleavage is nec­
essary, but not sufficient, to completely inhibit host cell 
protein synthesis and that a second event is required to 
block cellular translation (5) The increase in plasma 
membrane permeability and the resulting influx of so­
dium ions have been suggested as potential second 
events because high concentrations of sodium ions are 
inhibitory to host mRNA translation but not to the 
translation of vRNAs (6) The observation that a poor 
increase in plasma membrane permeability coincided 
with a reduced ability to inhibit cellular translation lends 
support to this idea Additional studies are required to 
shed more light on the possible participation of 2B in the 
shutoff of host cell protein synthesis 
The ability of protein 2B to release Ca2* from the ER 
may be involved in the induction of the bR-denved, 
membranous vesicles that accumulate during infection 
and at which viral plus-strand RNA synthesis takes 
place Protein 2BC is thought to be responsible for the 
induction of these vesicles (1,3) The function of 2B in 
precursor 2BC may involve its ability to release ER-
stored Ca2* The ER contains a gel of Ca2* binding pro­
teins that is responsible for the sequestration of Ca2* 
ions These Ca2* binding proteins have been proposed to 
form coordination complexes with Ca2* ions that are 
bound to the negatively charged phospholipid head 
groups on the luminal face of the ER membrane, thereby 
stabilizing the underlying membrane and preventing its 
vesiculation (11) It is assumed that vesicles derived 
from the ER normally bud from regions of the mem­
brane that are not stabilized by the Ca2*-protein gel The 
artificial evacuation of Ca2* ions from the lumen of the 
ER that occurs when cells are treated with Ca2* ιοηο-
phores has been proposed to destabilize the entire Ca2*-
protein gel and its associated membrane, leading to a 
mass vesiculation (11) By analogy with the effect of the 
lonophores, the release of ER-stored Ca2* by the 2B 
polypeptide in protein 2BC may be involved in the mas­
sive induction of ER-denved membrane vesicles by 
2BC Mutations that disrupt the membrane-perturbing 
activity of 2B may interfere with the ability of 2BC to 
induce vesicle proliferation and thereby account for 
defects in vRNA replication and virus growth 
The inhibition of protein secretion by protein 2B is 
likely to result from alteration or sequestration of mem­
branes or proteins required for secretory transport This 
inhibition may contribute to the assembly of the ER-
derived membrane vesicles that surround the viral repli­
cation complexes Inhibition of the protein secretory 
apparatus may provide another direct advantage to viral 
amplification In tissue culture cells, enteroviruses in­
hibit protein secretion even earlier than they inhibit 
cellular protein synthesis (7) Crucial responses of mam-
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malian host cells to viral infection, such as interferon 
secretion and antigen presentation in the context of 
MHC class I molecules, may be inhibited concomitantly 
with the inhibition of protein secretion. The importance 
of the inhibition of protein secretion for the viral replica­
tive cycle awaits further investigation. 
In conclusion, the results described in this thesis 
provide meaningful insight in the structure and function 
of coxsackievirus protein 2B. Protein 2B is a multifunc­
tional protein that appears to be involved in (i) replica­
tion of the viral RNA, (ii) the inhibition of host cell 
translation, (iii) the inhibition of vesicular protein trans­
port, and (iv) the release of virion progeny. These activi­
ties seem to be linked to the ability of 2B to increase the 
permeability of both the ER membrane and the plasma 
membrane by forming membrane-embedded pores, and 
thereby to account for (i) the release of Ca2+ from the 
ER, (ii) a disturbance of the ionic gradients maintained 
by the plasma membrane, and, ultimately, (iii) the mem­
brane lesions that allow virus release. Based on its abili­
ty to alter membrane permeability, protein 2B is classi­
fied as a new viroporin. Protein 2B represents the first 
example of a viroporin of a naked virus. This new in­
sight in the function of protein 2B in viral RNA replica­
tion and modification of cellular functions may open 
new avenues for research on the possible alterations in 
virus replication that may allow a persistent infection, 
and the involvement of these viruses in chronic diseases 
in humans. 
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Samenvatting 
Het genus Enterovirus, dat behoort tot de familie van 
de Picornavmdae, wordt gevormd door poliovirussen, 
Coxsackie A en В virussen, ECHO virussen, en een 
aantal enterovirus serotypen Enterovirussen zijn hu­
maan pathogenen die een breed spectrum aan verschil­
lende ziekten kunnen veroorzaken Het onderzoek dat in 
dit proefschrift beschreven is heeft met name betrekking 
op de Coxsackie В virussen Coxsackie В virussen ver­
oorzaken over het algemeen acute infecties die mild of 
zelfs asymptomatisch verlopen Deze virussen worden 
echter ook m verband gebracht met verschillende ernsti­
ge chronische aandoeningen bij de mens, zoals idio­
pathisch gedilateerde cardiomyopathie, polymyositis/ 
dermatomyositis en insuline-afhankelijke diabetes melli­
tus Een mogelijke verklaring voor een rol van Coxsackie 
В virussen in deze chronische ziekten is dat zij een 
persisterende infectie veroorzaken Normaal resulteert 
replicatie van deze virussen in celdood Een persiste­
rende infectie is mogelijk het gevolg van een verande­
ring in virusreplicatie Het proces van virusreplicatie 
wordt nog altijd met goed begrepen Het in dit proef­
schrift beschreven onderzoek is verricht om meer inzicht 
te krijgen in het moleculaire mechanisme van replicatie 
van coxsackievirussen 
Enterovirussen zijn kleine cytolytische virussen die 
een enkelstrengs RNA molecuul als drager van hun 
genetische informatie bezitten Het virale RNA is van 
positieve polariteit, hetgeen betekent dat het in de cel 
van de gastheer wordt gebruikt als boodschapper RNA 
voor de productie van virale eiwitten Infectie van een 
cel start met binding aan een specifieke receptor op de 
buitenkant van de cel Na opname van het virus in de cel 
wordt het RNA vrijgemaakt uit zijn eiwitmantel en via 
een cap-onafhankelijk mechanisme getransleerd in een 
groot polyproteine Dit polyproteine wordt door drie 
viraal gecodeerde proteases (2A, 3C en 3CD) geknipt tot 
de verschillende functionele eiwitten Hiertoe behoren 
de vier structurele capside eiwitten en de tien niet-struc-
turele eiwitten, zeven eindproducten (2A, 2B, 2C, ЗА, 
3B, 3C en 3D) en drie khevingsintermediairen (2BC, 
ЗАВ en 3CD) De replicatie van het virale plus-streng 
RNA start met de synthese van een complementaire 
min-streng RNA, die vervolgens dient als matrijs voor 
de synthese van een groot aantal plus-streng RNA mole­
culen De plus-streng RNA synthese vindt plaats in het 
replicatiecomplex, een gespecialiseerde structuur die 
bestaat uit het RNA en de virale replicatie eiwitten, en 
die wordt omgeven door een groot aantal membraanvesi-
cles Deze vesicles zijn afkomstig van het endoplas­
matisch reticulum (ER) en hun vorming wordt door het 
virus, waarschijnlijk door eiwit 2BC, geïnduceerd De 
nieuw gevormde plus-streng RNA moleculen worden 
vervolgens ingepakt in de capside eiwitten om nieuwe 
virussen te vormen Voor een efficient verloop van de 
hierboven beschreven processen induceert het virus een 
aantal veranderingen in biochemische functies en morfo-
logische structuren van de cel De belangrijkste verande-
ringen zijn remming van de gastheertranscriptie en gast-
heertranslatie, herstructurering van intracellulaire mem-
branen, remming van de eiwitsecretie, en verhoging van 
de permeabihteit van de plasmamembraan De geneti-
sche organisatie van het enterovirale RNA genoom en de 
mogelijke functies van de met-structurele eiwitten in 
RNA replicatie en modificatie van gastheer functies en 
structuren zijn samengevat in hoofdstuk 1 
In dit proefschrift is de structuur en functie onder-
zocht van het met-structurele eiwit 2B, een klein eiwit 
dat voorkomt aan de buitenkant van de membraan vesi-
cles waarop de plus-streng RNA synthese plaatsvindt 
STRUCTUUR VAN EIWIT 2B 
Om meer inzicht te verkrijgen in de structuur van 
eiwit 2B werd eerst een uitgebreide computeranalyse 
uitgevoerd De aminozuurvolgorde van 2B vertoonde 
geen enkele overeenkomst met cellulaire eiwitten Ana-
lyse van de hydropathie toonde aan dat het 2B eiwit 
twee hydrofobe domeinen bezit Beide domeinen bleken 
geconserveerd te zijn en ook in de 2B eiwitten van ande-
re enterovirussen voor te komen Een van deze domei-
nen vertoonde een hoog hydrofoob moment en bleek 
potentieel in staat om een kationische amfipathische o-
helix (een amfipathische helix met positief geladen 
aminozuren in zijn hydrofiele deel) te vormen De mate 
van hydrofobiciteit van het andere domein (dat verder 
zal worden aangeduid als "het hydrofobe domein") bleek 
typisch te zijn voor multimere transmembraanhelices 
In hoofdstuk 2 is een moleculair genetische analyse 
toegepast om na te gaan welke rol het hydrofobe domein 
speelt m de structuur en functie van het 2B eiwit Hier-
voor werden verschillende mutaties aangebracht in een 
cDNA kloon van Coxsackie B3 virus (CBV3) Van de 
cDNAs werd RNA afgeschreven en getransfecteerd in 
cellen om de effecten van de mutaties op de virusgroei te 
bestuderen Daarnaast werden de effecten van de muta-
ties op de replicatie van het virale RNA en de synthese 
en processing van het polyproteine onderzocht Uit de 
resultaten blijkt dat de hydrofobe eigenschappen van dit 
domein vereist zijn voor een functie van het 2B eiwit in 
de replicatie van het virale RNA en de virusgroei, maar 
niet voor de synthese en klieving van het polyproteine 
ben genetische analyse van de voorspelde kationi-
sche amfipathische α-helix in CBV3 eiwit 2B is beschre­
ven in hoofdstuk 3 Zowel de amfipathie als het kationi­
sche karakter van de helix bleken vereist te zijn voor de 
replicatie van het virale RNA en de virusgroei Deze 
resultaten ondersteunen het idee dat een kanonische 
amfipathische α-helix gevormd wordt en dat deze struc­
tuur vereist is voor een functie van het 2B eiwit in de 
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replicatie ал het virale RNA. 
De structurele vereisten van 2B voor zijn functie(s) 
in RNA replicatie werden verder onderzocht door het 
maken van chimere CBV3 cDNAs (hoofdstuk 6). In 
deze chimeren werd het complete 2B eiwit, of bepaalde 
structurele elementen daarvan, vervangen door het cor­
responderende segment van poliovirus eiwit 2B, een 
eiwit dat dezelfde structuur en functies bezit als CBV3 
2B, maar dat aanzienlijk verschilt in zijn aminozuur 
volgorde. CBV3 chimeren die het poliovirus 2B eiwit 
bezaten bleken niet in staat tot RNA replicatie. Dit sug­
gereert dat een seqentie-specifieke interactie tussen 2B 
en een ander viraal eiwit vereist ¡s voor dit proces. Van 
de hybride eiwitten bleek alleen het eiwit dat bestond uit 
het amino-terminale een-derde van poliovirus 2B en de 
rest van CBV3 2B functioneel te zijn in RNA replicatie 
en virusgroei. Hieruit volgt dat het domein dat verant-
woordelijk is voor de interactie met het andere virale 
eiwit waarschijnlijk gelegen is in het carboxy-terminale 
twee-derde van 2B. Hybride 2B eiwitten die of de amfi-
pathische helix of het hydrofobe domein van poliovirus 
2B bevatten bleken niet functioneel in RNA replicatie. 
Dit wijst erop dat deze twee domeinen mogelijk een 
directe interactie met elkaar aangaan. 
FUNCTIES VAN EIWIT 2B 
Om meer inzicht te krijgen in de functie van 2B 
werd het eiwit individueel tot expressie gebracht in COS 
cellen. In hoofdstuk 4 worden twee functies van het 2B 
eiwit beschreven. De expressie van eiwit 2B bleek te 
leiden tot (i) een verhoogde permeabiliteit van de plas-
mamembraan voor hygromycine B, een translatierem-
mer die normaal niet in staat is om de membraan te 
passeren, en (ii) een remming van de eiwitsecretie, het-
geen bleek uit de verstoorde secretie van een reporter 
eiwit dat in dezelfde cellen tot expressie werd gebracht. 
De rol van het hydrofobe domein en de amfipathische 
helix in deze functies werd onderzocht door de expressie 
van 2B eiwitten die mutaties in deze domeinen bevatten. 
Uit de resultaten bleek dat beide domeinen een belang-
rijke rol spelen bij het verhogen van de membraan-
permeabiliteit en het remmen van de eiwitsecretie. Som-
mige mutante 2B eiwitten bleken wel in staat om de 
permeabiliteit van de plasmamembraan te verhogen 
maar niet om de eiwitsecretie te remmen. Dit suggereert 
dat beide activiteiten mogelijk onafhankelijke functies 
van 2B zijn, in plaats van dat één van beide effecten het 
gevolg is van de ander. 
In hoofdstuk S is beschreven dat mutante virussen 
die minder 2B en 2C produceren, als gevolg van muta-
ties in de 2B/2C knipplaats, niet in staat zijn tot een 
volledige remming van de cap-afhankelijke eiwitsynthe-
se van de gastheer. Daarnaast bleken deze virussen ook 
een defect te vertonen in het verhogen van de permeabi-
liteit van de plasmamembraan, waarschijnlijk als gevolg 
van de verminderde hoeveelheid 2B eiwit. Dat deze 
mutante virussen niet in staat waren om de gastheer-
translatie te remmen ondersteunt de hypothese dat de 
klieving door het virale eiwit 2A van de eukaryotische 
initiatiefactor 4F, een onderdeel van het cap-bindende 
complex dat een rol speelt bij de cap-afhankelijke trans-
latie van cellulaire boodschapper RNAs, niet voldoende 
is voor de complete remming van de gastheertranslatie 
en dat hiervoor een tweede proces vereist is. Dat deze 
mutante virussen ook niet of nauwelijks in staat bleken 
om de permeabiliteit van de plasma membraan te verho-
gen suggereert dat een verhoging van de membraanper-
meabiliteit door 2B, en de veranderingen in intracellulair 
ionisch milieu die daarvan het gevolg zijn, vereist zijn 
voor een volledige remming van de gastheertranslatie. 
De eigenschap van het 2B eiwit om de permeabiliteit 
van membranen te veranderen en zijn localisatie op de 
membraan vesicles die van het ER afkomstig zijn, sug-
gereerden dat 2B mogelijk calcium vrijmaakt uit het ER, 
de belangrijkste intracellulaire opslagplaats van calcium. 
In hoofdstuk 7 wordt aangetoond dat gedurende een 
CBV3 infectie de calcium concentratie in het cytosol 
stijgt a.g.v de influx van extracellular calcium, en dat de 
calcium opslagplaatsen in het ER worden leeggemaakt. 
De individuele expressie van het 2B eiwit bleek inder-
daad voldoende te zijn om deze effecten te veroorzaken. 
Zowel de kationische amfipathische n-helix als het 
hydrofobe domein bleken hierbij een rol te spelen. 
Electronenmicroscopische studies toonden aan dat het 
2B eiwit waarschijnlijk niet alleen voorkomt op mem-
branen van het ER maar ook op de plasmamembraan. 
Tevens werd gevonden dat een virus met een mutant 2B 
eiwit een defect vertoonde in het vrijmaken van nieuwe 
virussen. Deze gegevens ondersteunen het idee dat 2B 
de permeabiliteit van zowel de ER membraan als de 
plasmamembraan verhoogt, en dat dit leidt tot de efflux 
van calcium uit het ER, een verstoring van de ionische 
gradiënten die door de plasma membraan in stand wor-
den gehouden, en, uiteindelijk, het vrijkomen van nieuw 
gevormde virussen. 
STRUCTUUR-FUNCTIE RELATIE 
In hoofdstukken 4 en 7 is aangetoond dat een katio-
nische amfipathische helix vereist is voor de eigenschap 
van 2B om membranen permeabel te maken. De aanwe-
zigheid van kationische amfipathische helix motieven is 
karakteristiek voor lytische peptiden, kleine peptiden die 
de permeabiliteit en structuur van membranen verstoren. 
Analoog aan de werking van deze peptiden zijn er twee 
modellen mogelijk voor de verhoging van de mem-
braanpermeabiliteit door 2B. Volgens het eerste model 
ligt de amfipathische helix evenwijdig aan de membraan 
en maakt hij de fosfolipiden in het membraan beter 
toegankelijk voor afbraak door fosfolipases. Het tweede 
model veronderstelt dat de amfipathische helices betrok-
ken zijn bij de vorming van porieën. Zulke porieën kun-
nen gevormd worden door multimeren van 2B die de 
hydrofiele delen van de helices naar elkaar richten en de 
hydrofobe delen naar de lipiden van de membraan. 
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Twee argumenten suggereren dat het onwaarschijn-
lijk is dat de amfipathische helix alleen verantwoordelijk 
is voor het verhogen van de membraanpermeabiliteit 
(d.i. het eerste model). Allereerst bleek deze activiteit 
gevoelig voor mutaties in het hydrofobe domein (hoofd-
stukken 4 en 7). Daarnaast bleek dat de amfipathische 
helix niet kon worden uitgewisseld met een structureel 
nauw verwante amfipathische helix (hoofdstuk 6). Een 
mogelijke verklaring hiervoor is dat zowel de amfipathi-
sche helix en het hydrofobe domein betrokken zijn bij de 
vorming van porieën in de membraan. Een hypothetisch 
structuurmodel van multimeren van 2B die zo'n porie 
vormen door de hydrofiele delen van de amfipathische 
α-helix naar elkaar te richten is weergegeven in hoofd­
stuk 8. 
CONCLUSIE 
De resultaten van dit proefschrift geven inzicht in de 
structuur en functie van het 2B eiwit. 2B is een multi­
functioneel eiwit dat betrokken lijkt te zijn bij (i) de 
replicatie van het virale RNA, (ii) de remming van de 
gastheertranslatie, (iii) de remming van de eiwitsecretie, 
en (iv) het vrijmaken van nieuw gevormde virussen. 
Deze activiteiten lijken het gevolg te zijn van de eigen­
schap van 2B om de permeabiliteit van cellulaire mem­
branen te verhogen, waarschijnlijk door het vormen van 
porieën in de membraan, hetgeen resulteert in (i) de 
efflux van calcium uit het ER, (ii) een verstoring van de 
ionische gradiënten die door de plasma membraan in 
stand worden gehouden, en, uiteindelijk, (iii) het ont-
staan van de membraan lesies waardoor nieuw gevorm-
de virussen de cel kunnen verlaten. De rol van eiwit 2B 
in de replicatie van het virale RNA is mogelijk verbon-
den met zijn eigenschap om calcium vrij te maken uit het 
ER. Deze eigenschap zou een rol kunnen spelen in de 
inductie van de membraanvesicles waarop de plus-streng 
RNA synthese plaats vindt door eiwit 2BC, aangezien is 
aangetoond dat een efflux van calcium kan leiden tot de 
afsnoering van vesicles van het ER. 
Op basis van zijn structurele en functionele eigen-
schappen kan het 2B eiwit worden ingedeeld in de fami-
lie van de viroporines, viruseiwitten die de plasma mem-
braan permeabel maken om nieuw gevormde virussen 
uit de cel vrij te maken. Het 2B eiwit is het eerste 
geïdentificeerde viroporine van een cytolytisch virus 
zonder envelop. 
De vindingen zoals die in dit proefschrift beschreven 
staan geven een beter inzicht in het proces van virus-
replicatie en in de veranderingen in cellulaire functies en 
structuren die plaatsvinden tijdens dit proces. Hopelijk 
zal dit een bijdrage kunnen leveren tot een beter begrip 
van het mogelijke verband tussen veranderingen in 
virusreplicatie en het ontstaan van coxsackievirus-
geassocieerde chronische aandoeningen bij de mens. 
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